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Biologische beschikbaarheid en impact van folaten aanwezig in genetisch gewijzigde 
rijst 
Het basisidee achter de ontwikkeling van een genetisch gewijzigde rijstvariant met een sterk 
verhoogde folaatconcentratie is te vinden in de beperkte mogelijkheid om voldoende folaten 
op te nemen uit het dieet in afgelegen agrarische regio’s. Omwille van de relatie tussen een 
tekort aan folaten en het voorkomen van neuraalbuisdefecten, die in ernst variëren van een 
lichte rugpijn tot een niet levensvatbare foetus, is een folaatrijk dieet aangewezen. Eén 
mogelijkheid om de folaatstatus te verhogen is door synthetisch foliumzuur te verwerken in 
alledaagse voedingswaren zoals ontbijtgranen en brood. Dergelijke geïndustrialiseerde 
technieken zijn echter niet beschikbaar in afgelegen regio’s. Folaatrijst kan echter lokaal 
verbouwd worden en kan in deze regio’s als een belangrijke bron van folaten in de voeding 
fungeren. 
Echter, aangezien folaatrijst een genetisch gewijzigde rijstvariant is, is het noodzakelijk om 
wetenschappelijk onderbouwd bewijs voor te leggen dat deze rijstvariant inderdaad een 
waardevolle bron van folaten is. Dit aangezien enkele genetisch gewijzigde voedingsmiddelen 
recent bekritiseerd werden omwille van hun beperkte bijdrage tot de totale vitamine- of 
mineraalinname.  
Er werd voor een dierenproef gekozen omwille van wettelijke verplichtingen en omdat dit een 
strikte controle van de studieparameters mogelijk maakt. Gezien de complexiteit van het 
folaatmetabolisme en de verdeling in het lichaam, werd voor een langdurige studie gekozen. 
Tijdens deze studie werden het folaatgehalte in het bloed, andere folaatgerelateerde klinische 
parameters en de algemene gezondheid van de dieren periodiek bekeken. Om de resultaten te 
kunnen evalueren werden de dieren opgesplitst in verschillende groepen die ofwel geen 
folaten, een beetje folaten uit ‘normale’ rijst, een grotere hoeveelheid foliumzuur uit 
gefortifieerde rijst of natuurlijke folaten uit folaatrijst of een grote hoeveelheid foliumzuur 
kregen. 
Om het biologisch effect van de verschillende diëten op het folaatgehalte in het bloed 
zichtbaar te maken, werd een analysemethode ontwikkeld om de hoeveelheid folaten te 
bepalen in 2 bloedfracties, namelijk in plasma en rode bloedcellen. Aangezien de term folaten 
enkele chemisch verschillende moleculen omvat die in zeer lage concentraties voorkomen, 
werd gebruik gemaakt van vloeistofchromatografie gekoppeld aan massaspectrometrie. Deze 
methode is in staat om de verschillende folaten van elkaar te onderscheiden en de concentratie 
individueel te bepalen.  
Tevens werd een specifieke analysemethode ontwikkeld voor de bepaling van individuele 
folaten in knaagdiervoeders om de mogelijke invloed van folaten aanwezig in het gebruikte 
knaagdiervoeder uit te sluiten. 
Bovendien werd de invloed van het folaatgehalte in de bloedbaan op de werking van het 
immuunsysteem onderzocht. Dit gebeurde door het uitvoeren van een studie naar de invloed 
van het gehalte van individuele folaten op de deling van witte bloedcellen.   
Samenvatting - Summary 
4 
 
Biological availability and efficacy of folates from bioengineered rice 
The basic concept of folate rice is to develop a means for rural areas to combat folate 
deficiency. Folate deficiency is of concern given the relation between folate status and birth 
defects, ranging in severity from mild back ache to stillbirth, due to a malformation of the 
neural tube. While western populations benefit from diverse and nutrient rich diets, even these 
populations are at risk for folate deficiency. One method to alleviate the health burden 
associated with folate deficiency is to add synthetic folic acid to commonly consumed food 
items such as breakfast cereals or bread. However, remote, mostly rural communities, do not 
have free access to folic acid fortification. As such, a rice variety with a high natural folate 
content that could be grown locally may serve to achieve an adequate folate status. 
However, since folate rice is a genetically engineered rice variety, public and governmental 
acceptance depends on scientific evidence that the folates contained within these rice grains 
are released into the bloodstream when consumed. This is because some genetically 
engineered food items have been criticized as a result of their limited influence on nutrient 
status. It is therefore of paramount importance to evaluate the impact of folate rice 
consumption on folate status. 
Given the need for strict control of nutrient intake and regulatory constraints, a rodent feeding 
trial was devised to evaluate the efficacy of folate rice as a dietary folate source. Due to the 
complexity of folate metabolism and body distribution, a long term study was performed 
including regular evaluation of folate status, folate related clinical parameters and general 
health. These results were compared between groups receiving no folate, a small amount of 
folate present in ‘normal’ rice, a larger amount of folate in either folate rice or folic acid 
fortified rice or ample folate as an optimal scenario. 
To quantify the biological outcome of folate rice consumption, an analytical method was 
developed to measure the amount of folates in 2 separate blood fractions, i.e. plasma and red 
blood cells. Given the low concentrations in which folates are present, a sensitive method 
using liquid chromatography coupled to tandem mass spectrometry was used. Since the term 
folate signifies several different molecules with different chemical and biological properties, 
the developed method required the measurement of individual folate species. 
Also, to exclude the influence of folates which might be present in the rodent diets used 
during the rodent trial, a separate method was developed to determine the folate concentration 
in the rodent diets used. 
Due to the necessity of folates for DNA-synthesis in white blood cells, the influence of folate 
concentration and speciation on the functioning of the immune system was investigated as 
well. 
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I.1. What are folates? 
Within the water soluble vitamins, the group of folates, also known as vitamin B9, is essential 
for the maintenance of adequate methylation potential in an individual and is involved in the 
synthesis of purines and pyrimidines.(Shane 2010) 
 
Figure I.1: Chemical structure and typical MS/MS fragmentation (indicated by broken lines) of a number 
of relevant folates (A) and chemical structure of MeFox, the metabolically inactive degradation product of 
5MeTHF (B) 
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Folates consist of three distinct parts: a pterin moiety with a varying oxidation state, a para-
aminobenzoic acid (pABA) molecule and a tail of repeating glutamic acid molecules bound at 
the γ-position. Based on the latter, mono-, oligo- and polyglutamates can be differentiated. As 
shown in Figure I.1, different functional groups may be bound at either or both the 5 and 10 
position.(De Brouwer et al. 2007) Folates can be present in 3 oxidation states, i.e. a fully 
oxidized form, known as folic acid (FA), a fully reduced form, known as tetrahydrofolate 
(THF), and an intermediate form, known as dihydrofolate (DHF). Stability of folates depends 
on both the oxidation state and the substitution with a methyl- or formyl group at the 5 and/or 
10-position. Folate polyglutamylation is an important factor for both intracellular folate 
retention and enzyme binding.(Osborne et al. 1993) FA is the fully oxidized synthetic form, 
commonly used in food fortification. It is, however, 5-methyltetrahydrofolate (5MeTHF) that 
is the predominant species in both natural food items and in clinical samples. 
I.2. Folates: biological accessibility and availability 
While plants and microorganisms are able to form folates de novo from pterin, p-
aminobenzoic acid and glutamate, most vertebrates, including humans, lack the enzymes 
necessary to perform folate synthesis. As a result, folates are essential vitamins and food 
items rich in folates should be an integral part of the human diet to assure an adequate folate 
intake.(Klipstein and Samloff 1966; Hoffbrand et al. 1971) 
Prior to the release in the systemic circulation, the absorption of folates from food items 
requires a multistep process which involves several enzyme systems to transport the 
molecules through membranes and change the oxidative state and substitution.(Shane 2010) 
While the term bioavailability may be used to describe different processes, in this thesis, the 
term bioavailability is used to indicate the fraction of a compound which is released in the 
gastro-intestinal (GI) tract, transferred to the systemic circulation and takes part in a 
metabolism. The term bioaccessibility only includes the release of the compound prior to 
absorption by the bowel epithelium. Biological efficacy describes the ability of a compound 
to induce a certain effect. 
2.1. Release of folates from food items 
Food items are chewed, mixed with saliva and swallowed, releasing a food bolus into the 
esophagus. Saliva contains an amylase and lipase activity and therefore marks the start of the 
digestion of the food matrix into smaller components. Upon passage through the stomach 
proteases and hydrochloric acid are released to turn the food bolus into a semifluid substance 
called chyme which is released into the small intestine.(Pedersen et al. 2002) 
In the small intestine folate polyglutamates present in the food item are cut to folate 
monoglutamates by the glutamate carboxypeptidase II-enzyme (GCPII), a γ-glutamyl 
hydrolase enzyme (GGH), present in the brush border of the bowel mucosa. This is important 
since only folate monoglutamates can be transported across the membrane by folate carrier 
proteins.(Chandler et al. 1986) 
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Several factors influence the accessibility of folates from dietary food sources. The effect of 
fats, acids and fibers on the absorption of folates in the bowel has been investigated, as has the 
structure of the food item. In general, acidic food items such as orange juice seem to reduce 
the activity of the GCPII-enzyme, thereby reducing the bioaccessibility of folate 
polyglutamates. Also, folates can remain trapped within the plant cells.(Ball 2005; Gregory 
3
rd
 2001) 
2.2. Absorption in the small intestine 
The reduced folate carrier (RFC) and the proton coupled folate transporter (PCFT) are known 
folate carriers.(Chandler et al. 1986) The latter of both transporters is most active at an acidic 
pH and is ubiquitously present in the small intestine. It has a similar affinity for both reduced 
folates and FA (binding affinity 0.5 to 0.8 µM at pH 5.5).(Shane 2010) The RFC-protein is 
largely inactive at acidic pH (< 6.5). As such, it is unlikely to be a major transporter due to the 
low pH, i.e. ±6, in the small intestine.(Shane 2010) 
Oxidized folates, such as folic acid, are reduced to DHF and further to THF by the DHF 
reductase (DHFR) enzyme in the epithelial cells of the small intestine. These reduced folates 
can then be methylated to 5MeTHF and either released into the portal circulation (i.e. the 
circulation system between the intestines and the liver) or stored as 5-methyltetrahydro-
pteroylpolyglutamates. These can be deconjugated by the GGH enzyme and are ultimately 
released into the portal circulation.(Shane 2010; Visentin et al. 2014) This process is 
schematically depicted in Figure I.2. 
 
Figure I.2: Schematic representation of the intestinal absorption of folates (Shane 2010; Visentin et al. 
2014) DHFR: dihydrofolate reductase; FPGS: folylpolyglutamate synthase; GCP II: γ-carboxypeptidase 
II; GGH: γ-glutamylhydrolase; PCFT: proton-coupled folate transporter; RFC: reduced folate carrier. 
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2.3. Folate absorption in the large intestine 
Apart from dietary intake, folates produced by the microflora in the bowel provide a minimal 
source of folate which is absorbed into the circulatory system. This can account for up to 5% 
of the average folate requirement for a healthy adult.(Aufreiter et al. 2009) As such, it is clear 
that the bowel microflora is not capable of maintaining an adequate folate status. However, 
under normal conditions, the folate intake can never be zero. 
2.4. Portal circulation and the liver 
Folates absorbed through the lumen of the small intestine are transported to the liver where 
they are either transported to the systemic circulation or undergo what is called an 
enterohepatic recirculation. Here, the folates are released into the bile and are excreted 
through the gall bladder back into the small intestine. These folates are then reabsorbed by the 
lumen carrier enzymes and return to the portal circulation. This cycle repeats itself until the 
concentration of folates near the carrier proteins is too low for effective transport across the 
membrane to occur.(Visentin et al. 2014) 
2.5. Systemic circulation and storage pools 
When folates are released into the systemic circulation by the liver, a portion is captured by 
folate carrier proteins freely circulating in the plasma fraction of the blood. Most specific is 
the folate binding protein (FBP). Other carriers are less specific, such as serum albumin. 
However, as this protein forms a significantly larger fraction of the total amount of protein 
present, it is capable of retaining far greater amounts of folate. The retention of folates by 
carrier proteins is of great importance to prevent the renal excretion of this vitamin.(Shane 
2010) 
Unlike in the small intestine, the RFC is responsible for the uptake of folates from plasma into 
the cytoplasm of the cells. It has, however, a significantly lower affinity (Kt= 3 µM) for the 
reduced folates than for FA (Kt= 200 µM).(Matherly and Goldman 2003) 
While folates take part in key metabolic processes, body storage of folates is limited. Clifford 
et al. investigated the distribution of folates in rats fed various levels of FA. In this study, the 
liver was found to contain the largest folate storage pool, with 26% of total body folate in case 
of prolonged (25 days) zero folate intake, to 44% of total body folate in case of ample folate 
intake. This indicates that the liver is capable of releasing folates in case of periodic low folate 
intake. The kidneys (5-6%), testes (2-1%), lungs (0.2-0.4%), spleen (0.1-0.3%) and heart (0.1-
0.2%) contain smaller fractions of the total body folate pool. Red blood cells (RBCs) also 
serve as a folate storage pool, with 8 (limited folate intake) to 3% (ample folate intake) of 
total body folate. While the absolute concentration in the RBCs rose, it was not possible to 
match the speed of the rise in the liver, likely due to the average lifespan of the RBCs of 
approximately 90 days. Distributing folate across the body, plasma also serves as a readily 
available storage pool, containing 0.03 to 0.3% of the total body folate. The GI tract can be 
seen as a folate storage pool since the bowel microflora contains approximately 3% of the 
total body folate.(Clifford et al. 1990) 
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I.3. Folates: key players in human health 
3.1. Intracellular metabolism 
In human cells, folates take part in two different metabolic cycles, as depicted in Figure I.3. In 
the methylation cycle, the methyl group of 5MeTHF is transferred via vitamin B12 
(cobalamin) to homocysteine, resulting in the formation of THF and methionine. Methionine 
is then activated by addition of an adenosyl group to S-adenosylmethionine. The latter is 
involved in many different metabolic processes, including methylation of lipids and DNA and 
the formation of DOPA and myelin, the insulating material of neural tissue.(Blom and 
Smulders 2011) In these processes, S-adenosylhomocysteine is formed, which can either be 
converted to pyruvate or accumulate in tissue. Given the role of vitamin B12 as a cofactor for 
the methionine synthase enzyme, deficiency for this vitamin will result in an accumulation of 
5MeTHF and homocysteine, the impairment of methylation processes and eventually neural 
damage. 
 
Figure I.3: Cytosolic folate metabolism; 5,10CH+THF, 5,10-methenylTHF; 5,10CH2THF, 5,10methyleneTHF; 
cSHMT, cytoplasmic serine hydroxymethyltransferase; DHFR, dihydrofolate reductase; FA, folic acid; 5FiTHF, 
5-formiminoTHF; 10FoFA, 10-formylFA; 5FoTHF, 5-formylTHF; 10FoTHF, 10-formylTHF; FTCT, glycine 
formiminotransferase/ formimidoyltetrahydrofolate cyclodeaminase and glutamate formiminotransferase/ 
formimidoyltetrahydrofolate cyclodeaminase; FTHFS, 10-formyltetrahydrofolate synthetase; hmTHF, 4α-
hydroxy-5-methylTHF; MeFox, pyrazino-s-triazine derivative of hmTHF; 5MeTHF, 5-methylTHF; MS, vitamin 
B12 dependent methionine synthase; MTHFC, methenyltetrahydrofolate cyclohydrolase; MTHFD, 
methenyltetrahydrofolate dehydrogenase; MTHFR, methylenetetrahydrofolate reductase; SAHH, S-adenosyl-L-
homocysteine hydrolase; SMAT, methionine adenosyltransferase; THF, tetrahydrofolate; TS, thymidylate 
synthase. (based on: Scott 1999; Stover 2010) 
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Disruption of the methylation cycle as a result of a vitamin B12 and/or folate deficiency is 
clinically measured as an elevated plasma homocysteine concentration, known as 
hyperhomocysteinemia. This is associated with an increased risk for cardiovascular diseases 
(CVD).(Ueland et al. 2000; Blom and Smulders 2011) Supplementation with folates is the 
method of choice to treat hyperhomocysteinemia. However, folate supplementation may 
promote cell proliferation and inflammation, which are crucial processes in atherosclerotic 
plaque formation and would therefore lessen the effects of a decrease in homocysteine 
concentrations.(Blom and Smulders 2011) Hyperhomocysteinemia has also been associated 
with an increased risk for neural diseases including dementia and Alzheimer’s 
disease.(Reynolds 2006) Best established is undoubtedly the profound influence of the folate 
status on the prevalence of neural tube defects (NTDs). During early pregnancy, a low folate 
status can lead to failure of the neural tube to close in the developing fetus, resulting -
depending on the severity- in disability or death.(Iyer and Tomar 2009) 
Secondly, 5,10-methylenetetrahydrofolate (5,10CH2THF) and 10-formyltetrahydrofolate 
(10FoTHF) take part in the de novo synthesis of pyrimidines and purines, respectively. 
Especially the methylation of uracil to thymidine is strongly influenced by the folate status. 
Folate deficiency has for instance been implicated in uracil incorporation in DNA, leading to 
chromosomal damage.(Blount et al. 1997) Severe folate deficiency also inhibits cell 
replication because it results in an inability to synthesize new DNA. This leads to the presence 
of enlarged RBCs in the bloodstream, called megaloblastic anemia. The presence of these 
enlarged cells is also used as an indicator for vitamin B12 deficiency. This deficiency leads to 
a halted folate cycle with accumulation of 5MeTHF. The use of FA as a folate supplement is 
problematic in this respect, since the presence of FA in the bloodstream leads to a bypass of 
the methionine synthase enzyme. Although this allows DNA replication to be maintained, 
alleviating megaloblastic anemia, the formation of methionine is still blocked, potentially 
leading to neural damage. (Molloy 2010) 
In cells, folates accumulate as polyglutamate derivatives, which are active in cellular 
metabolism.(Osborne et al. 1993) The folylpolyglutamate synthase (FPGS) activity is 
reported to be the highest in liver, while activity appears to be negligible in muscular tissue 
and mature blood cells.(Moran and Colman 1984) However, in RBCs folates are nearly 
completely present in the polyglutamate form.(van Haandel et al. 2012; Kiekens et al. 2015a) 
Although methods do exist for distinguishing individual folate polyglutamate species (Wang 
et al. 2010), the lack of pure reference standards limits the use of these methods for true 
quantitative folate determination in clinical matrices. 
3.2. Folate status 
Folate deficiency has received interest from a medical point-of-view since Minot and Murphy 
found, in 1923, that consumption of large amounts of liver cured pernicious anemia and since 
Lucy Wills’ discovery, in 1931, of a factor in yeast that corrected macrocytic anemia during 
pregnancy. In the 1930’s and 40’s, this factor, now known to be folate, was isolated from 
spinach, receiving its name from the Latin word for leaf: folium.(Hoffbrand and Weir 2001) 
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Since then, folate deficiency and related health issues have been intensely studied. While 
several anemias and neural tube defects can be directly linked to an inadequate folate status, 
direct proof of the role of folate in cardiovascular diseases, neural disorders and cancer 
remains elusive.(Stover 2004)  
In 2012, the World Health Organization (WHO) released an updated guideline on the use of 
folate concentrations in serum (or plasma) and red blood cells (RBCs) to assess the folate 
status in different populations. Such an assessment is useful to monitor trends in folate status 
and to evaluate the impact of public health interventions.(WHO 2012) A quantitative value 
for an adequate folate status is not easily determined since this depends on the metabolic 
indicator used to define the cut-off value. Since the 1970’s the prevalence of macrocytic 
anemia, a hematological indicator of folate deficiency, was used to categorize patients with 
various blood folate concentrations. While patients with serum or plasma folate 
concentrations below 6.8, between 6.8 and 13.4, between 13.5 and 45.3, or above 45.3 nM 
were respectively categorized as deficient, possibly deficient, normal and elevated, only a cut-
off value of 226.5 nM in RBCs was used to indicate folate deficiency.(WHO 1972; WHO 
1975) In 2005, the elevation of plasma homocysteine concentrations was chosen as a marker 
for folate deficiency, based on National Health and Nutrition Examination Survey (NHANES) 
III data. This population survey investigated the effect of dietary intake on folate status, 
related clinical parameters and health outcomes. The cut-off levels indicating folate 
deficiency (i.e. the folate concentrations below which homocysteine concentrations started to 
rise) were set at 10 and 340 nM for serum (plasma) and RBCs, respectively.(Selhub et al. 
2008; de Benoist 2008; Pfeiffer et al. 2012) As folate requirements are increased during 
pregnancy and lactation, a 2015 WHO guideline for women of reproductive age recommends 
in this population a RBC folate concentration above 906 nM to achieve the greatest reduction 
of NTD risk.(WHO 2015) In Belgium, a daily folate intake of 200 to 300 µg/day is 
recommended for adults. For women that want to get pregnant, a daily intake of 400 µg/day is 
advised to limit the risk for NTDs (Table I.1).(Hoge Gezondheidsraad 2015) 
Age Sex DFE [µg/day] 
0-6 months male/female 50 
7-12 months male/female 50 
1-3 years male/female 100 
4-6 years male/female 130 
7-10 years male/female 150 
11-14 years male/female 180 
15-18 years male/female 200 
adults (19-70 years) male/female 200-300 
> 70 years male/female 200 
pregnancy female 400 
breastfeeding female 300 
Table I.1: recommended daily folate intake in Belgium.(Hoge Gezondheidsraad 2015) Dietary folate equivalents 
(DFE) = µg folate present in food + (1,7 x µg folic acid supplements)  
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I.4. Folate fortification 
Based on a review of folate status in populations worldwide by McLean et al., it is clear that 
in some countries folate deficiency is a serious health risk. However, the situation is not 
uniform over different social groups within a single country, as can be seen in Figure I.4. In 
the United Kingdom for instance, folate deficiency is nearly absent in the adult population 
while more than 10% of the elderly appear to be folate deficient. This may be a result of 
differences in food or supplement consumption.(McLean et al. 2008) It is therefore difficult 
for a governing body to introduce one size fits all guidelines to achieve an adequate folate 
status in the entire population. 
 
Figure I.4: Prevalence of folate deficiency; figure obtained from McLean et 
al., 2008 Food and Nutrition Bulletin, 29,2: S38-S51; Inf: infant; PreS: 
preschool children; SAC: school aged children; L/PW: lactating or 
pregnant women; Eld: elderly persons. 
 
4.1. Traditional fortification strategies 
Some countries have instituted mandatory fortification programs to add synthetic folic acid to 
commonly consumed food items such as wheat flour. The countries implementing folic acid 
fortification in June 2010 can be found in Figure I.5. For instance, the United States started a 
fortification program in 1998 by adding 140 µg of FA per 100 g of enriched cereal grain 
product, which has been estimated to provide 100 – 200 µg of FA per day to women of 
childbearing age.(Crider et al. 2011)  
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Figure I.5: Fortification programs; figure obtained from Centers for Disease Control and Prevention 2010. 
Although EUROCAT, a European network of population-based registries for the 
epidemiologic surveillance of congenital anomalies, advised the introduction of mandatory 
folate fortification in 2009 (de Walle and Abramsky 2009), the European Food Safety 
Authority (EFSA) is more reluctant. While the working group that EFSA instigated 
acknowledges the beneficial relation between folate intake and a reduction of NTD risk, it 
questions the efficacy of the advised 400 µg/day dietary supplementation for women who 
may become pregnant and the effect of FA supplementation on the prevalence of 
cancer.(EFSA 2009) 
While folates are essential vitamins, an excessive intake of FA, which is the synthetic folate 
species commonly used as a supplement, leads to the unnatural presence of this folate species 
in the bloodstream. This has been associated with an increased risk of colorectal cancer and it 
may delay the detection of a vitamin B12 deficiency, leading to neural damage.(Crider et al. 
2011) It is in this respect that the EFSA concluded that not enough data are available 
concerning the long term effects of FA supplementation to justify the implementation of a 
mandatory fortification of food items.(EFSA 2009) However, given the globalized market, 
some products are available in European shops which are fortified with FA. These items, such 
as breakfast cereals, essentially provide an additional source of FA without the knowledge of 
the consumer. 
The introduction of FA fortification of cereal grain products in the USA in 1998 succeeded in 
increasing the folate status at a population level. This intervention doubled the plasma folate 
concentrations and increased the red blood cell folate concentrations by more than 50%. 
While these results clearly show that FA fortification is able to increase the folate status of a 
population, the desired folate levels, leading to a significant impact on the prevalence of 
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neural tube defects, were not reached.(Dietrich et al. 2005) However, when evaluating the 
effectiveness of FA fortification in the USA, the prevalence of neural tube defects decreased 
by 20 to 30%. This vastly exceeded the 2 to 10% decline expected to result from fortification 
at the 140 µg/100g level. A possible reason for this discrepancy is the higher than expected 
intake due to a large consumption of products containing fortified wheat flour.(Grosse et al. 
2005) 
4.2. Biofortification 
An alternative strategy for folate fortification is the introduction of ‘natural’ folates in 
common food items. These mostly reduced folates resemble natural food items rich in folates 
and are unlikely to negatively impact colorectal cancer and do not bypass the methylation 
cycle. Therefore they do not influence the detection of vitamin B12 deficiency by the 
appearance of megaloblasts (immature large RBCs) in the bloodstream.(Crider et al. 2011)  
While careful selection and consumption of food items rich in folates can increase individual 
folate intake, it requires a change to the daily diet. As such, focus has shifted towards 
alteration of recipes and bioprocessing including fermentation. Wine, beer, bread and yoghurt 
are examples of food items in which the folate content can be increased by using folate rich 
cereal strains or fermentation by yeast and lactic acid producing bacteria. Although this can 
double or quadruple the folate content within these food items (Jägerstad et al. 2005), the 
absolute increase in folate content remains rather limited. 
Another alternative is biofortification of food items, which aims at increasing the nutrient 
content by modifying the expression of metabolic enzymes. This can be performed either by 
increasing the expression level of naturally present metabolic enzymes or by introducing 
exogenous enzymes which are, for instance, not feedback regulated. This approach aims at 
eliminating bottlenecks in folate synthesis and ultimately, at increasing the folate 
concentration within the edible part of the plant. This technique has now been applied to 
increase folate concentrations in tomato fruit (Díaz de la Garza et al. 2007), wheat and rice 
seeds.(Storozhenko et al. 2007, Blancquaert et al. 2015, Piironen et al. 2008) 
Food fortification by genetic engineering is not limited to folate. To alleviate β-carotene 
deficiencies, a rice variety was developed, by introducing phytoene synthase and lycopene β-
cyclase genes from Narcissus pseudonarcissus and later from maize, which contains up to 37 
µg/g of β-carotene.(Beyer et al. 2002 and Paine et al. 2004) This rice variety, also referred to 
as golden rice, is undoubtedly the best known example of a vitamin-fortified crop, and has 
already been shown to be an effective source of β-carotene in a human study.(Tang et al. 
2009) 
4.3. Folate rice, a recipe for success? 
Already well over a decade, since 2004, a consortium within Ghent University, composed of 
the Laboratory of Functional Plant Biology, the Laboratory of Toxicology and the Department 
of Agricultural Economics, focuses on a better understanding of the folate pathway and the 
improvement of the folate content in crops. The role of the different partners lies in i) the 
generation of transgenic crops and their molecular and functional characterization, ii) the set-
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up and deployment of validated analytical strategies to steer and evaluate the success of the 
genetic modifications, as well as to monitor the biological effectiveness in vivo, and iii) the 
evaluation of economic aspects, amongst which the market potential and cost effectiveness. 
Being the most consumed staple crop worldwide, rice was an obvious candidate for 
biofortification. The metabolically engineered rice or folate rice was created in the 
Nipponbare variety. Several genetic interventions have been evaluated during the 
development of this rice variety. Arabidopsis GTP cyclohydrolase I (GTPCHI) and 
aminodeoxychorismate synthase (ADCS) genes from Arabidopsis thaliana were introduced 
into the rice genome as part of a co-expression strategy. The enzymes encoded by these genes 
are responsible for an increased formation of the deoxyneopterin and p-aminobenzoic acid 
building blocks, respectively (see Figure I.1), which, upon combination, yield a vast increase 
in folates, especially 5MeTHF.(Storozhenko et al. 2007 and Blancquaert et al. 2014) 
The success of this concerted effort can be deduced from the generation of rice lines with a 
>100-fold increased folate levels in seeds (Storozhenko et al., 2007) and from the scientific 
output, with currently 4 publications in Nature Biotechnology, in addition to many other 
publications in high-ranking (top 5-10%) peer-reviewed journals. One of the prime aims of 
this consortium is to offer a feasible alternative for folate supplementation, by developing 
folate rice as a valuable source of dietary folate, to decrease the prevalence of neural tube 
defects in severely affected regions. 
I.5. Analytical determination of folates 
The analytical determination of a folate concentration in a matrix largely depends on the 
objective of the method (i.e. measurement of total folate concentration versus the 
concentration measurement of individual folate species) and the properties of the matrix. Also 
the appropriate procedure for method validation is largely matrix dependent and no folate 
specific procedures are available. Given the substantial difference between food and clinical 
matrices, the determination of folates in these distinct matrices is discussed separately below. 
For both, the classical guidelines for bioanalytical method validation, as issued by EMA 
and/or FDA, can be followed.(European Medicines Agency 2011, U.S. Department of Health 
and Human Services 2015) More particularly, these guidelines state that the following should 
be included in a bioanalytical method validation: evaluation of selectivity, carry-over, limit of 
detection (LOD) and lower limit of quantification (LLOQ), linearity, precision (including 
incurred sample reanalysis), accuracy, matrix effect, recovery and stability. 
5.1. Plants and foodstuffs 
While most data on folate concentrations in food databases originate from microbiologic 
assays (MA) which only allow to determine the total folate content, hyphenated liquid 
chromatography – (tandem) mass spectrometry (LC-MS(/MS)) based methods have been 
developed to determine individual folate species. To determine the success of fortification of 
a food item with FA, methods using ultraviolet detection are used most.(Strandler et al. 2015) 
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Although the same analytical techniques are used to determine folates in various food items, 
the sample preparation needed varies widely between different food matrices. For starchy 
matrices like rice, a classical trienzyme treatment is performed, including i) α-amylase to 
hydrolyze starch into sugars and thereby facilitate the extraction of the folates from the 
matrix; ii) a protease to reduce or eliminate the protein binding of folates and iii) a folate 
conjugase to cut the folate polyglutamates to monoglutamates which can be assayed.(Tamura 
et al. 1997) This classical trienzyme treatment is adapted and optimized for each individual 
matrix. For the determination of folates in spinach for instance, the use of α-amylase is not 
strictly necessary since green leafy vegetables contain little starch. 
Since the start of the folate biofortification project at Ghent University, the measurement of 
folates in food items has been important to steer the genetic modifications. Starting with a 
method in which the folates were oxidized and cleaved into pABA to determine the total 
folate content using LC coupled to fluorescence detection, experience was gained within the 
lab and the research group in the field of food folate determination. (Zhang et al. 2003) Later, 
the introduction of MS detection increased method sensitivity and allowed to determine 
individual folate species. At this time, the trienzyme treatment was developed and used for 
folate determination in rice.(De Brouwer et al. 2008) The introduction of ultra-high pressure 
liquid chromatography (UHPLC) led to a further decrease of the minimal quantifiable 
concentrations and allowed a higher sample throughput. (De Brouwer et al. 2010) 
Lately, research into the determination of food folates has been oriented towards folate 
profiling in potatoes, in the context of an effort to increase the folate content also in this 
common staple crop (Van Daele et al. 2014) and a better understanding of the biofortification 
process by developing ways to quantitatively determine pterins, one of the folate building 
blocks.(Van Daele et al. 2016) Additionally, a method was developed for folate determination 
in rodent diets (Kiekens et al. 2015b; described in Chapter IV) as part of the bioavailability 
study described in Chapter VI.(Kiekens et al. 2015c) Also within the context of the 
determination of folates in food matrices, we developed a method for the determination of 
folate polyglutamates, as described in Chapter VIII. 
5.2. Clinical matrices 
Over the past decade, the quantitation of clinical folate status using a MA or a protein binding 
assay (PBA) has been evaluated based on emerging LC-MS/MS assays. These 
chromatographic assays provide an orthogonal determination strategy, focusing on exact 
chemical determination rather than relying on biological activity or on recognition by a folate 
binding protein. While the MA currently remains the gold standard method for the 
determination of biologically active folates, the PBA is susceptible to differences between the 
folate species present in the sample and the species, mostly FA, used for assay 
calibration.(Pfeiffer et al. 2004)  
The accuracy and precision obtained using LC-MS/MS and the possibility to quantify 
individual folate species has led to an increased interest to implement this technology for 
clinical folate research. The implementation of this technique in a routine clinical laboratory 
will depend on the automation of the sample preparation steps and the availability of LC-
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MS/MS equipment. PBAs are currently used most to determine the amount of folates in 
patient samples, primarily owing to the ease of these assays and their automatability. 
Comparability of analytical results with other labs is not a major concern for the clinician 
since the use of reference intervals specific for the assay will suffice to distinguish folate 
deficient patients from those with an adequate folate status. For scientific research purposes, 
however, method comparability is necessary to compare findings with those obtained by other 
research groups. As such, for research purposes, as well as for any other scenario where 
insight into the distinct folate species is required, LC-MS/MS is the method of choice.   
Whole blood or RBC folate analysis is not yet regularly performed for the determination of 
long term folate status over the lifetime of the RBCs, i.e. approximately 3 months. As this 
measurement is not influenced by recent folate intake, contrary to plasma or serum folate 
determination, a fasting period is not strictly necessary. 
Since plasma and RBC folate concentrations provide complementary information, 
respectively for acute and chronic folate deficiency, we opted to develop a method that could 
analyze both, using a very comparable sample treatment procedure to limit the use of 
resources, i.e. time, equipment and reagents. If routine clinical analysis using an LC-MS/MS 
assay is considered, such an approach should make a cost effective procedure achievable. 
Given the importance of folate determination in plasma and RBCs for the bioavailability trial 
discussed in Chapter VI and the novelty of this method within the research group, this subject 
is discussed further in Chapter III. 
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Main objective 
Already well over a decade, a consortium within Ghent University, composed of the 
Laboratory of Functional Plant Biology, the Laboratory of Toxicology and the Department of 
Agricultural Economics, focuses on a better understanding of the folate pathway and the 
improvement of the folate content in crops. The role of the different partners lies in i) the 
generation of transgenic crops and their molecular and functional characterization, ii) the set-
up and deployment of validated analytical strategies to steer and evaluate the success of the 
genetic modifications, as well as to monitor the biological effectiveness in vivo, and iii) the 
evaluation of economic aspects, amongst which the market potential and cost effectiveness. 
The success of this concerted effort can e.g. be deduced from the generation of rice lines with 
a >100-fold increased folate levels in seeds (Storozhenko et al., 2007). 
One of the prime aims of the consortium is to offer a feasible alternative for folate 
supplementation, by developing folate rice as a valuable source of dietary folate, to decrease 
the prevalence of neural tube defects in severely affected regions. However, although the 
ability to increase folate concentrations in rice grains represents a major achievement, this 
does not necessarily imply that this rice variety is a good source of dietary folate. To 
investigate whether the folates in folate rice are bio-accessible and bio-effective, an in vivo 
trial was necessary. As a means to quantify the effect of folate supplementation by providing 
folate rice, a method for the quantification of folates in plasma and red blood cells was 
necessary. Also, to prevent that folates present in rodent diet could influence the obtained 
results, a method had to be developed to determine the folate content in these diets. 
Hence, within this thesis, we developed and validated the analytical tools that were required 
to evaluate the biological effect of folate rice consumption. This was done within the context 
of the available knowledge concerning folate determination in food matrices using liquid-
chromatography with ultraviolet and fluorescence detection in spinach (Zhang et al. 2003) 
and liquid chromatography with mass spectrometric detection in rice (De Brouwer et al. 
2010), Arabidopsis thaliana and green leafy vegetables and alongside the development of 
methods for the LC-MS/MS-based determination of folates in potato (Van Daele et al. 2014) 
and pterins (Van Daele et al. 2016) in plant matrices.  
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Outline and detailed objectives 
In Chapter I, which gave a general background on folates, their relevance for human health, 
fortification and the relevance of folate determination, it was already pointed out that the 
analytical determination of a folate concentration can be looked at from different viewpoints. 
While in some instances knowledge about the (order of magnitude of a) total folate 
concentration might suffice, in other instances quantitative measurement of individual folate 
species is required. In the work described in this thesis, quantitative determination of 
individual folate species was required for both rodent feed (to be used in a rodent feeding 
trial), as for plasma and red blood cells (sampled following the rodent feeding trial). In the 
context of the latter, Chapter III points out the distinct points of attention that need to be 
taken into account when embarking upon folate determination in a clinical context, with 
special attention to LC-MS/MS. 
Consumption of wild type rice only results in a very limited folate intake. Therefore, in the 
rodent feeding trial we performed, the determination of folates in rodent diets required limits 
of detection and quantitation that were as low as possible to assure that only rice was the 
source of folate in the diet. A wide applicability of this method was also necessary since 
different ingredients may require different sample treatments, e.g. a protease treatment to 
disrupt the protein binding of folates. Using this method, the details of which can be found in 
Chapter IV, a truly folate free diet was selected for use during the rodent feeding trial. 
Since folate concentrations in plasma and red blood cells are key to study the outcome during 
the bioavailability trial, the development of a method for folate quantification in plasma and 
red blood cells, described in Chapter V, was required. While the LC-MS/MS settings were 
available from the determination of folates in food matrices, a new sample treatment 
procedure had to be developed. Given that both plasma (or serum) and red blood cell folates 
provide complementary information on folate status, the development of a method to measure 
the folate concentration in both matrices allows to obtain the maximal amount of information 
from a rodent feeding trial. A factor complicating the development of such a method was the 
limited amount of whole blood that can be obtained from periodic sampling of rats. Therefore, 
a method was required that allowed to determine both plasma and red blood cell folates from 
only one 300 µl aliquot of whole blood instead of two separate samples commonly used in 
literature. Ease of use was also a priority during method development since large amounts of 
samples would need to be processed periodically during the feeding trial. To treat plasma and 
RBC samples simultaneously, a sample treatment procedure including similar steps for both 
plasma and red blood cell folate analysis was required. Also, the implementation of a 96-well 
solid-phase extraction format was to be evaluated to increase sample throughput. 
The evaluation of the biological availability and efficacy of folate rice consumption was 
performed by means of a rodent feeding study, described in Chapter VI. In contrast to 
traditional studies, only recording the pharmacokinetics of a bolus folate intake, a long-term 
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study was to devised to evaluate the efficacy of folate rice consumption on both short and 
long term. However, this required that an appropriate feeding strategy was set up and a 
feasible manner for sample collection was found. Using the rodent feeding trial, we aimed at 
answering the simple question “is folate rice able to maintain an adequate folate status when it 
is part of the diet?” To have a benchmark for the folate levels measured, we compared the 
results obtained from rats that were fed folate rice with those obtained from rats fed wild type 
or folic acid fortified rice. Also a positive and negative control group, receiving respectively 
ample and no folate in their diet, were included. Over a period of three months, we not only 
determined the folate levels in plasma and RBCs, but also the homocysteine levels  
(a metabolic marker linked to folate status), as well as other parameters. 
As we could observe in our rodent trial, folates are essential for maintaining a healthy status, 
by their effects on many physiological processes. One of the systems whose function is 
influenced by folate status is the immune system. Although this was evaluated to a limited 
extent by others (Courtemanche et al. 2004), the question remained whether a low folate 
status leads to low intracellular folate concentrations and whether or not the folate species 
used during in vitro incubation influences the intracellular folate concentrations and the 
proliferation rate of the cells. As we had the analytical tools at hand, we decided to investigate 
this relationship, and added either folic acid or 5-methyltetrahydrofolate to in vitro cultures of 
peripheral blood mononuclear cells, at different concentration levels. To determine the 
intracellular folate concentration, an adapted method for folate determination in lymphocyte 
lysates and the development of procedures for cell incubation and the selective isolation of 
different cell types were required. How these experiments were performed can be found in 
Chapter VII. 
For biofortified rice, information on the degree of folate polyglutamylation was available via 
the determination of folate monoglutamates and total folates (monoglutamates + 
polyglutamates). However, the measurement of individual folate polyglutamate species was to 
be investigated since this would provide further information on the folate polyglutamate chain 
length in rice samples with varying gene expression. Since not all folate polyglutamate 
standards were commercially available, the in house synthesis of the necessary reference 
materials was required to achieve a method able to quantify all relevant polyglutamate 
species. The analytical method and procedure for the preparation of the reference standards 
can be found in Chapter VIII. 
In Chapter IX, the broader international context, relevance and future perspectives are 
described. A comparison between folate rice and traditional folate fortification strategies and 
the prevalence of folate deficiency can be found in this chapter. 
A summary of the project described in this thesis, as well as the conclusions, can be found in 
Chapter X.  
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III.1. Abstract 
Public interest for the influence of nutrient status on human health has increased over the past 
decade. Adequate nutrient intake serves a preventive function in relation to human health. By 
implementing fortification programs, an adjustment to adequate nutrient levels has been 
attempted in several countries. One such fortification strategy consists of the addition of folic 
acid to cereal grain products. However, a folic acid supplementation strategy on an industrial 
scale is not always possible, especially for remote communities.  
The limited dietary diversity in remote regions increases the risk for folate deficiency, 
increasing the need for an effective supplementation strategy. As such, the development of a 
rice variety with a substantially increased folate content could, when cultured locally, provide 
a source of additional folate intake in these regions. This rice species, known as folate rice, 
should be capable of significantly decreasing the burden of folate related illnesses on these 
communities. However, given that folate rice is genetically modified and contains higher than 
normal folate concentrations, the efficacy of folate rice as a source of dietary folate was to be 
verified.  
Evaluation of further developments in folate research depends on the availability of analytical 
methods capable of determining the different folate species in both food matrices and clinical 
samples. Substantial improvement in method comparability is key to evaluate the effect of 
different folate fortification strategies. Also, the use of short term studies to evaluate folate 
bioavailability proves problematic given the differences in absorption of different folate 
species. As such, the measurement of red blood cell folate concentrations can provide 
additional information on folate status over greater lengths of time. This approach could be 
beneficial for population based studies since this measurement is less influenced by recent 
folate intake. 
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III.2. Clinical folate analysis 
Since the introduction of liquid chromatography tandem-mass spectrometry (LC-MS/MS) in 
clinical laboratories, folate analysis has shifted from microbiological (MA) or protein binding 
assays (PBA) to chromatographic methods. Although several chromatographic methods have 
been developed, validated and published, interlaboratory variability limits the comparability 
of the results. In this chapter we provide an overview of the strategies for sample treatment 
and analysis and how these may influence the final analytical result. Analyte stability in 
function of pH and temperature, measures taken to counter oxidation and the use of 
anticoagulants will all be covered. Also the use of certified reference materials is discussed. 
2.1. Introduction 
The multitude of sample treatment procedures preceding LC-MS/MS hinders comparability of 
clinical and scientific data on one hand and of international reference ranges on the other. 
This has proven to be the Achilles’ heel of current folate determinations in clinical samples. 
In this chapter, we focus on the use of LC-MS/MS for folate quantitation in blood, plasma and 
serum, by providing a non-exhaustive overview of methods improving the existing analytical 
procedures since the year 2000. We will focus especially on strategies and trends that have 
emerged during the last 5 to 10 years to address the issues concerning folate quantitation in 
these matrices. 
2.2. Reference range 
Based on the homocysteine response, the cut-off levels indicating folate deficiency (i.e. the 
folate concentrations below which homocysteine concentrations started to rise) were set at 10 
and 340 nM for serum (plasma) and RBCs, respectively. Since these reference concentrations 
encompass different folate species, the quantification of these different species requires the 
utmost sensitivity for the less abundant folate species. Under normal conditions, total folate 
concentrations are unlikely to exceed 100 and 1000 nM for plasma and RBCs respectively 
(see also Chapter V and VI).(Selhub et al. 2008; de Benoist 2008; Pfeiffer et al. 2010) 
2.3. Genetic variation vs. folate status 
Given the complexity of the folate pathway and the numerous enzymes involved, it is not 
surprising that several genetic polymorphisms in the human genome have been identified that 
play a role in the folate biosynthesis pathway. The most studied is a single nucleotide 
polymorphism (SNP) in the methylene tetrahydrofolate reductase gene at nucleotide 677 
(MTHFR 677 C>T), changing an alanine to a valine, which results in a thermolabile and less 
efficient enzyme.(Huang et al. 2008) This SNP is very rare in the African population but 
approximately 10% of Caucasians and 20% of Asians are homozygous for this functional 
polymorphism.(Franco et al. 1998) While intracellular folates in 677C homozygotes and in 
heterozygotes mostly consist of 5MeTHF, 677T homozygotes have a much lower fraction of 
5MeTHF and are at higher risk for low folate status, leading to hyperhomocysteinemia and 
related CVDs, and posing a higher risk for NTDs. 
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Additionally, other polymorphisms have been described that may influence folate status. As 
described by DeVos et al., SNPs can occur in nearly all metabolically relevant enzymes such 
as FPGS and GGH enzymes governing polyglutamylation, MTHFR, as well as methionine 
synthetase (5MeTHF-homocysteine methyltransferase, MTR). Also the folate carriers PCFT 
and RFC, as well as the folate hydrolase 1 (FOLH1) present in the brush border, are subject to 
polymorphic variation.(DeVos et al. 2008) However, not all polymorphisms have a 
significant influence on the intracellular folate profile and/or concentration. Ideally, a method 
for the analysis of folates in plasma or serum and RBCs should be able to discern differences 
in concentrations of all relevant folate species, including the degree of polyglutamylation. 
2.4. The measurement of folates in clinical matrices  
The relevant folate species are 5MeTHF, THF, DHF, 5,10CH2THF and 10FoTHF.(Bailey and 
Gregory 3rd 1999) However, as a result of folate instability and interconversions, not all of 
these can be quantified directly. Moreover, oxidation of 5MeTHF leads to the formation of 4’-
hydroxy-5-methyltetrahydrofolate (hmTHF), which structurally rearranges to a pyrazino-s-
triazine derivative known as MeFox. This folate species is metabolically inactive. However, 
since it may be formed during sample treatment or storage and may interfere with 
determination of other folates, it is of interest to measure this compound as well when aiming 
at an accurate folate profiling of a sample.(Pfeiffer et al. 2015) 
Plasma or serum folate measurement is widely applied in clinical laboratories and, to this day, 
provides clinicians with an indication of the folate status. However, this method relies on an 
adequate (overnight) fasting period to assure that steady-state folate concentrations are 
measured, since only these correlate with folate stores elsewhere in the body. Absorption 
following ingestion of chemically pure 5MeTHF is rapid, with peak plasma concentrations 
readily occurring after one hour. Food 5MeTHF is absorbed more slowly, with peak plasma 
concentrations after only 2 hours. Following consumption of oxidized folate, i.e. FA, peak 
plasma concentrations are reached after only 3 hours because a reduction by DHFR is 
required prior to release in the portal circulation.(Konings et al. 2002)  
2.4.1. Sample preparation 
Samples for clinical folate analysis are typically obtained following venepuncture. Serum 
samples are more commonly used for folate analysis than plasma samples. 
Ethylenediaminetetraacetic acid (EDTA) is the most used anticoagulant to generate plasma as 
well as for whole blood folate analysis. An alternative sampling strategy, limiting the burden 
on the patient, is the collection of dried blood spots (DBS), obtained following a finger or heel 
prick.(Velghe et al. 2016) Already in 1999, O’Broin and Gunter reported on the use of a MA 
for screening the folate status in neonates in DBS.(O’Broin and Gunter 1999) Recently, Kopp 
and Rychlik published a stable isotope dilution assay using LC-MS/MS to determine 
5MeTHF in dried blood and serum spots.(Kopp and Rychlik 2015) Hereby, aliquots of blood, 
plasma or serum were spotted on paper pretreated with L-ascorbic acid (AA). The folates 
were extracted from 3 mm punches by sonication in a buffer containing 2-(N-morpholino)-
ethanesulfonic acid, Triton X-100 and dithiothreitol (DTT). To measure total folate, whole 
blood spot extracts were treated with rat serum and chicken pancreas GGH. Plasma folates 
could be determined from whole blood spots by first performing heat denaturation to abolish 
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endogenous GGH activity. These authors found that 5MeTHF could be determined at LOD’s 
of 1.5, 2.2 and 9.1 nM for serum, plasma and whole blood, respectively, and that spotted 
samples were stable for 11 days when kept desiccated at -20°C. During storage and 
extraction, the presence of labeled internal standards compensated for the degradation of the 
folates present. Pretreating the paper with AA did not provide adequate stabilization of THF, 
which consequently could not be quantified.(Kopp and Rychlik 2015) For longer storage, 
lower storage temperatures (-80°C) are required, as shown by Zimmerman et al.(Zimmerman 
et al. 2013) 
2.4.2. Anticoagulant vs sample stability 
Using a variety of analytical methods, Hannisdal et al. investigated the influence of 
anticoagulants on folate stability during storage at room temperature. Strikingly, these authors 
found a significant impact of EDTA-treatment on the stability of 5MeTHF. During the first 
hours of storage a significant oxidation of this folate to MeFox was observed. Given its 
biological inactivity, this compound is not measured using a MA. However, the total folate 
content (including MeFox), either measured via LC-MS/MS or gas chromatography mass 
spectrometry (GC-MS) analysis of pABA-glutamate(s), is not influenced by this oxidation 
reaction.(Hannisdal et al. 2009a) In a study investigating the stability of fat- and water-soluble 
vitamins during long term storage at -20°C, a similar pattern was observed for EDTA-plasma 
samples analyzed by a competitive binding assay. Based on the data obtained, storage was 
considered acceptable up to 6 months, provided that samples were kept at -20°C.(Ocké et al. 
1995) Serum samples as well as citrate or heparin treated plasma samples showed less 
oxidation and should therefore be preferred when long term storage is foreseen.(Hannisdal et 
al. 2009a) However, depending on the anticoagulant used, measured plasma folate 
concentrations may differ to a limited extent.(Fazili and Pfeiffer 2004) Also the folate 
concentration in erythrocytes was found to be influenced by the anticoagulant. O’Broin et al. 
found substantial losses of folate activity (assessed by MA) in the presence of EDTA during 
storage at room temperature, which were observed to a lesser extent in heparinized samples. 
While heparinization may improve sample stability upon storage, fresh heparinized samples 
readily had a slightly lower (3.61%) folate activity as compared to fresh EDTA-treated 
samples.(O’Broin et al. 1980) 
2.4.3. Stability during sample preparation 
Erythrocyte folate analysis is commonly performed by 10-fold dilution of whole blood with a 
1% AA solution in deionized water (pH=±3). The use of an antioxidant during cell lysis 
ensures immediate protection against oxidative damage of intracellular folates. Also when an 
alternative lysis procedure is performed, for instance using a selective ammonia based buffer 
(Kiekens et al. 2015; Chapter V), the addition of AA is required to protect the intracellular 
folates against degradation. However, the utilized procedure differs between labs and is 
mentioned as a possible source of variability between methods due to incomplete lysis. This 
was shown in a comparative study, in which lysis with a 1% AA solution without 
neutralization provided complete and reproducible lysis.(O’Broin and Kelleher 2001) 
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Addition of a thiol such as DTT or 2-mercaptoethanol is required to capture the formaldehyde 
released by degradation of AA at elevated temperature. This is relevant since free 
formaldehyde causes the methylation of THF to 5,10-methenyltetrahydrofolate 
(5,10CH
+
THF) and, as such, influences the measured folate distribution.(De Brouwer et al. 
2007) 
Though performed in a food matrix, Patring et al. investigated the effect of different reducing 
agents on the stability of folates during sample preparation. The addition of 2-
mercaptoethanol, DTT, 2,3-dimercapto-1-propanol and 2-thiobarbituric acid in combination 
with sodium ascorbate was evaluated for different experimental conditions. The choice of 
antioxidant had an effect on the measurement of THF following various sample treatment 
procedures including heat treatment, freeze-thawing and frozen storage. While 2,3-
dimercapto-1-propanol was most effective, these authors suggested to evaluate the stability of 
all folates for each specific sample treatment procedure, a suggestion we concur.(Patring et al. 
2005) 
Whole blood or RBC samples are commonly incubated at 37 °C for extended periods of time 
to deconjugate the folate polyglutamates present, enabling determination of total folate 
content. Since folates are relatively sensitive to elevated temperatures and oxidative stress, 
their stabilization during this step is critical. De Brouwer et al. investigated the influence of 
pH on folate recovery following 2 hours of incubation in a phosphate buffer with a pH 
ranging between 4 and 8.(De Brouwer et al. 2007) While most folates proved stable at the 
different pH levels, some degradation was observed for THF at acidic pH. Both DHF and 
5,10CH2THF are extremely sensitive to incubation at a pH lower than 8. Though Strandler et 
al. suggest the possible occurrence of 5,10CH2THF in living cells, this compound -being the 
active intermediary for enzymatic methylation of uridylate to thymidylate- has yet to be 
observed in clinical samples due to its limited stability.(Strandler et al. 2015) This property 
implies that 5,10CH2THF, as well as DHF, cannot be measured in RBC samples using the 
currently available methods.(De Brouwer et al. 2007; Strandler et al. 2015) Likewise, 
10FoTHF, a possible intermediary during the purine biosynthesis, cannot be detected when 
acidic conditions (e.g. a mobile phase with a pH<8) are employed, since it converts to 
5,10CH
+
THF.(De Brouwer et al. 2007) 
Akhtar et al. studied the influence of light on the stability of FA in aqueous solutions and 
found that a high pH, exceeding 10.0, was optimal to minimize degradation.(Akhtar et al. 
1999) However, since most sample treatment steps are performed at or below neutral pH, 
sample treatment is best performed under subdued light. 
2.4.4. Enzyme treatment 
Theoretically, no enzyme treatment is necessary for the analysis of folates in serum or plasma 
samples: while intracellular folate retention depends on polyglutamylation, only mono-
glutamates have been observed in plasma.(Shane 2010) This is owing to the presence of GGH 
in plasma, an exopeptidase that deconjugates any polyglutamate that would be released in 
plasma following cell lysis.(Galivan et al. 2000) 
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Large quantities of proteins capable of binding folates, most importantly FBP, are found in 
clinical samples, rendering folates unavailable for analysis. Total folate measurement requires 
release of these bound folates via protease treatment or via gentle acidification, since both the 
specific (FBP) and non-specific binding capacity is negligible below pH 4.(Kamen and 
Caston 1986) In folate binding assays, strong alkali in combination with reducing agents like 
DTT are used to denature all endogenous folate binding proteins.(Beggs et al. 1995) 
2.4.5. Microbiological assay 
The oldest, though still used, method for clinical folate analysis consists of the incubation of 
diluted serum with the bacterium Lactobacillus rhamnosus (formerly known as Lactobacillus 
casei). The growth rate of this bacterium, measured as optical density, can be correlated to the 
folate concentration in the cellular environment.(Hoffbrand et al. 1966; O’Broin et al. 1973) 
This method remains the benchmark for clinical folate analysis given its clear correlation with 
a biological outcome. Though originally developed to measure folates in serum samples 
(O’Broin et al. 1973), this method is also applied to whole blood lysates as a measure of RBC 
folates. In 2011 Pfeiffer et al. published the results of a sample exchange study between 3 
laboratories performing the MA.(Pfeiffer et al. 2011) The results were found to be 
significantly influenced by the bacterial strain used during the assay (chloramphenicol 
resistant ATCC 27773 vs. wild-type ATCC 7469) and even more by the folate species used to 
construct the calibration curve. FA, which is relatively stable and therefore relatively easy to 
manipulate, is predominantly used to calibrate the assay. However, bacterial growth is ±25% 
lower, and therefore analytical results ±25% higher, compared to calibration with 5MeTHF. 
Although calibration with 5MeTHF, the main folate species in clinical samples, likely 
resembles actual samples more closely, its limited stability complicates calibration. Last, it 
should be remarked that the presence of antibiotics -inhibiting bacterial growth- will 
negatively influence the results.(Shane 2011) 
2.4.6. Protein binding assay 
While the MA requires overnight to 2 days of incubation, the protein binding assay does not. 
This significantly speeds up the procedure, allowing compatibility with high-throughput 
systems readily available in clinical labs. Additionally, in contrast to the MA this assay is not 
influenced by the presence of antibiotics in the sample. The assay was originally performed as 
a competitive binding radiolabel assay using 
3
H-FA.(Archibald et al. 1972) More recent 
assays use ruthenium labeled FBP (Elecsys
®
 Folate III) or FBP coated paramagnetic 
microparticles (Abbott Architect Folate) in a competition reaction to measure folates in the 
sample. Following incubation of the sample with the respective FBP preparation, biotinylated 
FA and magnetic microparticle-bound streptavidin (Elecsys
®
 Folate III) or a FA – acridinium 
conjugate are added. The readout is based on chemiluminescence, the light emission being 
inversely proportional to the folate concentration in the sample. As such, high signal 
intensities are measured at low concentrations, improving sensitivity. While both are 
automated assays, a similar principle - with either colorimetric or chemiluminescent readout- 
can be applied off-line (e.g. in a 96-well format). In these assays, endogenous folates and a 
FA – horseradish peroxidase (HRP) conjugate compete for binding to immobilized FBP (e.g. 
VAST CLIA Microwells
®
 and VAST ELISA Microwells
®
 Folate Test System from 
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Monobind Inc. and AccuDiag™ Folate from Cortez Diagnostics).(Roche Diagnostics 
International 2014; Abbott Ireland 2010; Monobind Inc. 2015a; Monobind Inc. 2015b; 
Diagnostic Automation/ Cortez Diagnostics Inc. 2014) 
Following a comparison of 5 binding assays to the reference radiolabel assay, Owen and 
Roberts found that although comparable results were obtained for serum folate, results of 
RBC samples strongly varied between different methods. These authors suggested that the 
obtained results strongly depend on the lysis procedure, utilizing AA solutions with differing 
concentration or detergents such as saponin or Triton X-100.(Owen and Roberts 2003) 
Moreover, as protein binding assays rely on the selective binding of folates to FBP that is 
added in the assay, an optimized sample pretreatment step is necessary to release folates from 
endogenous FBP. Finally, it should also be noted that FBP has a different affinity towards 
distinct folate species, which may lead to a bias.(Dakshinamurti 1994)  
2.4.7. LC-MS/MS analysis 
Multiple chromatographic methods have been developed for the measurement of 5MeTHF 
and other folate species. The availability of LC-MS(/MS) equipment has fueled the 
development of higher-order assays to measure folates in both serum or plasma and RBCs. 
Below, we focus on the most recent developments for clinical folate analysis. For an in-depth 
overview of other methods, we refer to Pfeiffer et al.(Pfeiffer et al., 2010) 
GC-MS based methods rely on the cleavage of the 9-10 bond between the pterin and the 
pABA-Glu moiety, followed by derivatization.(Santhoshkumar et al. 1995) Though these 
methods allow for a total folate measurement, they do not allow for individual folate 
speciation and rely on a quantitative (i.e. complete and selective) folate cleavage. 
While most LC-MS/MS methods attempt to quantify the different folate species as they occur 
at the time of phlebotomy, some methods explicitly interconvert some folate species. By 
acidifying the final sample, both Wang et al. and van Haandel et al. determined 10FoTHF and 
5FoTHF as 5,10CH
+
THF.(Wang et al. 2010; van Haandel et al. 2012) While at a pH below 
10, almost instantaneous conversion of 10FoTHF to 5,10CH
+
THF will occur, it is possible to 
determine 5FoTHF and 5,10CH
+
THF separately (cfr. Fazili and Pfeiffer 2004, Smith et al. 
2006, De Brouwer et al. 2007, Kirsch et al. 2010, Fazili et al. 2013a, and Kiekens et al. 2015 
(Chapter V)). 
2.4.7.1. Sample Cleanup 
To limit the presence of matrix compounds and assure method selectivity, sample cleanup is 
performed prior to LC-MS/MS analysis. This can range from simple protein precipitation to 
combined affinity and solid phase extraction (SPE). As with any sample cleanup procedure, 
simplicity and robustness need to be balanced against the sensitivity and throughput that will 
eventually be required. 
While extensive sample treatment is often preferred to obtain purified extracts, some methods 
simply use protein precipitation with an organic solvent, like methanol or acetonitrile, 
followed by evaporation to dryness and reconstitution in mobile phase.(Garbis et al. 2001) 
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For serum or plasma, this approach seems feasible since these are relatively clean matrices. 
For RBCs, however, either SPE alone or SPE combined with affinity extraction is needed. 
Given its selectivity, FBP is ideally suited to extract folates from complex matrices. While 
FBP is now commercially available in purified form, it can also be obtained from bovine 
milk. For affinity extraction procedures, FBP is bound to agarose beads and stored 
refrigerated in the presence of sodium azide as a preservative.(Hart et al. 2002; Nelson et al. 
2004) Sample preparation is performed in a column configuration, with elution under acidic 
conditions since FBP shows little folate retention at a pH below 4. The fact that FBP does not 
have equal affinity for all folate species necessitates a substantial excess of binding sites to 
quantitatively retain all folates.(Dakshinamurti 1994) The number of samples which can be 
purified using one column is limited due to degradation of and irreversible binding to the 
protein. As such, there is a gradual decrease of binding capacity, which has to be controlled to 
avoid erroneous sample handling.(Nygren-Babol and Jägerstad 2012) 
Recently developed methods have shown the value of SPE. Especially for the analysis of 
numerous samples, SPE is preferred over FBP columns. For low-throughputs, manual 
column-format SPE can be used, while for higher throughputs, the different SPE steps can be 
automated and/or 96-well formats can be used.(Fazili et al. 2013a) Both reversed phase and 
ion exchange sorbents can be used to separate folates from matrix constituents, the former 
being used more frequently. Phenyl and octadecyl sorbents are most frequently used and 
elution is often performed using a small percentage of organic solvent, either methanol or 
acetonitrile, acidified to correspond to the mobile phase. Samples can be concentrated prior to 
injection by evaporation or by using a vacuum system, followed by reconstitution in the initial 
mobile phase or in another appropriate solvent.(Garbis et al. 2001; Hart et al. 2002; Pfeiffer et 
al. 2004; Nelson et al. 2004; Smith et al. 2006; Owens et al. 2007; Thorpe et al. 2007; 
Hannisdal et al. 2009b; Kirsch et al. 2010; Monch et al. 2010; Kirsch et al. 2012; Fazili and 
Pfeiffer 2013b; Kiekens et al. 2015 (Chapter V)) 
2.4.7.2. Chromatographic separation 
Both standard HPLC and UHPLC have been applied for the separation of folate species in 
clinical samples. Using traditional reversed phase columns, typically C8 or C18, folate species 
can relatively easily be separated. MeFox, despite being an oxidation product of 5MeTHF, is 
also worth measuring as it allows insight into possible oxidative stress the sample was subject 
to during e.g. sample storage or treatment. However, care should be taken to differentiate 
MeFox from its isobar 5FoTHF, which requires optimization of chromatography.(Fazili and 
Pfeiffer 2013b; Hannisdal et al. 2009a) Alternatively, when using MS/MS-based detection, it 
is possible to distinguish both folate species by selecting certain product ions (see 2.4.7.3), 
although maximal sensitivity may not be achieved this way.(Fazili and Pfeiffer 2013b)  
Separation is mostly achieved by applying gradient elution with acidic mobile phases 
containing either acetic or formic acid in ultrapure water and methanol, acetonitrile or a 
combination of both. The use of salt buffers is not common and mainly reserved for HILIC 
chromatography.(Garbis et al. 2001) In 2006, Patring et al. investigated the elution pattern of 
folates when varying the stationary phase and the mobile phase constituents. The ionization of 
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the α- (pKa= 3.1 - 3.5) and γ- (pKa= 4.6 - 4.8) carboxyl groups of the glutamate part of the 
folate molecule was found to influence the retention behavior. A pH<3 is needed to 
completely suppress the ionization of both carboxyl groups. At higher pH (>3), the retention 
of the folates decreases to a varying extent depending on the column chemistry. This also 
negatively impacts peak symmetry and peak width. This effect is also noticed when the 
amount of organic solvent at the time of injection is increased. High retention of folates was 
achieved on columns with either polar endcapping or with a high carbon content. When 
volatile modifiers are used, i.e. either acetic or formic acid, retention is generally increased 
while peak shape deteriorates, though this effect was most pronounced using polar endcapped 
columns.(Patring et al. 2006) As evidenced by column usage of the methods shown in Table 
III.1, it is hard to predict which column will work best, based on column characteristics. 
2.4.7.3. Detection methodology 
Both ultraviolet, fluorescence (Vahteristo et al. 1996; Ndaw et al. 2001) and electrochemical 
(Bagley and Selhub 2000) detection have been applied for folate analysis in food items. 
Reduced folates show strong fluorescence (290-295 nm→ 356 nm), making this type of 
detection highly efficient and specific for the detection of THF, 5MeTHF and 5FoTHF in 
food matrices and for quality control purposes. Typical methods using fluorescence detection 
for 5MeTHF in food items have an LOD of 20 to 40 fmol on column. (Vahteristo et al. 1996; 
Ndaw et al. 2001) Oxidized folates do not fluoresce but all folates can be detected using a UV 
detector (±280 nm), albeit at the expense of sensitivity, which drops with a factor 50 to 100 
compared to fluorescence detection.(Ndaw et al. 2001) With detection limits down to 0.2 to 
0.4 fmol on column, recent LC-MS methods for the determination of folates in plasma or 
serum are 50 to 100 times more sensitive than fluorescence detection. As such, the use of 
fluorescence detection for clinical folate analysis would be limited to the quantification of 
RBC or whole blood folates due to the higher folate concentration in these samples. UV and 
electrochemical detection are not able to match the sensitivity of fluorescence detection and 
cannot be used for clinical samples as they would require vast sample volumes.(Bagley and 
Selhub 2000) 
For clinical analyses, MS (and more particularly MS/MS) is most used as detection technique 
hyphenated with liquid chromatography. Folates, containing both alkaline (pterin moiety) and 
acidic (glutamate moiety) sites, can be positively and negatively charged in the pH range of 
mobile phases containing volatile modifiers such as acetic and formic acid. As such, MS 
systems can be operated both in positive and negative mode. Electrospray ionization (ESI) is 
most commonly used as an interface system to vaporize the mobile phase. To achieve high 
ionization efficiencies, a modifier (i.e. formic or acetic acid) is commonly used and is either 
included in the mobile phase (cfr. 2.4.7.2) or infused post column.(Owens et al. 2007) In 
general, folates show predominant single ionization in either negative or positive mode, with 
the latter being used most. However, double ionization can occur, though more in positive 
than in negative mode. As such, singly charged ions are typically used as Q1 ions (MW+1 or 
MW-1) during MS/MS-analysis. Generally, 2 fragment ions are monitored, as this allows to 
add the ion ratio as an extra identification criterion. In positive mode, the most abundant 
fragment ion, used as quantifier, generally consists of the ionized remainder (pterin-pABA
+●
), 
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following neutral loss of the glutamic acid
●
 moiety.(Smith et al. 2006; Patring and Jastrebova 
2007) 5,10CH
+
THF differs from the other folates in that the glutamate moiety is not split off 
due to the withdrawal of electrons from the nitrogen atom at the 10 position and the resulting 
influence on ion stabilization.(Smith et al. 2006) During fragmentation, the formyl groups 
bound to the nitrogen at the 5 or 10 position have a tendency to split off. This phenomenon, 
the expulsion of CO, does not influence the charge of the remaining ion and has little 
influence on the signal intensity of the ion which is monitored.(Freisleben et al. 2003) The 
second fragment ion is typically formed via cleavage of the bond between position 6 and 9 or 
9 and 10, yielding ions of 166 (representing the reduced pterin cation), 176 or 194 Da (the 
latter two resulting from loss of both Glu and pABA). For 5,10CH
+
THF, the second fragment 
ion that is typically followed is formed after the loss of glutamate-C=O.(De Brouwer et al. 
2008) The quantitative LC-MS/MS determination of 5FoTHF and MeFox is complicated by 
their identical molecular mass of 474 amu and the fact that both are predominantly 
fragmented to a fragment ion of 327 amu. Both compounds also have a tendency to coelute. 
Though baseline resolution is achievable, the less abundant ions of 284 and 299 amu, specific 
for MeFox and 5FoTHF, respectively, can be used as quantifiers.(Fazili and Pfeiffer 2013b) 
2.4.8. Method comparability 
Method comparability has remained a substantial issue hindering folate analysis because of 
the influence of several procedural aspects such as the use of calibrators, strains of micro-
organisms and antioxidants. To this day, the MA, despite its limitations, is still considered the 
gold standard for folate measurement. As such, the performance of alternative methods such 
as PBA and LC-MS/MS assays is measured against this MA.(Yetley et al. 2011) For serum or 
plasma, the total folate results obtained using the MA (calibrated with 5MeTHF) and LC-
MS/MS analysis were found to be in good agreement, although slightly higher concentrations 
were found with LC-MS/MS. Results obtained using a PBA (calibrated with FA) were much 
(i.e. close to 30%) lower than those of either the MA or LC-MS/MS assay. This is likely due 
to a lower recovery of certain folate species, amongst which 5MeTHF, in the PBA.(Fazili et 
al. 2007) As such, results depend on whether 5MeTHF or FA is used as a calibrator. (Fazili et 
al. 2007) For RBC folates, a good agreement was found between results obtained by MA and 
those obtained by LC-MS/MS, although here total folates determined by LC-MS/MS were 
10% lower than those scored by MA. Again, a substantial difference was seen between the 
results obtained by MA and PBA, the results in the latter being 45% lower. Importantly, this 
difference was genotype dependent, with as an underlying cause a differential recovery of 
different folate species.(Fazili et al. 2008) As such, the MA was maintained as reference 
method for whole blood or RBC folate measurement.(Yetley et al. 2011) 
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plasma/serum 
method year sample source Folate species monitored 
sample 
preparation 
LOD-range 
[nM] 
start volume [µl] 
(
+
whole blood) 
Garbis et al. 2001 plasma 5MeTHF, THF, FA, 5FoTHF PP-EV 0.04 - 0.43 2000 
Hart et al. 2002 plasma 5MeTHF PP-AE 0.2 5000 
Rychlik et al. 2003 plasma 5MeTHF PP-SPE 3.5 1000 
Kok et al. 2004 EDTA plasma 5MeTHF, FA PP-AE-SPE-EV 0.012, 0.05 2000 
Pfeiffer et al. 2004 serum 5MeTHF, 5FoTHF, FA SPE 0.05-0.13 275 
Nelson et al. 2004 
serum and citrate 
plasma 
5MeTHF 
PP-AE or AE-
SPE-EV 
0.07 (affinity) 
or 0.87 (SPE) 
500 
Huang et al. 2008 EDTA plasma 5MeTHF, 5,10CH
+
THF, THF, FA SPE-EV 1.5 300 
Liu et al. 2009 plasma 6S-5MeTHF, 6S-5FoTHF, 6R-5FoTHF PP-EV-SPE 54.41, 105.7* 200 
Hannisdal et al. 2009b serum 5MeTHF, FA, 5FoTHF, hmTHF (now known to be MeFox) PP-EV 0.07 - 0.52 60 
Mönch et al. 2010 EDTA plasma 5MeTHF, THF, FA, 5FoTHF, 10FoFA SPE 0.05 - 5 400 
Kirsch et al. 2010 serum 5MeTHF, 5,10CH
+
THF, THF, FA, 5FoTHF SPE-EV 0.09 - 0.9 250 
van Haandel et al. 2012 EDTA plasma 5MeTHF, 5,10CH
+
THF, THF, FA PP 0.1 - 0.5 50 
Fazili et al. 2013a serum 5MeTHF, 5,10CH
+
THF, THF, FA, 5FoTHF, MeFox SPE 0.06 - 0.31 150 
Kiekens et al. 2015 EDTA plasma 5MeTHF, 5,10CH
+
THF, THF, FA, 5FoTHF, 10FoFA PP-SPE 0.33-0.5 300
+
 
Zheng et al. 2015 plasma 5MeTHF, FA PP-EV 11.0, 0.56 500 
RBC 
method year sample source folate species monitored 
sample 
preparation 
LOD-range 
[nM] 
start volume [µl] 
Fazili and Pfeiffer 2004 EDTA whole blood 5MeTHF, 5,10CH
+
THF, THF, FA, 5FoTHF, 10FoFA SPE 0.05 - 2.5 100 
Smith et al. 2006 EDTA whole blood 
5MeTHF, 5,10CH
+
THF, 5,10CH2THF, DHF, THF, FA, 
5FoTHF, 10FoTHF 
PP-AE-SPE-EV 0.4 - 20* 100 
Huang et al. 2008 EDTA whole blood 5MeTHF, 5,10CH
+
THF, THF, FA SPE-EV 1.5 500 
Mönch et al. 2010 lyphilized RBCs 5MeTHF, THF, FA, 5FoTHF, 10FoFA SPE 4 - 54 100 
Kirsch et al. 2012 EDTA whole blood 5MeTHF, THF, FA, 5FoTHF, 10FoFA SPE-EV 0.12 - 0.40 200 
van Haandel et al. 2012 EDTA whole blood 5MeTHF, 5,10CH
+
THF, THF, FA PP 0.2 - 1.0 50 
Kiekens et al. 2015 EDTA whole blood 5MeTHF, 5,10CH
+
THF, THF, FA, 5FoTHF, 10FoFA PP-SPE 0.33-0.5 300 
Table III.1: Overview of recent LC-MS methods for folate measurement. *LLOQ as no LOD was reported; AE, affinity extraction using folate binding protein; EV, 
evaporation to dryness; LLOQ, lower limit of quantification; LOD, limit of detection; PP, protein precipitation; SPE, solid phase extraction.  
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2.4.8.1. Assay calibration 
One of the major issues complicating folate analysis is the comparability of analytical results 
between labs throughout the world. Therefore, correct calibration of an assay is of paramount 
importance to obtain correct results. 
Perhaps the most important part of an assay is its calibration using pure reference standards. 
These can be obtained from various sources, such as Merck Eprova (Schaffenhausen, 
Switzerland), Schircks Laboratories (Jona, Switzerland) or Sigma-Aldrich (Saint-Louis, MO, 
USA). As mentioned above, several authors have indicated that the calibrator choice can 
strongly influence analytical results.(Pfeiffer et al. 2004; Fazili et al. 2007) More specifically, 
owing to a difference in recovery for individual folate species, the protein-binding assay is not 
able to match the results of both an LC-MS/MS assay or MA. In LC-MS/MS, the actual panel 
of folates that is measured will determine the eventual total folate concentration, as the latter 
is derived from the sum of the individual folate species. On the other hand, the composition of 
the panel of folates that can be reliably quantified, depends on the availability of pure 
reference standards.  
While the use of MS allows to differentiate individual folate species, the technique does 
suffer from matrix-associated effects, including differences between individual samples 
influencing the measured signal. For this reason, isotopically labeled internal standards are 
commonly used for LC-MS/MS folate analyses, then named stable isotope dilution assays, to 
compensate for the influence of the matrix on recovery and ionization efficiency. For this 
purpose, isotopologues of the parent compounds are used in which either carbon or hydrogen 
atoms are replaced with 
13
C or 
2
H atoms. A mass difference of 4 to 5 atomic mass units (amu) 
ensures that the analyte and the IS can be monitored separately, given the presence of natural 
isotopologues in samples (up to +2 amu).(Freisleben et al. 2002) While deuterated ISs are 
easier to manufacture, deuterium ions from the IS and hydrogen atoms from the aqueous 
solvent can interchange, which impacts the isotopic purity of the IS and may influence the 
analytical result. Also, given their location at the outside edge of the molecule, deuteration 
can change the charge density of the molecule, thereby slightly influencing its retention 
time.(Stokvis et al. 2005) For this reason, 
13
C-labeled ISs are preferred over deuterium 
labeled ISs. Unfortunately, not every folate form has its own labeled IS commercially 
available. In that case, the nearest folate species in terms of stability and elution time is used 
as an IS. However, it should be evaluated on a case-by-case basis which IS is most 
appropriate for a specific folate. 
The limited stability of folates also requires careful storage of prepared calibrators and, if 
these are gravimetrically prepared, likewise careful storage of the powder form. Reduced 
folates are susceptible to oxidative degradation while some, like 5FoTHF, are very 
hygroscopic. Therefore, it is advised to verify the purity of the standard material as part of the 
preparation of stock solutions. This can be performed spectrophotometrically based on the 
molar extinction measured by Blakley.(Blakley 1969) In addition, it is worth bearing in mind 
that AA, commonly used to stabilize folates in solutions, absorbs light at the same 
wavelengths as folates, making the spectrophotometric verification of folate concentrations in 
the presence of this antioxidant impossible.(Karayannis et al. 1977) 
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2.4.8.2. Possible certified reference materials and the values measured 
Key to the evaluation of method performance is the use of reference materials with a known 
folate content. These are commercially available samples that allow the comparison of results 
obtained in different laboratories. Ideally, the concentration obtained should match, although 
for sensitive compounds, such as folates, this may be a tall order. 
To accurately assess the performance of an entire method, a certified reference material 
(CRM) should resemble a real sample as close as possible. The spiking of folates to samples 
can be problematic due to differences in protein binding and may lead to divergent extraction 
behavior. It is therefore preferred to mix different blood pools to obtain a certain folate 
concentration. However, this is not always possible due to the limited and unpredictable 
presence of non-5MeTHF-folates. 
Two WHO international standards are available for folates through The National Institute for 
Biological Standards and Control (NIBSC), one consisting of lyophilized serum (03/178) and 
the other of a lyophilized whole blood lysate (95/528). The NIBSC serum reference material 
has been assigned reference values for total folate, as well as for 5MeTHF, 5FoTHF and FA. 
The consensus concentrations were reached following the analysis of the standard material by 
24 laboratories in 7 different countries, published by Thorpe et al. in 2007.(Thorpe et al. 
2007) These included 19 protein binding assays, 3 MA and 2 LC-MS/MS assays. Though 
significant variability was observed between the results obtained using the different assays, 
this study showed the potential of such a reference material. When the reference standard 
03/178 for folates in serum was used to correct for the systematic error between the 
laboratories, significant gains in comparability were obtained.(Thorpe et al. 2007)  
Also NIST (National Institute of Standards and Technology, Gaithersburg, MD, USA) has 
issued a standard for folates in serum, the standard reference material (SRM) 1955.(Satterfield 
et al. 2006) To replace the SRM 1955 when stocks were depleted, a new standard reference 
material was prepared, i.e. the SRM 3949. This is a set of three serum samples, devised to 
contain, apart from 5MeTHF and FA, the minor folate species THF, 5FoTHF, MeFox and 
5,10CH
+
THF. Given the limited availability of analytical results, consensus concentrations for 
the different folate species using a variety of methods have not been reached yet.(Camara et 
al. 2015)  
For whole blood lysate (95/528), a consensus value was assigned following a study in which 
13 laboratories participated for a total of 34 assay results. Unfortunately, only MA and PBAs 
were used.(Thorpe et al. 2004) However, recently we published an LC-MS/MS method for 
the analysis of folates in RBC samples which includes data obtained using this reference 
material.(Kiekens et al. 2015; Chapter V) Table III.2 lists the consensus concentrations for the 
reference materials (serum and whole blood) for the different analytical techniques, where 
available. 
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 MA PBA LC-MS/MS 
 
matrix level 
total folate 
[nM] 
total folate 
[nM] 
FA    
[nM] 
5MeTHF 
[nM] 
5FoTHF 
[nM] 
sum 
[nM] 
NIST 
SRM 
1955 
serum 
I 5.6±1.2 4.5±0.4 0.49±0.17 4.26±0.25 1.3±0.4 6.0±0.4 
II 14±3 10±1 1.05±0.16 9.73±0.24 2.3±0.8 13±1 
III 44±11 25±3 1.07±0.24 37.1±1.4 3.6±1.3 41±2 
NIBSC 
03/178 
serum 
 
12.6±3.3 8.75-19.2
a
 0.74±0.47 9.75±1.1 1.59±0.13 12.1±3 
NIBSC 
95/528 
whole 
blood 
 
9.45-19.33
b
 6.75-16.68
b
 n.a. n.a. n.a. n.a. 
Table III.2: Consensus concentrations for NIST and NIBSC reference materials. Values obtained from 
Thorpe et al. a: for serum (Thorpe et al. 2007) and b: for whole blood (Thorpe et al. 2004); MA: 
microbiologic assay; PBA: protein-binding assay; n.a.: not available. 
III.3. Conclusion 
Despite the knowledge obtained following decades of research investigating the dietary 
sources and metabolism of folate, the analytical determination of these essential vitamins in 
clinical samples remains difficult. Due to the relative instability of folates in solution, care 
must be given during sample preparation to avoid conversions between folate species and 
their degradation. While there is increasing evidence that sample preparation factors may 
strongly impact analytical results, it remains difficult to find an optimal sample preparation 
procedure that allows the accurate measurement of folates in the original sample. 
Given the problematic storage stability of EDTA-anticoagulated samples, heparin or citrate 
may be preferred over EDTA to limit the degradation and interconversion during sample 
storage. While whole blood lysis using a diluted AA solution is commonly performed, small 
variations in the procedure can significantly influence the analytical outcome. The use of a 
thiol in combination with AA has proven to be required for the stabilization of THF in food 
samples. This approach may prove beneficial to stabilize this folate species in clinical samples 
as well. Higher order methods consisting of SPE followed by LC-MS/MS analysis are being 
implemented in some clinical labs to allow for a detailed evaluation of the folate status of an 
individual. However, given the problematic analytical calibration, a harmonization of folate 
calibrator preparation is recommended to compare results obtained using different procedures. 
In this respect, the use of certified reference materials, analyzed using a variety of methods, 
including MA, PBA and, importantly, also LC-MS/MS assays, would prove beneficial to 
compare analytical results. 
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IV.1. Abstract 
A method for the quantitative determination of folates in rodent diets is very important for 
correct interpretation of folate intake during feeding trials, given the possible discrepancy 
between the actual folate concentration in the diet and that mentioned on the product sheet. 
This discrepancy may be accounted for by e.g. inaccurate folic acid (FA) supplementation 
and/or the presence of endogenous reduced and substituted folates. Liquid chromatography 
tandem-mass spectrometry (LC-MS/MS) is the method of choice to differentiate and quantify 
the individual folate species present. We developed a method, validated based on Food and 
Drug Administration (FDA) guidelines, that allows the measurement of added and 
endogenous folates by quantitative determination of 5 folate monoglutamates with linear 
ranges from 8 µg to 2 mg/kg feed. This information, combined with feed intake data, allows 
insight into the actual folate intake in animal feeding studies. The relevance of this method 
was illustrated by the analysis of several feed samples of varying composition, by the 
investigation of the effect of casein incorporation and by evaluating the variability of the 
folate content between pellets and production batches. 
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IV.2. Introduction 
Deficiencies of folates have been related to several health disorders such as neural tube 
defects (NTDs) (Zeisel 2009), neural damage
 
(Crider et al. 2012) and an increased cancer 
risk.(Laird and Jaenisch 1996) Animal studies investigating the relation between folate intake 
and health disorders, e.g. studies in which mice receive a folate depleted diet to investigate the 
prevalence of NTDs (Heid et al. 1992), typically use an amino acid based diet, supplemented 
with various amounts of FA. However, due to a variety of factors, such as a limited chemical 
stability, the presence of endogenous folates in feed ingredients and analytical inaccuracies , 
the actual folate concentration may differ from the concentration mentioned on the product 
sheet. Also, folate concentrations may vary as a result of differences in production and storage 
conditions or feed formulation. Therefore, it is key to quantify the exact amount of folates 
ingested by the animals as determined in the diet at time of consumption. 
Rodent diets used for animal studies can generally be subdivided into three categories. Firstly, 
unrefined diets are composed of primary ingredients obtained from natural sources. Second, 
and most used, are purified diets in which the ingredients are purified or consist of refined 
forms of natural sugars, proteins and oils and purified micronutrients. A third class of diets is 
composed of chemically pure ingredients such as peptides and reagent grade 
micronutrients.(Reeves 1997) Though for open diets the exact formulation is known, i.e. 
disclosed by the manufacturer, this is not the case for a closed formula diet. However, its 
basic components remain the same and will include some form of proteins, peptides, starches, 
sugars, fibers, oils and fats. These ingredients are ground when not in powdered form, 
homogenized and pressed into pellets.  
Though FA is generally added to the rodent diet as a source of folate, the addition of natural 
food constituents such as plant starches and animal or plant based protein can result in the 
presence of endogenous folates.(Reeves et al. 1993) The presence of these non-FA folates 
may impede a correct interpretation of short term feeding trials due to a difference in 
absorption characteristics, as observed by Castorena-Torres et al.(Castorena-Torres et al. 
2014) We recently demonstrated that during long term studies, it is essential to precisely 
determine the folate content to accurately interpret the clinical data resulting from a specific 
folate intake.(Kiekens et al. 2015; Chapter VI) Another factor possibly hindering correct 
interpretation of data from a feeding trial is the labile nature of folates. Due to oxidative and 
thermal degradation during production and transport, the folate content as specified by the 
manufacturer may deviate substantially from that actually consumed by the animals.(Scott et 
al. 2000) 
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Several methods have been developed for the analysis of other compounds in rodent diets, for 
instance for quantification of estrogenic isoflavones (Degen et al. 2002) or the vitamins A and 
E.(Rushing et al. 1991) To our knowledge, we are the first to report a method that not only 
allows the total folate content to be measured, but also enables folate speciation in rodent 
feed. However, publications describing analytical methods for the analysis of folates in food 
items are plentiful. One such method for food analysis, i.e. the analysis of folates in potato
 
(Van Daele et al. 2014), features a tri-enzyme treatment followed by ultrafiltration and ultra-
high pressure/performance LC-MS/MS (UPLC
®
-MS/MS) analysis. Though a tri-enzyme 
treatment is indispensable
 
(Tamura et al. 1997), ultrafiltration is not adequate for feed analysis 
due to the presence of loosely bound minerals, triglycerides and proteins within the feed 
matrix. This can be solved by incorporation of a solid phase extraction (SPE) step to purify 
the raw samples, as was also used for specific food analyses.(Vahteristo et al. 1996; Doherty 
and Beecher 2003) Moreover, an optimized method should have a wide linear range to allow 
quantification of both high concentrations of FA, when added to the diet, and the endogenous 
folates, which are present at far lower concentrations. 
IV.3. Objectives 
When performing a bioavailability study, all sources of dietary folate must be taken into 
account to evaluate the observed results. Since rodent diets often incorporate natural 
ingredients such as casein, starches and cellulose, it is conceivable that the folate 
concentration in a diet is not zero even without added folate. To investigate the presence of 
folates in commercial rodent diets, an analytical method was developed. 
IV.4. Materials and methods 
4.1. Reagents and materials 
Tetrahydrofolate (THF), 5-methyltetrahydrofolate (5MeTHF), 5,10-methenyltetrahydrofolate 
(5,10CH
+
THF), 10-formylfolic acid (10FoFA), 5-formyltetrahydrofolate (5FoTHF) and FA 
were purchased from Schircks Laboratories (Jona, Switzerland). 
13
C-labeled internal 
standards (ISs), with a labeling yield higher than 98%, were obtained from Merck Eprova 
(Glattbrugg, Switzerland). 
13
C5-FA was used as internal standard for FA, 10FoFA and 
5FoTHF, while 
13
C5-THF, 
13
C5-5MeTHF and 
13
C5-5,10CH
+
THF were used as ISs for their 
respective isotopologues. All calibrators and IS solutions were prepared in a final 
concentration of 100 µg/ml in a 50 mM sodium phosphate buffer, pH 7.4, containing 1% L-
ascorbic acid (AA) and 0.5% DL-dithiothreitol (DTT) / methanol (MeOH) (50/50 v/v%). 
Deionized water (H2O-MQ) was produced in house by means of a Synergy UV water-
purification system from Millipore (Billerica, MA, USA). Acetonitrile (ACN) and MeOH of 
LC-MS quality were purchased from Biosolve (Valkenswaard, The Netherlands). Ammonium 
acetate, phosphoric acid and ammonium hydroxide were obtained from Merck & Cie. 
(Darmstadt, Germany). Formic acid, trisodium phosphate, AA and DTT, α-amylase (Type Ia, 
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700-1400 U/mg protein; E.C. 3.2.1.1) and protease type XIV (>3.5 U/mg; E.C. 3.4.24.31) 
were purchased from Sigma Aldrich (Diegem, Belgium). The protease powder was dissolved 
at a concentration of 5 mg/ml in deionized water. As a source of γ-glutamylhydrolase enzyme 
(GGH; E.C. 3.4.19.9), non-sterile, non-hemolyzed rat serum was obtained from Harlan 
Laboratories (Horst, The Netherlands), while lyophilized chicken pancreas powder was 
obtained from Pel-Freez Biologicals (Rogers, AR, USA). Both the protease solution and the 
rat serum were stirred on ice for 1 hour with 100 mg/ml of activated charcoal (Sigma-Aldrich) 
to remove endogenous folates.(De Brouwer et al. 2008) Following removal of the activated 
charcoal by centrifugation at 4500 g for 15 minutes at 4 °C, the solutions were filtered over a 
0.45 µm syringe filter (CA-S 30/0.45, Whatman, GE Healthcare, Little Chalfont, UK), 
divided into aliquots (1.5 ml) and frozen at -20 °C. The chicken pancreas solution was 
prepared by dissolving 400 mg powder in 25 ml of a 0.2 M phosphate buffer (pH 4.6) to 
which a suspension of 0.5 g activated charcoal and 0.05 g dextran in 5 ml of H2O-MQ were 
added. After a 30 minute incubation, centrifugation and filtration were performed as described 
for protease and rat serum, after which the pH was adjusted to 6.1 and the solution was 
aliquoted and frozen at -20 °C.(Pedersen 1988) SPE was performed using Bond Elut SAX 
tubes containing 500 mg sorbent in 3 ml tubes, purchased from Agilent (Palo Alto, CA, 
USA). 
Five different feed samples were used in this study. TD.06691 is a closed formula chemically 
pure diet in which casein is replaced by single peptides to remove all endogenous folates. The 
TD.95247 FA deficient diet is a purified diet in which the casein has been extracted with 
ethanol while TD.94045 is an AIN-93G diet in which standard casein is used as a protein 
source, with FA added in a concentration of 2 mg/kg. The 7012 diet is an unrefined diet using 
primary ingredients without casein and 7 mg/kg added FA. To evaluate the influence of casein 
on the folate speciation in a rodent diet both standard casein and ethanol-extracted casein 
were tested. All these samples were obtained from Teklad Diets (Harlan Laboratories, 
Madison, WI, USA). As a standard unrefined diet using primary ingredients and casein, a rat 
& mice maintenance diet (Carfil Quality, Oud-Turnhout, Belgium) was used. 
4.2. Calibrator and QC-matrix 
The blank amino acid defined diet (TD.06691) was used to prepare both the calibrators and 
QC-samples. This diet also contains 1% succinylsulfathiazole which is used in many rodent 
feeding trials to inhibit the de novo synthesis of folates by intestinal bacteria. The 
concentration of calibrators, quality controls and validation samples can be found in Table 
IV.1. 
4.3. Method optimization 
To evaluate the optimal pH during deconjugation with rat serum (5.3 to 7.4), equal amounts 
of 5MeTHF di-, tri-, tetra- and hexaglutamate (Schircks Laboratories) were spiked to blank 
rodent feed at a total concentration of 500 µg 5MeTHF/kg while the pH was altered using an 
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8% phosphoric acid solution. The addition of stripped chicken pancreas extract, as a 
secondary source of GGH, or oxalic acid, to capture zinc ions which may inhibit 
deconjugation by rat serum deconjugase (Horne et al. 1981), was also evaluated. Finally, the 
amount and\or incubation time of α-amylase (10, 20 or 50 µl; 15 or 30 min), protease (100 or 
200 µl; 30, 60 or 120 min) and rat serum (100, 150 or 200 µl; 120 min) were evaluated by 
duplicate analysis. 
sample 
THF 
[µg/kg] 
FA 
[µg/kg] 
5MeTHF 
[µg/kg] 
5,10CH
+
THF 
[µg/kg] 
10FoFA 
[µg/kg] 
5FoTHF 
[µg/kg] 
zero 0 0 0 0 0 0 
calibrator 1 7.980 7.840 8.041 8.161 7.840 8.197 
calibrator 2 23.94 23.52 24.12 24.48 23.52 24.59 
calibrator 3 59.85 58.80 60.31 61.21 58.80 61.48 
calibrator 4 147.6 145.0 148.8 151.0 145.0 151.6 
calibrator 5 498.8 490.0 502.6 510.0 490.0 512.3 
calibrator 6 997.5 980.0 1005 1020 980.0 1025 
calibrator 7 1995 1960 2010 2040 1960 2049 
QC1 39.90 39.20 40.20 40.80 39.20 40.99 
QC2 718.2 705.6 723.7 734.5 705.6 737.7 
LLOQ 7.980 7.840 8.041 8.161 7.840 8.197 
3*LLOQ 23.94 23.52 24.12 24.48 23.52 24.59 
MID 199.5 196.0 201.0 204.0 196.0 204.9 
0.75*ULOQ 1496 1470 1508 1530 1470 1537 
Table IV.1: Concentration of calibrators, quality controls (QCs) and validation samples. 
LLOQ: lower limit of quantitation; MID: intermediate concentration; ULOQ: upper limit of 
quantitation. 
4.4. Sample preparation 
All materials used were light protected and all manipulations were performed under subdued 
light from a yellow 15 W bulb. A homogenous aliquot of 200 mg rodent diet was weighed in 
a 15 ml polypropylene centrifuge tube. To this, 5 ml of a phosphate solution (50 mM sodium 
phosphate, 1% L-AA, 0.5% DTT, pH 7.4) including internal standards (ISs) at 250 µg/kg was 
added. After thorough mixing, the tubes were placed in a boiling water bath for 10 minutes 
followed by chilling on ice to room temperature. 
4.5. Tri-enzyme treatment 
When at room temperature, 25 µl of the α-amylase solution was added to the suspension of 
rodent diet and phosphate solution, which was then incubated for 15 minutes at room 
temperature. A further incubation at 37 °C for 30 minutes was performed after addition of 100 
µl of protease solution. After incubation, the sample was placed in a boiling water bath for 10 
minutes, chilled on ice to room temperature and centrifuged for 15 minutes at 4500 g and 4 
°C. While minimally disturbing the remainder of the rodent feed on the bottom and the fatty 
layer on top, 3.5 ml of supernatant was transferred to a new light protected centrifuge tube. 
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The pH was adjusted to 6±0.15 by adding phosphoric acid. The sample was incubated for 2 
hours at 37°C after the addition of 200 µl of stripped rat serum. After deconjugation, the pH 
was adjusted to 7.4, using 5 N NaOH, after which the samples were again placed in a boiling 
water bath for 10 minutes and subsequently chilled on ice. Prior to centrifugation for 15 
minutes at 4500 g and 4 °C, 3.25 ml of H2O-MQ was added to reduce the ionic strength. 
4.6. Sample cleanup 
SPE was performed using Bond Elut SAX tubes containing 500 mg sorbent per 3 ml tube. 
The sorbent was activated with 3 ml of hexane followed by 3 ml of MeOH and conditioned 
with 4 x 2.5 ml of 1.22 mM sodium phosphate (pH 7.4). Next, 5.5 ml of the supernatant 
obtained after tri-enzyme treatment (cfr. 4.5) was loaded onto the sorbent. To remove 
interferences, the sorbent was washed twice with 1.5 ml of 25 mM sodium phosphate, 0.5% 
L-AA, 0.25% DTT and 10% MeOH. The folates were eluted in two steps of 1 ml 0.52M 
ammonium acetate, 1% AA, 0.5% DTT and 5% MeOH (pH 7.4). 
4.7. LC-MS/MS analysis 
Samples were analyzed using a Waters Acquity UPLC
®
 system coupled to an ABSciex API 
4000
TM
 triple quadrupole mass spectrometer equipped with a TurboIonSpray
®
 probe. The 
autosampler was equipped with a 10 µl sample loop and samples were kept at 4 °C prior to 
injection. After injection the needle was cleaned with 600 µl of 10/90 v/v% H2O-MQ/ACN 
followed by 1200 µl of 90/10 v/v% H2O-MQ/ACN. Chromatographic separation was 
achieved using a mobile phase composed of H2O-MQ (A) and ACN (B), each containing 
0.1% of formic acid, with a flow rate of 0.6 ml/min on a Waters HSS T3-column (150 mm x 
2.1 mm; 1.8 µm, equipped with Vanguard pre-column) held at 60 °C. The composition of the 
mobile phase starts with 100% solvent A and was kept constant for 1 minute. Thereafter the 
amount of solvent B was increased linearly to 10% in 2 minutes and to 12% in 1 minute after 
which the column was cleaned for 1 minute with 95% solvent B and equilibrated to initial 
solvent composition for 3 minutes. This amounts to a total time of approximately 8.5 minutes 
between injections. Mass spectrometric detection was performed in scheduled multiple-
reaction monitoring mode. Electrospray ionization was used to ionize the analytes with the 
ion spray voltage set at 2500 V and a temperature of 600 °C. Nitrogen was used as curtain 
gas, gas 1 and gas 2, with respective pressure settings at 25, 75 and 90 psig, and as collision 
gas at setting 11. The interface heater was switched on. In Figure IV.1 chromatograms of a 
blank diet, a blank diet spiked at LLOQ level and a standard rodent diet are shown. The signal 
obtained for 5MeTHF in the blank diet originates from incomplete removal of this folate 
species from stripped rat serum and is lower than 20% of the LLOQ. The transitions 
monitored per compound were the same as described before (Van Daele et al. 2014), specific 
transitions and settings can be found in Table IV.2.  
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Figure IV.1: UHPLC-MS/MS chromatogram (A) of a “blank” feed sample, (B) a blank feed 
sample spiked at approximately 8 µg/kg, (C) a sample of a standard rodent diet (Carfil). Please 
note the difference in scale of the y-axis in panel C compared to panels A and B. 
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compound 
Q1 ion 
[Da] 
Q3 ion 
[Da] 
DP 
[V] 
EP 
[V] 
CE 
[V] 
CXP 
[V] 
THF 446.2 
299.3 
59 
4 26 13 
166.3 10 54 12 
FA 442.1 
295.3 
54 
9 24 22 
176.2 9 60 16 
5MeTHF 460.4 
313.2 
91 
10 27 8 
194.2 8 45 14 
5,10CH
+
THF 456.2 
412.1 
115 
9 44 13 
282.1 8 63 16 
10FoFA 470.1 
295.3 
76 
2 32 16 
176.2 4 66 10 
5FoTHF 474.2 
327.1 
46 
6 27 18 
299.3 6 43 8 
13
C5-THF 451.1 299.3 64 6 27 16 
13
C5-FA 447.2 295.3 65 3 27 26 
13
C5-5MeTHF 465.3 313.2 66 6 27 13 
13
C5-5,10CH
+
THF 461.0 416.2 79 8 45 9 
Table IV.2: Mass spectrometric settings compound related MS parameters using an 
ABSciex API4000
TM
 instrument. For 10FoFA and 5FoTHF the internal standard of FA is 
used. The transition used as quantifier is indicated in bold. DP: declustering potential; 
EP: entrance potential; CE: collision energy; CXP: collision cell exit potential; V: volt. 
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4.8. Validation 
The method was validated based on the FDA guidelines for bioanalytical method validation. 
Selectivity, carry-over, precision, accuracy, linearity, matrix effect, recovery and stability 
were evaluated.(U.S. Department of Health and Human Services 2001) 
4.8.1. Selectivity and carry-over 
Method selectivity was tested using blank rodent diet (TD.06691) obtained from Harlan. This 
is a purified diet without casein, which should therefore contain no endogenous folates. Cross-
interferences were evaluated by adding 6 folates and 4 labelled ISs individually to this diet in 
a concentration of 2 mg/kg. For the analytes, the acceptance criterion for the selectivity 
assessment was set at 20% of the peak area corresponding to the LLOQ level, while for the 
labelled ISs only 5% was considered acceptable. Carry-over was evaluated by injecting blank 
samples after calibrators with identical concentrations and acceptance criteria as for the 
evaluation of selectivity. 
4.8.2. Linearity, accuracy and precision 
The actual LLOQ was verified as the concentration which could be measured with a %bias 
and relative standard deviation (%RSD) below 20%. Duplicate analysis of 1 zero sample and 
7 calibrators was performed on 4 non-consecutive days to evaluate linearity. 
Homoscedasticity was evaluated by plotting the residuals versus the nominal values. The sum 
of the residual error was used to evaluate the need for a weighted or transformed model (1/x, 
1/x², 1/y, 1/y², √x, ln(x), log(x)). For the selected model to be acceptable, back-calculated 
mean concentrations should be within 15% of the nominal value (20% at LLOQ-level). 
Accuracy and precision were evaluated using 4 spiked samples (LLOQ - 0.75*ULOQ, Table 
IV.1), prepared and analyzed in duplicate on 4 non-consecutive days. A single-factor 
ANOVA was used to calculate intra- and interbatch variability (%RSD). Accuracy (%bias) 
was calculated as the measured value divided by the nominal value. Acceptance criteria for 
%bias and %RSD are 15%, except at LLOQ, where they are 20%. Also, the dilution integrity 
of samples exceeding the ULOQ was verified by fivefold dilution of blank matrix spiked at a 
concentration of 8 mg/kg with sample buffer prior to solid phase extraction (n=2).  
4.8.3. Recovery and matrix effects 
Matrix effect and recovery were evaluated at 3 concentration levels (3*LLOQ – 0.75*ULOQ, 
Table IV.1) in blank matrix material TD.06691 according to Matuszewski et al.(Matuszewski 
et al. 2003) The analytes were spiked in duplicate either before (A) or after (B) the extraction 
and SPE procedure. Also, analytes were spiked in SPE elution buffer to obtain a sample free 
of matrix (C). Absolute recovery was calculated as the percent ratio of peak areas A over B, 
while absolute matrix effect was calculated as the percent ratio of the peak areas B over C. 
Relative recovery and matrix effect are expressed as %RSD of the absolute recovery and 
matrix effect values and should not exceed 15%. 
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4.8.4. Stability 
To investigate the stability of folates in rodent diets, six folate monoglutamates were spiked to 
blank matrix at a 100 and 1 000 µg/kg level. Triplicate analysis of samples stored at 4 or  
-20 °C was performed weekly over a total period of 4 weeks. Autosampler stability, at 4 °C, 
was assessed by reinjection of samples stored for 24 hours in the autosampler while 
concentrations were calculated based on fresh calibrators. Also, the effect of up to three 
freeze-thaw cycles was evaluated by freezing and thawing the samples in cycles of 1 hour. 
Stability is acceptable if the concentration measured does not deviate more than 15% from 
that measured initially. 
4.9. Application 
The accuracy of the method was evaluated via the measurement of a certified reference 
material, namely: BCR 121 Wholemeal Flour issued by the Institute for Reference Materials 
and Measurements of the European Commission.(Unit for Reference Materials EC-JRC-
IRMM 2007) Also, the folate content was evaluated in five different rodent diets with varying 
composition and expected folate content. To evaluate the reproducibility of the folate 
concentration between different feed batches and between different pellets within one batch, 
pellets of two different production batches were obtained of which 4 individual pellets were 
analyzed in duplicate per batch. Also, casein and ethanol extracted casein (Fonterra, 
Auckland, New Zealand), used as a protein source in many diets, were analyzed to evaluate 
the efficacy of the ethanol extraction. To correlate the results between feed analysis and 
casein treatment, casein samples consisted of only 40 mg instead of 200 mg for rodent diets 
since the rodent diets used in this study contain on average 20% protein. 
IV.5. Results and discussion 
5.1. Method optimization 
Due to the application of LC-MS/MS analysis, the results are not influenced by preservatives 
and anti-microbial agents which may be present in rodent feed. This is a major improvement 
over microbiologic assays commonly used for food and feed analysis. Sample preparation 
encompasses classical tri-enzyme treatment with an amylase, protease and folate conjugase 
treatment to degrade starches and proteins and to hydrolyze folate polyglutamates, 
respectively. However, since the feed matrix may have an effect on the activity of the 
enzyme, the amount of enzyme and length of incubation were optimized. 
5.2. Optimization of polyglutamate deconjugation 
Though GGH is reported to have a pH optimum between 6.2 and 7.2 (Horne et al. 1981), 
deconjugation was found to be optimal at a pH of approximately 6.00 with an optimal range 
between 5.85 and 6.15 (see Figure IV.2). No compounds exerting an inhibitory effect could 
be inferred based on literature.(Galivan et al. 2000) Neither the addition of oxalate nor 
chicken pancreas extract improved polyglutamate deconjugation and was therefore not 
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included for further method optimization. The optimized enzyme amounts and incubation 
times were as described in section 4.5. 
 
Figure IV.2: Influence of pH on the deconjugation efficiency using rat serum γ-
glutamylhydrolase following spiking the di-, tri-, tetra- and hexaglutamate form of 5-
methyltetrahydrofolate (5MeTHF) to a total concentration of 500 µg/kg. 
5.2.1. Separation of oils and fats 
The addition of water-immiscible organic solvents, such as hexane, ethyl acetate and 1-
octanol, followed by vortexing and centrifugation, was evaluated to separate fats and oils 
from the feed extract prior to tri-enzyme treatment. Although this indeed led to a better 
separation after centrifugation, the layer formed at the interface stuck to the pipette tip and 
fragments were sucked into the aqueous extract upon transfer. Hence, this step did not 
improve the analytical results and was therefore omitted. 
5.3. Solid phase extraction 
Early during method development, reversed phase (C18 and Phenyl) and ion-exchange solid- 
phase extraction were compared. While equivalent folate recovery was obtained, the strong-
anion exchange (SAX) packing gave less background noise and was therefore preferred. 
5.4. Method validation 
5.4.1. Selectivity and carry-over 
No interferences or cross-talk was observed for any of the folates analyzed. However, 
5,10CH
+
THF was partly oxidized to 5FoTHF during initial experiments with a boiling step at 
pH 6.0. Therefore, it is necessary to adjust the pH to 7.4 prior to performing the boiling step 
after conjugase treatment. This prevents the oxidation of 5,10CH
+
THF at elevated 
temperature, which was also observed by De Brouwer et al. and Jagerstad and Jastrebova.(De 
Brouwer et al. 2007; Jagerstad and Jastrebova 2013) Carry-over measured in a blank sample 
injected after the highest calibrator did not exceed 2.8% of the LLOQ, which is acceptable 
according to the FDA guideline.(U.S. Department of Health and Human Services 2001) 
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5.4.2. Linearity, accuracy and precision 
Based on the evaluation of the sum residual error and homoscedasticity, 1/x was chosen as 
weighting factor for all folates. This transformation also led to the best intra- and interbatch 
precision and accuracy. The values for both precision (%RSD) and accuracy (%bias) can be 
found in Table IV.3 (raw data in Table IV.4) and did not exceed the 15 or 20% acceptance 
criteria. Also, the back-calculated concentrations of the calibrators fell within the acceptance 
criteria. The LLOQ and ULOQ for the different folates are 8 µg/kg and 2 mg/kg, respectively 
(Table IV.1). 
folate 
conc. 
intrabatch 
precision 
[%RSD] 
interbatch 
precision 
[%RSD] 
accuracy 
[%bias] 
THF 
LLOQ 14.1 14.1 -0.8 
3*LLOQ 9.8 9.8 -1.9 
MID 3.9 3.9 -1.4 
0.75*ULOQ 4.1 4.1 -0.8 
FA 
LLOQ 7.4 8.0 -4.5 
3*LLOQ 2.4 4.6 0.8 
MID 2.5 2.5 1.0 
0.75*ULOQ 1.4 4.2 -2.9 
5MeTHF 
LLOQ 10.1 10.1 3.0 
3*LLOQ 6.5 10.7 -2.0 
MID 3.5 6.2 3.4 
0.75*ULOQ 4.3 4.3 2.3 
5,10CH
+
THF 
LLOQ 16.1 18.7 2.2 
3*LLOQ 5.1 13.8 -3.5 
MID 10.5 10.5 8.1 
0.75*ULOQ 3.7 3.7 3.2 
10FoFA 
LLOQ 7.2 12.3 -5.0 
3*LLOQ 9.4 9.4 -3.0 
MID 5.2 5.2 -4.8 
0.75*ULOQ 3.5 6.6 -5.1 
5FoTHF 
LLOQ 9.0 9.0 5.5 
3*LLOQ 9.9 9.9 3.3 
MID 3.4 3.4 3.0 
0.75*ULOQ 1.7 3.0 0.2 
Table IV.3: Accuracy and precision data at 4 concentration levels analyzed in twofold 
on 4 non-consecutive days. LLOQ: lower limit of quantitation; MID: intermediate 
concentration; ULOQ: upper limit of quantitation. 
When the folate concentration measured exceeds the ULOQ, fivefold dilution with extraction 
buffer without internal standards prior to solid phase extraction allows to extend the 
measurable range up to 10 mg/kg feed. Duplicate analysis of a diluted sample originally 
spiked at a concentration of 8 mg/kg gave acceptable results, with a difference less than 
10.5% compared with the nominal concentration. As such, it is possible to measure individual 
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folate species in a concentration range of 8 µg/kg to 10 mg/kg. This encompasses the normal 
range present in rodent feed and allows quantification of natural folates present in feed 
ingredients and of synthetic folate, generally FA, added to the diet.  
folate 
[µg/kg] 
level replicate 
nominal 
value 
day 
1 2 3 4 
THF 
LLOQ 
a 7.980 7.740 7.496 8.597 8.861 
b 7.980 7.833 9.103 6.334 7.352 
3*LLOQ 
a 23.94 24.90 23.56 25.17 26.35 
b 23.94 23.26 21.59 20.52 22.57 
MID 
a 199.5 185.5 197.2 209.7 198.7 
b 199.5 199.5 197.0 195.1 191.5 
0.75*ULOQ 
a 1496 1490 1524 1466 1511 
b 1496 1555 1390 1505 1433 
FA 
LLOQ 
a 7.840 6.712 7.551 8.428 8.180 
b 7.840 7.367 7.775 7.006 7.970 
3*LLOQ 
a 23.52 23.23 24.31 24.68 23.67 
b 23.52 24.40 24.50 25.48 22.88 
MID 
a 196.0 202.7 204.5 200.6 201.7 
b 196.0 190.2 203.5 207.2 201.0 
0.75*ULOQ 
a 1470 1432 1425 1503 1432 
b 1470 1403 1433 1526 1474 
5MeTHF 
LLOQ 
a 8.041 7.650 7.565 8.545 7.094 
b 8.041 7.632 6.950 8.763 8.365 
3*LLOQ 
a 24.12 27.30 26.51 25.14 25.14 
b 24.12 23.46 21.52 22.11 25.99 
MID 
a 201.0 216.7 209.5 210.1 194.5 
b 201.0 221.7 194.3 200.7 203.1 
0.75*ULOQ 
a 1508 1499 1585 1577 1519 
b 1508 1494 1463 1486 1627 
5,10CH
+
THF 
LLOQ 
a 8.161 5.070 7.642 8.067 9.196 
b 8.161 8.562 8.777 8.237 9.722 
3*LLOQ 
a 24.48 19.90 26.41 21.98 22.74 
b 24.48 22.53 25.74 21.02 24.44 
MID 
a 204.0 209.2 217.2 179.8 226.2 
b 204.0 234.6 222.9 233.0 202.1 
0.75*ULOQ 
a 1530 1604 1549 1601 1511 
b 1530 1453 1504 1586 1545 
10FoFA 
LLOQ 
a 7.840 7.605 6.999 9.181 7.568 
b 7.840 6.985 7.396 7.961 6.969 
3*LLOQ 
a 23.52 22.50 23.57 22.71 25.19 
b 23.52 24.58 25.60 21.89 19.82 
MID 
a 196.0 188.2 186.8 188.8 175.0 
b 196.0 205.2 186.9 192.4 196.7 
0.75*ULOQ 
a 1470 1503 1390 1368 1437 
b 1470 1520 1461 1370 1315 
5FoTHF 
LLOQ 
a 8.197 9.012 7.791 8.556 8.992 
b 8.197 7.622 8.628 9.062 7.685 
3*LLOQ 
a 24.59 27.14 23.13 22.15 27.45 
b 24.59 24.96 27.61 22.67 22.70 
MID 
a 204.9 210.2 200.2 213.3 194.7 
b 204.9 212.9 202.0 200.3 209.6 
0.75*ULOQ 
a 1537 1532 1479 1471 1519 
b 1537 1550 1517 1461 1461 
Table IV.4: Raw concentration data for the assessment of accuracy and precision. LLOQ: lower 
limit of quantitation; MID: intermediate concentration; ULOQ: upper limit of quantitation. 
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5.4.3. Recovery and matrix effects 
Given the use of carbon-13 labelled ISs, the IS-corrected matrix effect remained limited 
(within 15%) for all folates at all three concentration levels. The relative matrix effect ranged 
from 0.2 to 11.3%. Given the limited recovery of 5,10CH
+
THF without compensation by the 
IS (±4.7%), it is not possible to reliably obtain a quantitative result for this compound. For all 
other folates, non-IS corrected absolute recovery exceeded 30% while IS-corrected absolute 
recovery exceeded 88.0% and was reproducible as relative recovery only exceeded the 
acceptance criterion of 15% for 5MeTHF at the MID concentration level (15.9%). Detailed 
data can be found in Table IV.5 (raw peak area data: Table IV.6). 
 
conc. THF FA 5MeTHF 5,10CH
+
THF 10FoFA 5FoTHF 
absolute ME 
without IS 
3*LLOQ 57.3 89.8 72.9 61.4 96.8 88.3 
MID 55.0 84.3 68.2 54.7 88.5 89.3 
0.75*ULOQ 54.3 86.5 60.8 50.2 85.6 82.5 
absolute ME 
with IS 
3*LLOQ 91.9 101.7 100.2 93.6 109.7 99.9 
MID 96.8 98.3 96.5 99.0 103.2 104.1 
0.75*ULOQ 101.5 106.9 88.8 93.3 105.8 101.9 
relative ME 
without IS 
3*LLOQ 1.7 1.7 3.4 1.3 7.4 8.2 
MID 6.7 4.3 3.9 3.0 0.7 1.1 
0.75*ULOQ 2.1 1.5 4.3 0.2 0.3 0.9 
relative ME 
with IS 
3*LLOQ 9.3 2.5 2.1 11.3 7.7 8.8 
MID 7.7 4.4 9.5 7.1 0.2 2.0 
0.75*ULOQ 2.4 4.5 4.5 4.1 6.7 5.0 
absolute RE 
without IS 
3*LLOQ 46.8 37.7 45.2 4.9 33.1 40.0 
MID 36.6 36.7 38.2 4.5 31.3 39.5 
0.75*ULOQ 44.2 37.7 48.2 4.7 35.6 49.6 
absolute RE 
with IS 
3*LLOQ 112.6 107.1 111.8 114.5 94.5 112.3 
MID 98.5 102.8 104.6 105.8 88.0 110.3 
0.75*ULOQ 98.0 97.5 102.8 118.6 92.2 128.5 
relative RE 
without IS 
3*LLOQ 11.9 1.2 6.0 0.0 8.2 5.4 
MID 8.6 2.0 9.8 0.2 3.2 6.9 
0.75*ULOQ 3.1 2.5 3.7 0.2 1.1 0.1 
relative RE 
with IS 
3*LLOQ 6.6 9.2 12.2 4.1 14.3 1.5 
MID 9.0 0.8 15.9 13.2 5.0 14.1 
0.75*ULOQ 0.1 0.6 7.4 18.8 9.5 9.5 
Table IV.5: Results following the analysis of matrix effects and recovery. The maximal achievable 
recovery of 53.5% was not taken into account in the values of the absolute recovery without IS. LLOQ: 
lower limit of quantitation; ME, matrix effect; MID: intermediate concentration; RE, recovery; 
ULOQ: upper limit of quantitation. 
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Analyte 
type level replicate THF FA 5MeTHF 5,10CH
+
THF 10FoFA 5FoTHF 
spiked at 
the start 
3*LLOQ 
a 1.72E+03 4.58E+03 3.31E+03 6.08E+02 2.70E+03 5.22E+03 
b 2.32E+03 5.05E+03 4.36E+03 5.59E+02 3.53E+03 5.79E+03 
MID 
a 1.15E+04 3.52E+04 2.41E+04 4.17E+03 2.25E+04 4.08E+04 
b 1.38E+04 3.96E+04 3.23E+04 4.02E+03 2.51E+04 5.14E+04 
0.75*ULOQ 
a 1.23E+05 2.93E+05 2.51E+05 3.05E+04 1.90E+05 4.22E+05 
b 1.10E+05 2.72E+05 2.34E+05 2.73E+04 1.93E+05 4.46E+05 
spiked at 
the end 
3*LLOQ 
a 4.48E+03 1.24E+04 8.09E+03 1.24E+04 9.86E+03 1.45E+04 
b 4.20E+03 1.31E+04 8.81E+03 1.14E+04 9.08E+03 1.32E+04 
MID 
a 3.76E+04 9.99E+04 7.70E+04 9.65E+04 7.73E+04 1.18E+05 
b 3.23E+04 1.04E+05 7.16E+04 8.77E+04 7.48E+04 1.16E+05 
0.75*ULOQ 
a 2.65E+05 7.42E+05 4.94E+05 6.26E+05 5.46E+05 8.52E+05 
b 2.62E+05 7.56E+05 5.14E+05 5.94E+05 5.31E+05 8.98E+05 
without 
matrix 
3*LLOQ 
a 7.99E+03 1.40E+04 1.15E+04 2.05E+04 9.66E+03 1.54E+04 
b 7.18E+03 1.44E+04 1.17E+04 1.83E+04 9.92E+03 1.60E+04 
MID 
a 6.30E+04 1.23E+05 1.08E+05 1.70E+05 8.78E+04 1.31E+05 
b 6.43E+04 1.19E+05 1.09E+05 1.67E+05 8.40E+04 1.31E+05 
0.75*ULOQ 
a 5.02E+05 8.68E+05 8.55E+05 1.25E+06 6.36E+05 1.04E+06 
b 4.70E+05 8.63E+05 8.05E+05 1.18E+06 6.22E+05 1.08E+06 
Internal Standard 
type level replicate THF FA 5MeTHF 5,10CH
+
THF 10FoFA 5FoTHF 
spiked at 
the start 
3*LLOQ 
a 3.21E+04 1.50E+04 5.95E+04 4.97E+03 1.50E+04 1.50E+04 
b 4.59E+04 1.85E+04 8.49E+04 4.31E+03 1.85E+04 1.85E+04 
MID 
a 2.91E+04 1.51E+04 5.53E+04 4.28E+03 1.51E+04 1.51E+04 
b 3.38E+04 1.61E+04 6.39E+04 3.74E+03 1.61E+04 1.61E+04 
0.75*ULOQ 
a 2.57E+04 1.09E+04 5.42E+04 2.72E+03 1.09E+04 1.09E+04 
b 2.36E+04 9.99E+03 4.51E+04 2.02E+03 9.99E+03 9.99E+03 
spiked at 
the end 
3*LLOQ 
a 9.80E+04 4.62E+04 1.75E+05 1.13E+05 4.62E+04 4.62E+04 
b 8.97E+04 4.83E+04 1.77E+05 1.03E+05 4.83E+04 4.83E+04 
MID 
a 8.76E+04 4.38E+04 1.65E+05 9.55E+04 4.38E+04 4.38E+04 
b 8.30E+04 4.37E+04 1.64E+05 9.39E+04 4.37E+04 4.37E+04 
0.75*ULOQ 
a 5.42E+04 2.68E+04 1.04E+05 5.88E+04 2.68E+04 2.68E+04 
b 5.51E+04 2.72E+04 1.07E+05 5.79E+04 2.72E+04 2.72E+04 
without 
matrix 
3*LLOQ 
a 1.49E+05 5.21E+04 2.45E+05 1.60E+05 5.21E+04 5.21E+04 
b 1.51E+05 5.49E+04 2.39E+05 1.68E+05 5.49E+04 5.49E+04 
MID 
a 1.50E+05 5.13E+04 2.40E+05 1.75E+05 5.13E+04 5.13E+04 
b 1.51E+05 5.07E+04 2.25E+05 1.68E+05 5.07E+04 5.07E+04 
0.75*ULOQ 
a 1.06E+05 3.45E+04 1.54E+05 1.13E+05 3.45E+04 3.45E+04 
b 9.87E+04 3.22E+04 1.54E+05 1.04E+05 3.22E+04 3.22E+04 
Table IV.6: Raw peak area data for the assessment of matrix effect and recovery. LLOQ: lower limit of 
quantitation; MID: intermediate concentration; ULOQ: upper limit of quantitation. 
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5.4.4. Stability 
Both storage conditions proposed by the manufacturer were tested, i.e. 4 and -20 °C. As can 
be seen in Table IV.7, samples stored at 4 °C were not adequately stable since especially THF 
was susceptible to degradation with on average 17% loss already after one week. Up to one 
week of storage at 4 °C was acceptable for the other folates. Stability at -20 °C was acceptable 
up to 2 weeks of storage according to the 15% acceptance criterion except for FA at the high 
concentration level which was 20% higher than at the start. 
weeks at 4°C weeks at -20°C 
folate conc. 0 1 2 3 4 0 1 2 3 4 
THF 
low 100 84.9 54.8 32.2 25.3 100 108 98.8 83.6 50.4 
high 100 81.5 78.1 52.1 33.6 100 92.8 96.6 55.3 43.9 
FA 
low 100 104 89.2 60.8 47.5 100 115 99.0 88.7 49.6 
high 100 100 100 77.2 46.8 100 108 120 75.2 53.9 
5MeTHF 
low 100 98.4 84.6 65.4 48.5 100 98.5 106 72.7 45.9 
high 100 97.8 108 82.6 50.4 100 90.9 114 91.5 47.5 
5,10CH
+
THF 
low 100 112 82.6 79.8 57.0 100 85.1 98.4 77.1 55.5 
high 100 84.2 94.8 82.7 50.1 100 82.7 94.1 78.6 48.3 
10FoFA 
low 100 112 79.8 55.3 66.3 100 96.9 89.8 67.2 70.6 
high 100 95.8 79.4 73.4 69.9 100 90.3 87.0 70.3 59.6 
5FoTHF 
low 100 123 82.7 49.9 66.2 100 97.2 90.5 60.9 68.2 
high 100 96.2 80.7 66.8 71.8 100 97.1 94.1 67.1 63.6 
Table IV.7: Results obtained during the evaluation of long term stability. Results are depicted as % 
recovery relative to the concentration measured at the 0 time point. Low concentration=0.1 mg/kg; high 
concentration=1.0 mg/kg.  
The evaluation of the stability of samples in the autosampler of the UPLC
®
 instrument 
revealed no problems during storage up to 24 hours (cfr. Table IV.8). Only for THF did 
freeze-thaw cycles affect the measured folate concentration. After 3 cycles, the degradation of 
THF exceeded the 15% acceptance criterion (cfr. Table IV.9). 
deviation [%] THF FA 5MeTHF 5,10CH
+
THF 10FoFA 5FoTHF 
low 
concentration 
-1.51 1.95 0.24 -9.39 -8.46 -10.7 
high 
concentration 
-4.95 0.36 -4.40 -1.77 -12.7 -9.63 
Table IV.8: Autosampler stability expressed as the percentage difference between samples analyzed 
immediately after sample treatment and following 24 hours in the autosampler (n=3; average 
values are shown). Quantitation of the latter was done using a freshly prepared calibration curve. 
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5.5. Application 
The analysis of five feed varieties (in duplicate) clearly illustrated the relevance of a method 
for the analysis of folates in rodent diets. Both the TD.06691 and the TD.95247 diets are 
reported to be FA deficient. However, though in the former no folates could be quantified, the 
incorporation of purified casein in the latter leads to a total folate content of 45.6 µg/kg, with 
FA and 10FoFA present in quantifiable amounts (28.6 and 17.0 µg/kg respectively). 
According to the specification sheet, 7 mg of folate/kg is present in the 7012 diet (as added 
FA). This was confirmed by a measured total folate content of 6.91 mg total folate/kg. 
However, only 82.9% of this consists of FA (5.73 mg/kg), while also 5FoTHF (6.7%; 0.465 
mg/kg), 5MeTHF (5.8%; 0.402 mg/kg), 10FoFA (4.0%; 0.279 mg/kg) and THF (0.6%; 41.5 
µg/kg) are present. Though the product sheet of the TD.94045 diet reports the addition of 2 
mg/kg FA, only 1.33 mg/kg FA (95.9% of the total amount of folates present) was measured, 
which is 31% lower than reported by the manufacturer. However, also trace amounts of 
5FoTHF (2.2%; 31.0 µg/kg) and 10FoFA (1.4%; 20.0 µg/kg) were present in this diet, leading 
to a total folate content of 1.38 mg total folate/kg. Like the TD.94045 diet, 2.00 mg FA/kg is 
added to the rodent maintenance diet obtained from Carfil, according to the product sheet. 
However, a total folate concentration of 5.63 mg/kg was measured of which 4.98 mg/kg was 
FA (86.9%) while also 5FoTHF (7.1%; 0.404 mg/kg), 10FoFA (5.3%; 0.303 mg/kg) and 
5MeTHF (0.8%; 43.9 µg/kg) were present. These results, including total folate concentration 
and speciation are represented graphically in Figure IV.3A. The variability of folate 
concentrations between different production batches was evaluated using the diet obtained 
from Carfil. For two batches, we performed duplicate analysis of four pellets (Figure IV.3B).  
% bias # cycles THF FA 5MeTHF 5,10CH
+
THF 10FoFA 5FoTHF 
low 
concentration 
1 7.2 -0.8 -0.3 -4.0 -0.8 3.5 
2 8.1 -1.6 -1.5 5.1 6.3 6.9 
3 -28.4 -1.9 -0.3 3.4 -1.0 3.3 
high 
concentration 
1 2.9 5.0 3.3 -5.8 3.7 5.1 
2 -4.4 -1.6 -3.5 -9.4 -0.2 0.8 
3 -18.8 -3.6 -3.1 -9.2 -16.9 -16.0 
Table IV.9: Results obtained for 1 to 3 freeze-thaw cycles. Percent bias is expressed relative to the 
average value (n=3) obtained without any freeze-thaw cycle. 
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Figure IV.3: Measured folate species in various rodent diets, analyzed in duplo, including 
standard deviation on total folate content and a dotted line indicating the FA concentration 
mentioned by the manufacturer (A) and evaluation of homogeneity of the folate concentration of 
2 production batches and 4 different pellets per batch indicated as B(#batch)P(#pellet). The 
average total folate concentration was indicated for each batch by a dotted line. Significant 
differences were observed for FA, 5MeTHF and total folate (B).  
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Though no appreciative difference was observed between pellets of each production batch, 
there was a significant difference between these batches for FA (p=0.002), 5MeTHF 
(p=0.000) and total folate (p=0.002), analyzed using an independent t-test at the 95% 
confidence level. An 18.9% difference in FA concentration was measured between both 
batches (4.98 and 4.04 mg/kg) while the 5MeTHF concentration differed by 41.2% (45.7 and 
79.5 µg/kg, respectively), as can be seen in Figure IV.3B. As such, the use of pellets from 
different production batches during a long term feeding trial may exert an influence because 
of variable folate concentrations, especially since the concentrations of the distinct folates do 
not differ equally. These results again illustrate the importance of an analytical method 
capable of quantifying individual folate species. 
When analyzing casein without the rest of the ingredients present, a total folate concentration 
of 494 µg/kg casein was found. Here, mainly 5FoTHF (45.5%; 225 µg/kg), 5MeTHF (24.3%; 
120 µg/kg), 10FoFA (19.5%; 101 µg/kg) and FA (10.8%; 53.2 µg/kg) were present. While 
commonly performed to remove endogenous compounds, amongst which folates, ethanol 
extraction only succeeds partly in removing folates from casein, with a measured remaining 
total folate concentration of 179 µg/kg. While 5FoTHF was the major folate form present in 
untreated casein, only FA (63.4%; 114 µg/kg) and 10FoFA (36.6%; 65.5 µg/kg) could be 
quantified in ethanol extracted casein. As such, ethanol extraction is demonstrated to be 
insufficient to completely remove all endogenous folates. 
The BCR 121 certified reference material consists of a ground wholemeal flour with a 
certified total folate concentration of 500 µg/kg with an uncertainty of 70 µg/kg. Though 
wholemeal flour differs from rodent feed in terms of fat, protein and starch content and 
consistency, it was used to evaluate the accuracy of the method. Following duplicate analysis, 
we measured a total folate content of 443 µg/kg with a standard deviation of 4 µg/kg, which 
corresponds to the certified range. Also, individual folate concentrations (59, 25, 48, 111 and 
199 µg/kg for THF, FA, 5MeTHF, 10FoFa and 5FoTHF respectively) were comparable to 
those found in literature.(Doherty and Beecher 2003; Pawlosky et al. 2003; Van Daele et al. 
2014)  
IV.6. Conclusion 
It is clear that for the correct interpretation of results obtained during animal feeding trials, it 
is very important to determine the actual feed intake and the folate concentration at the time 
of feeding. This conclusion is supported by our analysis of various feed samples, in which we 
observed substantial differences between the specified folate content and the actual folate 
content and the presence, up to 17%, of reduced and substituted folates. 
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V.1. Abstract 
A stable isotope dilution LC–MS/MS method is the method of choice for the selective 
quantitative determination of several folate species in clinical samples. By implementing an 
integrated approach to determine both the plasma and red blood cell (RBC) folate status, the 
use of consumables and time remains limited. 
Starting from a single 300 μl whole blood sample, the folate status in plasma and RBCs can 
be determined after separating plasma and RBCs and sequential washing of the latter with 
isotonic buffer, followed by reproducible lysis using an ammonium-based buffer. 
Acidification combines both liberation of protein bound folates and protein precipitation. 
Sample cleanup is performed using a 96-well reversed-phase solid phase extraction 
procedure, similar for both plasma and RBC samples. Analyses are performed by UHPLC–
MS/MS. 
Method validation was successfully performed based on EMA-guidelines and encompassed 
selectivity, carry-over, linearity, accuracy, precision, recovery, matrix effect and stability. 
Plasma and RBC folates could be quantified in the range of 1–150 nM and 5–1500 nM, 
respectively. 
This method allows for the determination of 6 folate monoglutamates in both plasma and 
RBCs. It can be used to determine short and long term folate status in both normal and 
severely deficient subjects in a single analytical sequence. 
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V.2. Introduction 
Folates, a group of essential water-soluble B-vitamins (B9), are key cofactors in both the 
methylation cycle and DNA-synthesis. Folate deficiency has been implicated in several health 
disorders, with a proven link between periconceptional folate deficiency and the prevalence of 
neural tube defects.(Zeisel 2009) Other health issues such as increased cancer risk due to a 
disruption of DNA methylation and misincorporation of uracil may be related to folate 
deficiency.(Laird and Jaenisch 1996) Also, an impaired or halted methylation cycle causes 
neural damage through the reduced myelination of the nervous system (Crider et al. 2012) 
and leads to increased plasma homocysteine concentrations.(Shane 2010; Kiekens et al. 2015 
(Chapter VI)) Following several decades of research it is evident that knowledge of nutrient 
status, including folate concentrations, is of paramount importance for the evaluation of 
individual health. 
Clinical folate status is traditionally determined in serum by a competitive folate binding 
protein (FBP) assay or a microbial assay. However, more recently developed liquid 
chromatographic tandem mass spectrometric (LC–MS/MS) methods allow to discriminate 
between different metabolically active folate species for which the microbial and ligand 
binding assays are not equally specific.(Owen and Roberts 2003; Yetley et al. 2011; Pfeiffer 
et al. 2011) 
For LC–MS/MS analysis of folates in plasma or serum, several methods have been published, 
differing in certain steps. Nelson et al. showed that affinity extraction with FBP led to lower 
detection limits, compared to reversed-phase solid phase extraction (SPE).(Nelson et al. 2004) 
However, Hannisdal et al. omitted the purification step and simply used protein precipitation 
and evaporation as sample cleanup technique, yielding similar results.(Hannisdal et al. 2009a) 
Also, Garbis et al. showed that hydrophilic interaction liquid chromatography can be used to 
separate four different folate species.(Garbis et al. 2001) Using an automated phenyl-based 
SPE system, a sensitive and high-throughput method for the measurement of serum folates 
was devised by Fazili et al.(Fazili et al. 2013) 
Lysis of whole blood samples for folate analysis is commonly performed using an  
L-ascorbic acid (AA) solution as a lysing agent.(Fazili and Pfeiffer 2004; Smith et al. 2006; 
Kirsch et al. 2012) However, this strategy was criticized due to differences in the assayable 
folate concentrations, attributable to differences in solution strength, which may lead to 
incomplete lysis, non-linear dilution curves and variable lysis times.(Wright et al. 2000) The 
addition of AA to whole blood lysates causes deoxygenation of hemoglobin due to the 
acidification of the sample. Since folates are trapped within the structure of oxyhemoglobin, 
deoxygenation is required for deconjugation.(Wright et al. 1998) Alternatively, lyophilized 
RBCs have also been used as a starting material to which an extraction buffer is 
added.(Monch et al. 2010) 
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Since most LC–MS/MS procedures only measure folate monoglutamates, it is necessary to 
incubate the lysate at 37 °C for 2–12 h to allow human γ-glutamylhydrolase (GGH), present 
in plasma, to deconjugate the folate polyglutamates present in the sample. Mostly heat 
inactivation is used to stop this reaction.(Smith et al. 2006) Samples can be purified using 
affinity extraction with FBP, followed by SPE to concentrate the sample.(Smith et al. 2006) 
However, most used is ion-exchange or reversed-phase SPE without affinity extraction.(Fazili 
et al. 2005; Monch et al. 2010) Mixed-mode sorbents (i.e. reversed phase + ion-exchange 
interaction) can be used, though this necessitates an evaporation-dissolution step to remove 
the organic solvent from the sample.(Kirsch et al. 2012) 
For plasma and RBCs it is difficult to obtain a blank matrix. A surrogate matrix, consisting of 
lyophilized egg white and sunflower oil in an isotonic sodium chloride solution, is sometimes 
used.(Monch et al. 2010) Another approach is to serially dilute samples with water in order to 
estimate the detection limits of the method.(Fazili et al. 2005) In both approaches, the 
obtained results may not be a true reflection of actual method performance. A better approach, 
as applied by e.g. Kirsch et al., may be to use a matrix treated with activated charcoal to 
assess method performance, although it should be noted that this matrix also differs in many 
aspects from non-treated matrix since other compounds are also removed from the 
matrix.(Kirsch et al. 2012) 
To selectively quantify plasma, RBC free and RBC total folate, we developed a new LC–
MS/MS method, with the focus on the sample preparation steps. This method was set up as 
such, that most of the treatment steps, consumables and solvents were shared for both plasma 
and RBC analyses, thereby optimizing the workflow and augmenting sample throughput. 
Also, reproducible RBC lysis, an obstacle troubling previously published methods, was 
achieved using a lysis buffer specific for RBCs, while addition of dithiothreitol (DTT) assures 
the release of folates from hemoglobin. To assess method performance, a full validation was 
performed, based upon European Medicines Agency (EMA) guidelines, including selectivity, 
carry-over, linearity, accuracy, precision, recovery, matrix effects and stability in whole 
blood, prepared extracts and while being in the autosampler.(European Medicines Agency 
2011) Additionally, certified reference materials for both plasma and RBCs were analyzed to 
assure interlaboratory accuracy. 
V.3. Objectives 
To determine the folate status (e.g. following consumption of folate rice), a method was 
needed to measure folates in both plasma (short term status) and RBC (long term status). 
However, since in a rodent study only a small volume of whole blood can be obtained 
following (periodic) sampling, the method should be able to determine both plasma and RBC 
folates from a limited volume of whole blood.  
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V.4. Materials and methods 
4.1. Reagents and materials 
The six folate monoglutamates studied are: tetrahydrofolate (THF), 5-methyltetrahydrofolate 
(5MeTHF), 5,10-methenyltetrahydrofolate (5,10CH
+
THF), 10-formylfolic acid (10FoFA), 5-
formyltetrahydrofolate (5FoTHF) and folic acid (FA). The folate reference standards were 
obtained from Schircks Laboratories (Jona, Switzerland), while the labeled internal standards 
(ISs), with a labelling yield higher than 98%, were obtained from Merck Eprova (Glattbrugg, 
Switzerland). At the pH values reached during sample preparation and analysis, the 
metabolically active 10-formyltetrahydrofolate (10FoTHF) is detected as 5,10CH
+
THF. Also, 
5,10-methylenetetrahydrofolate (5,10CH2THF) is unstable at acidic pH and is measured as 
THF.(De Brouwer et al. 2007; Jagerstad and Jastrebova 2013) All calibrators and 
13
C5 
labelled IS solutions were prepared at a final concentration of 200 µM in a 50 mM sodium 
phosphate buffer, pH 7.5, containing 1% AA and 0.5% DTT/methanol (50/50 v/v%). 
13
C5-FA 
was used as IS for FA, 5FoTHF and 10FoFA, whereas 
13
C5-THF, 
13
C5-5MeTHF and 
13
C5-
5,10CH
+
THF were used as IS for their respective isotopologues. Stripped rat serum was 
obtained starting from non-sterile, non-hemolyzed rat serum, obtained from Harlan (Horst, 
The Netherlands), which was stirred on ice for 1 h with 100 mg/ml of activated charcoal 
(Sigma–Aldrich, Schnelldorf, Germany) to remove endogenous folates. Following removal of 
the activated charcoal by centrifugation at 4500 × g for 15 min at 4 °C, the solution was 
filtered over a 0.45 μm syringe filter (GD/X CA 25/0.45, Whatman, GE Healthcare, Little 
Chalfont, UK), divided into aliquots (1.5 ml) and frozen at −80 °C. Acetonitrile (ACN) and 
methanol of LC–MS quality were purchased from Biosolve (Valkenswaard, The 
Netherlands). Formic acid, trisodium phosphate, AA and DTT were obtained from Sigma–
Aldrich. SPE was performed in a 96-well format with Bond Elut C18 100 mg sorbent, 
purchased from Agilent (Palo Alto, CA, USA). Deionized water (H2O-MQ) was produced in 
house by means of a Synergy UV water-purification system from Millipore (Billerica, MA, 
USA). 
4.2. Preparation of stripped calibrator and QC-matrix 
EDTA-anticoagulated blood samples were obtained from healthy volunteers, 4 male and 2 
female, aged 25–37. To remove endogenous folates, plasma and RBC extracts were treated 
with activated charcoal as described for rat serum in Section 4.1. 
4.3. Sample preparation 
Folate analysis was performed starting from 300 μl EDTA-anticoagulated venous blood. 
Plasma extracts were prepared by adding 500 μl of phosphate buffered saline (PBS) to the 
whole blood sample. After centrifugation at 1000 × g for 5 min at 4 °C, 500 μl of supernatant 
was withdrawn. To this aliquot 50 μl of a 1% AA, 0.5% DTT solution (containing all ISs in a 
final concentration of 3.0 nM) was added to stabilize the folates. Following 15 min of 
incubation at room temperature, the samples were either analyzed immediately or frozen at 
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−80 °C. To the remainder of the samples, containing the RBCs, 1 ml of PBS at room 
temperature was added, followed by resuspension, centrifugation at 1000 × g for 5 min at 4 
°C and removal of 1 ml supernatant. This washing procedure was repeated two more times. 
After the final removal of 1 ml supernatant, 800 μl of lysis buffer (168 mM NH4Cl; 10 mM 
KHCO3; 0.1 mM EDTA) was added.(Chernyshev et al. 2008) Selective RBC lysis occurred 
during a 10-min incubation at room temperature, after which cell residues were spun down by 
centrifugation at 2500 × g for 10 min at 4 °C. One milliliter of supernatant was withdrawn and 
100 μl of IS/AA/DTT solution was added. After incubation for 15 min at room temperature, 
these samples were analyzed further or frozen at −80 °C. A flowchart describing the sample 
preparation procedure is shown in Figure V.1. 
4.4. Enzyme treatment and protein precipitation 
To measure the total folate content in RBCs, 100 μl of stripped rat serum was added to 500 μl 
of RBC lysate and incubated for 2 h at 37 °C. This stripped rat serum serves as an exogenous 
source of GGH to deconjugate the folate polyglutamates present in RBC samples. The 
reaction was halted by addition of 300 μl of 10 vol% acetic acid in water. This acidification of 
the sample also liberates protein-bound folates and causes protein precipitation.(Kamen and 
Caston 1986) While no enzyme treatment is necessary to measure free monoglutamates in 
plasma and RBCs, these samples were also acidified by adding 275 µl or 300 μl of 10% acetic 
acid, respectively. The acidified samples were incubated for 20 min at 4 °C prior to 
centrifugation at 11,000 × g for 15 min at 4 °C. 
4.5. Sample clean-up 
SPE was performed using a Bond Elut 96-well plate containing 100 mg C18 sorbent per well. 
The sorbent was activated with 2 × 600 μl of methanol and conditioned with 2 × 600 μl of 
1.67/30.30/68.03 v/v/v% CH3COOH/PBS/H2O-MQ including 303 mg AA and 30,3 mg DTT 
per 100 ml. Next, plasma and RBC samples were diluted with an equal volume of water of 
which 1 ml for plasma extracts and 800 μl for RBC extracts was loaded onto the sorbent. The 
sorbent was then washed with 2 × 600 μl of conditioning buffer prior to elution with 450 μl of 
elution buffer (7.5/92.5 v/v% ACN/50 mM trisodium phosphate with 1% AA and 0.1% DTT; 
pH = 7.3). The SPE procedure is also summarized in Figure V.1. 
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Figure V.1: Flowchart describing the sample preparation procedure for the analysis of plasma and RBC folate; 
IS-solution: internal standard solution containing L-ascorbic acid and DL-dithiothreitol 
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4.6. LC-MS/MS analysis 
Samples were analyzed using a Waters Acquity UPLC
®
 system coupled to an ABSciex API 
4000™ triple quadrupole mass spectrometer equipped with a TurboIonSpray® probe. The 
autosampler was equipped with a sample loop of 10 μl and samples were kept at 4 °C prior to 
injection. After injection the needle was cleaned with 600 μl of 10/90 v/v% H2O-MQ/ACN 
followed by 800 μl of 90/10 v/v% H2O-MQ/ACN. Chromatographic separation was achieved 
using a mobile phase composed of H2O-MQ (A) and ACN (B), each containing 0.1% of 
formic acid, with a flow rate of 0.6 ml/min on a Waters HSS T3-column (150 mm × 2.1 mm; 
1.8 μm) held at 60 °C. The composition of the mobile phase starts with 100% solvent A and is 
kept constant for 1.6 min. Thereafter the amount of solvent B is increased to 10% in 1.2 min 
and to 16% in another 0.7 min after which the column is cleaned for 1.5 min with 95% 
solvent B and equilibrated to initial solvent composition for 3 min. This amounts to a total 
time of approximately 9 min between injections. Mass spectrometric detection was performed 
in scheduled multiple-reaction monitoring mode. Electrospray ionization was used to ionize 
the analytes with the ion spray voltage set at 2500 V and a temperature of 600 °C. Nitrogen 
was used as curtain gas, gas 1 and gas 2, with respective pressure settings at 25, 75 and 90 
psig, and as collision gas at setting 11. The interface heater was switched on. The transitions 
monitored per compound were the same as described before (De Brouwer et al. 2008) and can 
be found together with the settings in Table V.1. 
Compound Retention 
time [min] 
Molecular 
ion [Da] 
Fragment 
ion [Da] 
DP 
[V] 
EP 
[V] 
CE 
[V] 
CXP 
[V] 
THF 
3.36 446.2  299.3 59 4 26 13 
3.36 166.3 59 10 54 12 
FA 
3.97 442.1 295.3 54 9 24 22 
3.97 176.2 54 9 60 16 
5MeTHF 
3.45 460.3 313.2 52 5 25 20 
3.45 194.2 62 2 54 14 
5,10CH
+
THF 
3.57 456.2 412.1 115 9 44 13 
3.57 282.1 113 8 63 16 
10FoFA 
3.84 470.1 295.3 76 2 32 16 
3.84 176.2 70 4 66 10 
5FoTHF 
3.89 474.2 299.3 54 12 46 8 
3.89 166.3 52 12 52 14 
13
C5-THF 3.36 451.1 299.3 64 6 27 16 
13
C5-FA 3.97 447.2 295.3 65 3 27 26 
13
C5-5MeTHF 3.45 465.3 313.2 66 6 27 13 
13
C5-5,10CH
+
THF 3.57 461.0 416.2 79 8 45 9 
Table V.1: Compound related MS parameters as used for the instrument programming. For 
10FoFA and 5FoTHF the internal standard of FA is used. DP: declustering potential; EP: entrance 
potential; CE: collision energy; CXP: collision cell exit potential; V: volt. 
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4.7. Validation 
The developed method was validated based on the EMA guidelines for bioanalytical method 
validation.(European Medicines Agency 2011) Selectivity, carry-over, limit of detection 
(LOD) and lower limit of quantification (LLOQ), linearity, precision (including incurred 
sample reanalysis), accuracy, matrix effect, recovery and stability were evaluated. 
4.7.1. Selectivity and carry-over 
Selectivity was evaluated by analyzing plasma and RBC lysates from six individual donors (4 
male and 2 female), both with and without treatment with activated charcoal. Cross-
interferences were evaluated by adding the 6 folates and 4 labelled ISs individually to stripped 
plasma or RBC extract in a concentration of 100 nM for plasma samples (150 nM for 
5FoTHF) and 300 (THF and 5,10CH
+
THF), 500 (5MeTHF, FA and 10FoFA) or 750 nM 
(5FoTHF) for RBC extracts. For the analytes, the acceptance criterion for the selectivity 
assessment was set at 20% of the peak area corresponding to the LLOQ level, while for the 
labelled ISs only 5% was considered acceptable. Carry-over was evaluated by injecting blank 
samples after calibrators with identical concentrations and acceptance criteria as for the 
evaluation of selectivity 
4.7.2. Linearity, accuracy and precision 
The actual LLOQ was verified as the concentration which could be measured with a %bias 
and relative standard deviation (RSD) below 20%. The LOD was calculated as one third of 
the LLOQ. Duplicate calibration curves of 7 calibrators and 1 zero sample for plasma or 9 
calibrators (8 for THF and 5,10CH
+
THF) and 1 zero sample for RBC were constructed on 4 
non-consecutive days to evaluate linearity (Table V.2). Homoscedasticity was evaluated by 
plotting the residuals versus the nominal values. The sum of the residual error was used to 
evaluate the need for a weighted or transformed model (1/x, 1/x
2
, 1/y, 1/y
2, √x, ln(x), log(x)). 
For the selected model to be acceptable, back-calculated mean concentrations should be 
within 15% of the nominal value (20% at LLOQ-level). Accuracy and precision were 
evaluated using 4 QCs (LLOQ to 0.75* upper limit of quantification (ULOQ), Table V.2), 
prepared and analyzed on 4 non-consecutive days. A single-factor ANOVA was used to 
calculate inter- and intrabatch variability (%RSD). Accuracy (%bias) was calculated as the 
measured value divided by the nominal value. Acceptance criteria for %bias and %RSD are 
15%, except at LLOQ level, where they are 20%.(Wille et al. 2011) An RBC sample of a 
healthy volunteer was analyzed in duplicate on 3 non-consecutive days to evaluate the 
precision of a sample requiring deconjugation of the folate polyglutamates. Also, the dilution 
integrity of RBC extracts exceeding the ULOQ was verified by two- or fourfold dilution of 
RBC matrix spiked at a concentration of 600–3000 nM with SPE elution buffer prior to 
UHPLC–MS/MS analysis (n = 4). 
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A: plasma 
level 
THF 
[nM] 
FA 
[nM] 
5MeTHF 
[nM]  
5,10CH
+
THF 
[nM] 
10FoFA 
[nM] 
5FoTHF 
[nM] 
0 0 0 0 0 0 0 
1 0.9990 1.001 1.001 1.000 1.000 1.500 
2 1.998 2.002 2.003 2.000 2.000 3.000 
3 3.995 4.003 4.005 4.001 4.000 6.000 
4 9.990 10.01 10.01 10.00 10.00 15.00 
5 19.98 20.02 20.03 20.00 20.00 30.00 
6 39.95 40.03 40.05 40.01 40.00 60.00 
7 99.89 100.1 100.1 100.0 100.0 150.0 
QC1 4.994 5.004 5.007 5.001 5.001 7.500 
QC2 24.97 25.02 25.03 25.01 25.00 37.50 
LLOQ 0.9990 1.001 1.001 1.000 1.000 1.500 
3*LLOQ 2.997 3.002 3.004 3.001 3.000 4.500 
MID 14.98 15.01 15.02 15.00 15.00 22.50 
0.75* ULOQ 74.91 75.06 75.10 75.02 75.01 112.4 
 
B: RBC 
level 
THF 
[nM] 
FA 
[nM] 
5MeTHF 
[nM]  
5,10CH
+
THF 
[nM] 
10FoFA 
[nM] 
5FoTHF 
[nM] 
0 0 0 0 0 0 0 
1 5.010 5.008 5.000 5.005 5.001 7.520 
2 10.02 10.02 10.00 10.01 10.00 15.04 
3 25.00 25.04 25.00 25.02 25.01 37.60 
4 50.10 50.08 50.00 50.05 50.01 75.20 
5 70.10 100.2 100.0 70.06 100.0 150.4 
6 100.2 200.3 200.0 100.1 200.0 300.8 
7 200.0 300.5 300.0 200.2 300.1 451.2 
8 301.0 500.8 500.0 300.3 500.1 752.0 
9 
 
1002 1000 
 
1000 1504 
QC1 30.10 35.06 35.00 30.03 35.01 52.64 
QC2 200.0 400.6 400.0 200.2 400.1 601.6 
LLOQ 5.010 5.008 5.000 5.005 5.001 7.520 
3*LLOQ 15.03 15.02 15.00 15.01 15.00 22.56 
MID 80.20 250.4 250.0 80.07 250.1 376.0 
0.75* ULOQ 220.0 741.2 740.0 220.2 740.2 1113 
Table V.2: Calibration, quality control and validation concentrations. MID, intermediate 
concentration; LLOQ, lower limit of quantification; QC, quality control sample; ULOQ, 
upper limit of quantification.  
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4.7.3. Recovery and matrix effects 
Matrix effect and recovery were evaluated at 3 concentration levels (3*LLOQ to 0.75*ULOQ, 
Table V.2) in matrix obtained from 6 individual sources according to Matuszewski et 
al.(Matuszewski et al. 2003) At the 3*LLOQ concentration level, charcoal treated matrix was 
used. To prepare the MID and 0.75*ULOQ concentration levels, the matrix was not treated 
with charcoal. The analytes were spiked either before (A) or after (B) the extraction and SPE 
procedure. Also, analytes were spiked in SPE elution buffer to obtain a sample free of matrix 
(C). Absolute recovery was calculated as the percent ratio of peak areas A over B, while 
absolute matrix effect was calculated as the percent ratio of the peak areas B over C. Relative 
recovery and matrix effect are expressed as %RSD of the absolute recovery and matrix effect 
values and should not exceed 15%. 
4.7.4. Stability 
The stability of folates in whole blood samples was verified by storing whole blood at 4 °C 
for 0, 1, 2, 7 and 10 days, while protected from light, before performing the entire sample 
preparation procedure in triplicate. Autosampler stability was assessed by reinjection of 
samples stored for 24 h in the autosampler at 4 °C, while concentrations were calculated 
based on fresh calibrators. Long term stability of plasma and RBC lysates at −80 °C was 
evaluated by analysis of samples in duplo after 0, 1, 2 and 4 weeks including freshly prepared 
calibration curves. Also, the effect of up to three freeze-thaw cycles was evaluated by freezing 
and thawing the samples (n=2) in cycles of 1 h. Stability is acceptable if the concentration 
measured does not deviate more than 15% from that measured initially. 
4.8. Application 
The accuracy of the method was evaluated via the measurement of two certified reference 
materials, namely: Vitamin B12 and Serum Folate (03/178) and Folate in Whole Blood 
Haemolysate (95/528), both WHO International Standards issued by the National Institute for 
Biological Standards and Control (NIBSC). The reference material for serum has previously 
been measured by e.g. Fazili et al.(Fazili et al. 2013) 
V.5. Results and discussion 
5.1. Method optimization 
5.1.1. Sample treatment 
The method starts from 300 μl of whole blood. Following removal of the plasma sample, the 
RBC pellet is washed to remove plasma residues. To evaluate the washing procedure of RBCs 
we monitored the removal of GGH activity by measuring the concentration of 5MeTHF 
monoglutamate in RBC lysates after 2 h of incubation at 37 °C without addition of rat serum 
GGH. Whole blood lysate, sole plasma removal and 1 to 4 washing steps were evaluated. The 
amount of 5MeTHF monoglutamates remained stable after at least 2 washing steps, indicating 
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that human GGH was sufficiently removed. One additional washing step was included to 
ensure reproducible removal of plasma proteins, plasma folates and other constituents. Since 
plasma GGH is removed prior to RBC lysis, the presence of different folate polyglutamates 
may be visualized using the chromatographic method developed by Wang et al.(Wang et al. 
2010) 
Given the need for complete and reproducible RBC lysis, several solvent compositions 
described in literature were evaluated. These were either based on the selective absorption of 
ammonia by RBCs (0.15 M NH4Cl, 10 mM NaHCO3, 10 mM EDTA at pH 7.4), hyper- (1% 
AA) or hypotonicity (deionized water) or susceptibility to ethanol or saponin.(Alter et al. 
1979; Chi and Wu 1991; Philpott et al. 2001; Vuorte et al. 2001; Arias et al. 2010) The 
addition of 1% AA, ethanol or saponin resulted in incomplete lysis and would require at least 
one freeze-thaw cycle for full lysis. In contrast, the ammonia lysis buffer and deionized water 
led to full lysis of RBCs. The former was selected because it has been reported to selectively 
lyse RBCs, leaving other cells unaffected.(Alter et al. 1979) However, this buffer showed 
limited shelf life, with prolonged storage resulting in increased lysis times. Therefore, it was 
used within fourteen days after preparation and was stored at 4 °C. 
5.1.2. Folate deconjugation 
Since folates trapped within the quaternary structure of oxyhemoglobin are not accessible to 
GGH, deoxygenation of hemoglobin is necessary to measure the total amount of folates in the 
sample. While other methods rely on the Bohr effect (decrease of pH) to decrease oxygen 
binding affinity (Wright et al. 2000), in our method DTT was added to RBC extracts, which 
gently deoxygenates hemoglobin to produce a mixture of deoxy-, met- and sulfhemoglobin, 
leading to a release of folates.(Herzfeld et al. 1990) 
To deconjugate the folate polyglutamates present in RBCs, the samples are incubated with 
stripped rat serum, which serves as a reliable source of the necessary GGH enzyme. Addition 
of 100 μl stripped rat serum to 500 μl of RBC lysate, containing AA, DTT and ISs, and 
incubation for 2 h at 37 °C proved optimal to assure full deconjugation. However, the 
incubation of RBC extracts at 37 °C led to a minor conversion of THF to 5,10CH
+
THF. From 
literature it could be concluded that this reaction, which is catalyzed by a formate-activating 
enzyme (or formyltetrahydrofolate synthetase) present in RBCs, can be prevented by 
denaturing the enzyme at 55 °C for 5 min or by addition of NaCl to a concentration of 50 
mM.(Bertino et al. 1962) Since the latter inhibited the deconjugation of folate polyglutamates, 
the heat treatment was preferred. 
5.1.3. Protein precipitation 
A significant part of folates is bound to FBP. These folates can be released by acidification to 
a pH below 5.5, which strongly diminishes the binding capacity of FBP.(Kamen and Caston 
1986) This offers an advantage over previously published methods which may suffer from 
poor reproducibility due to incomplete lysis and uncontrolled protein binding.(Wright et al. 
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2000) Thus, 10% acetic acid was added as this combines protein precipitation and the 
liberation of protein-bound folates. Moreover, this renders an additional treatment with 
protease unnecessary. 
5.1.4. Solid phase extraction 
Since both reversed-phase and ion-exchange SPE (Nelson et al. 2004; Fazili et al. 2005; 
Monch et al. 2010) have been used for the determination of folates in plasma and RBC 
extracts, the retention behavior of 6 folate monoglutamates on various sorbent types was 
evaluated. Strong-anion exchange (Agilent Bond-Elut SAX) showed inferior retention of 
5,10CH
+
THF, but gave less background noise. However, since 5,10CH
+
THF was regularly 
detected in plasma and RBC samples, the superior recovery obtained using the reversed-phase 
sorbents was of greater importance. Comparable results were found with phenyl and C18 (both 
Agilent Bond-Elut) sorbents. The C18 sorbent was selected for further optimization. 
5.2. Method validation 
5.2.1. Selectivity and carry-over 
Method selectivity was evaluated using spiked stripped blood samples of 6 apparently healthy 
volunteers. Apart from a limited conversion of THF to 5,10CH
+
THF in RBC extracts, the MS 
signals for none of the folates exceeded 20% of the LLOQ of the others. A 5 min treatment at 
55 °C restricted the conversion of THF to 5,10CH
+
THF to on average 3.1% of the amount of 
THF present in the RBC sample. When the THF concentration exceeds 33 nM, an apparent 
5,10CH
+
THF concentration will be observed which is higher than 20% of the LLOQ. In non-
stripped samples, no interfering peaks were observed that would hamper folate analysis, based 
on an evaluation of peak shape and baseline resolution. No unacceptable carry-over was 
observed in either plasma or RBCs for any of the folates analyzed (Table V.3). 
Carry-over  
[% of LLOQ] 
THF FA 5MeTHF 5,10CH
+
THF 10FoFA 5FoTHF 
plasma 0 7.7 8.6 4.7 13.4 1.7 
RBC 0 0 5.6 9.3 8.0 0.8 
Table V.3: Carry-over calculated as the percentage of the peak area obtained from the chromatogram of a 
blank sample after injection of a high calibrator compared to the peak area at the LLOQ (n=2). 
5.2.2. Linearity, accuracy and precision 
The data were heteroscedastic; a linear unweighted model was preferred for all folates in both 
matrices, since weighting provided little benefit based on the evaluation of the sum relative 
error. Also, the back-calculated concentrations of the calibrators fell within the acceptance 
criteria using this linear model. The LLOQ and ULOQ range from 1 to 1.5 and 100 to 150 
nM, respectively, for plasma and from 5 to 7.5 and 300 to 1500 nM, respectively, for RBCs 
(Table V.2). 
In plasma the interbatch variation for 5FoTHF at the LLOQ level slightly exceeded the 20% 
acceptance criterion (21.3%), which may be improved using the commercially available 
13
C5-
 Chapter V: Folate determination in plasma and red blood cells 
102 
 
5FoTHF as IS. All other accuracy and precision values fell within 15% bias resp. RSD (or 
20% at the LLOQ level) (Table V.4). 
A: plasma 
concentration 
level 
THF FA 5MeTHF 5,10CH
+
THF 10FoFA 5FoTHF 
intrabatch 
precision 
[% RSD] 
LLOQ 13.3 10.0 4.9 7.7 10.9 15.9 
3*LLOQ 7.8 9.3 6.7 7.2 3.4 7.6 
MID 5.1 6.6 2.4 8.4 9.7 4.5 
0.75*ULOQ 5.5 4.8 3.1 8.4 4.4 8.3 
interbatch 
precision 
[% RSD] 
LLOQ 15.5 19.5 7.0 9.0 20.0 21.3 
3*LLOQ 7.8 9.5 7.9 7.2 15.2 13.2 
MID 6.8 6.6 4.1 8.4 9.7 6.7 
0.75*ULOQ 5.5 4.8 3.8 8.4 7.8 8.3 
accuracy 
[% bias] 
LLOQ 0.2 -9.7 6.7 -0.1 -9.1 -5.3 
3*LLOQ -1.8 1.8 2.6 2.5 5.5 2.9 
MID 1.0 -1.4 -1.9 -1.3 5.7 3.5 
0.75*ULOQ -0.9 -1.4 0.1 2.2 -1.3 3.1 
B: RBC concentration 
level 
THF FA 5MeTHF 5,10CH
+
THF 10FoFA 5FoTHF 
intrabatch 
precision 
[% RSD] 
LLOQ 19.1 4.8 6.3 10.1 7.1 8.0 
3*LLOQ 13.9 8.5 4.4 7.5 7.8 10.7 
MID 8.9 2.1 1.2 6.4 5.1 6.5 
0.75*ULOQ 11.3 1.7 1.7 7.9 4.0 5.7 
interbatch 
precision 
[% RSD] 
LLOQ 19.1 10.9 10.4 13.8 9.3 10.9 
3*LLOQ 13.9 8.5 4.4 7.5 7.8 14.0 
MID 8.9 3.2 2.0 7.0 5.1 6.5 
0.75*ULOQ 11.9 2.1 0.8 7.9 5.8 5.7 
accuracy 
[% bias] 
LLOQ 16.9 -5.4 -8.3 -3.5 -4.5 14.1 
3*LLOQ -6.7 -5.7 -3.4 0.3 2.4 2.7 
MID -3.3 -1.2 -0.7 -7.3 -1.3 -2.5 
0.75*ULOQ 5.1 -0.2 0.4 5.9 -2.4 2.7 
Table V.4: Accuracy and precision data (n=4x2) for plasma (A) and RBCs (B). MID, intermediate 
concentration; LLOQ, lower limit of quantification; ULOQ, upper limit of quantification. 
To assess the reproducibility of measurements in a true RBC extract, in which mainly folate 
polyglutamates are present, incurred samples were analyzed in duplicate during three different 
analytical runs. In these samples only 5MeTHF and 5,10CH
+
THF could be quantified, with a 
respective intrabatch precision (%RSD) of 7.5 and 9.6% and a respective interbatch precision 
(%RSD) of 7.7 and 9.6%, at a respective average concentration of 124 and 22.8 nM. A two- 
or four-fold dilution of samples exceeding the ULOQ with SPE elution buffer proved 
possible, with overall bias and RSD of 5MeTHF, THF and 5FoTHF below 15%. For all other 
folates (5,10CH
+
THF and 10FoFA) twofold dilution is possible (Table V.5). 
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dilution 
factor 
 THF FA 5MeTHF 5,10CH
+
THF 10FoFA 5FoTHF 
1/4 
average [nM] 2376 2118 2099 745.1 2308 2947 
target [nM] 2398 2003 2000 600.5 2000 3008 
accuracy [%] -0.900 5.73 4.96 24.1 15.4 2.01 
precision [%] 11.0 9.58 11.3 10.1 4.73 6.02 
1/2 
average [nM] 2713 2061 2130 685.2 2236 2903 
target [nM] 2398 2003 2000 600.5 2000 3008 
accuracy [%] 13.14 2.90 6.50 14.1 11.8 -3.48 
precision [%] 11.85 4.32 2.02 8.07 3.43 6.35 
Table V.5: Results obtained during the assessment of the dilution integrity for RBC folates (n=3). 
To investigate whether the treatment of the matrix with activated charcoal, used to prepare 
calibrators, affected the calibration results, two calibration curves were compared. One was 
prepared in stripped matrix, the other in untreated matrix. As can be seen in Table V.6, the 
slope of both the plasma and the RBC calibration curves deviated less than 7.3 and 6.8% 
between stripped and untreated matrix. Also, cross-calculated concentrations fell within the 
acceptance criteria, except for RBC folates at LLOQ level, which was likely due to the high 
background folate concentrations in untreated RBC samples. As such, the use of stripped 
matrix does not influence the analytical results. 
 plasma RBC 
folate 
slope              
treated 
matrix 
slope         
untreated 
matrix 
difference 
[%] 
slope              
treated 
matrix 
slope         
untreated 
matrix 
difference 
[%] 
THF 0.0167 0.0155 -7.3 0.0069 0.0066 -5.0 
FA 0.0878 0.0871 -0.8 0.0374 0.0362 -3.1 
5MeTHF 0.0166 0.0173 4.4 0.0073 0.0076 4.8 
5,10CH
+
THF 0.0188 0.0181 -3.7 0.0081 0.0086 6.8 
10FoFA 0.0867 0.0905 4.4 0.0399 0.0408 2.0 
5FoTHF 0.0114 0.0122 7.0 0.0081 0.0077 -4.9 
Table V.6: Effect of treatment of the matrix with activated charcoal on the slope of the calibration 
lines for both plasma and RBCs. 
5.2.3. Recovery and matrix effects 
Matrix effects and recoveries for both plasma and RBCs are shown in Table V.7, both with 
and without compensation by the ISs. Overall, IS-compensated recoveries lay between 91.2 
and 107.5% for plasma and 84.8 and 117.2% for RBCs, while IS-compensated matrix effects 
– with a single exception for 5FoTHF – did not exceed 20%. Both 10FoFA and 5FoTHF 
showed slightly different recoveries and matrix effects than 
13
C5-FA, which is used as an IS 
for these compounds. Though some values for IS-compensated relative recovery and matrix 
effect exceeded the 15% acceptance criterion, none were larger than 20%. The relative 
recovery and matrix effect values without IS-compensation demonstrate the necessity of using 
labelled ISs to compensate for the variability between samples. 
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  Conc. level 
THF FA 5MeTHF 5,10CH+THF 10FoFA 5FoTHF 
  
without IS with IS without IS with IS without IS with IS without IS with IS without IS with IS without IS with IS 
plasma 
absolute 
matrix effect 
[%] 
3*LLOQ 92.9 104.0 99.7 106.6 83.6 99.7 94.4 104.8 90.1 101.3 103.6 108.7 
MID 88.0 102.8 87.7 103.7 78.2 105.2 82.7 96.5 87.1 86.8 90.6 109.0 
0.75*ULOQ 84.8 106.2 87.3 108.7 85.6 103.9 82.5 109.0 88.3 105.8 88.6 111.2 
relative 
matrix effect 
[%RSD] 
3*LLOQ 6.6 2.1 3.3 3.2 6.0 5.2 10.4 6.4 8.4 4.7 8.4 9.0 
MID 9.9 3.6 9.6 12.5 9.8 6.1 9.3 4.8 12.3 16.3 8.4 11.9 
0.75*ULOQ 7.6 6.3 9.3 9.6 8.6 3.0 8.6 2.3 7.2 9.9 7.5 9.8 
absolute 
recovery [%] 
3*LLOQ 47.4 91.2 48.4 91.2 51.4 97.4 54.8 94.6 53.0 98.4 51.1 94.3 
MID 57.1 97.8 60.5 103.9 58.1 98.4 61.8 101.3 61.8 107.5 57.7 97.9 
0.75*ULOQ 54.5 99.4 55.3 98.0 55.8 106.2 58.0 100.8 57.5 102.7 57.0 101.1 
relative 
recovery 
[%RSD] 
3*LLOQ 16.1 9.8 19.9 10.4 14.4 6.4 16.9 15.3 12.8 16.9 14.8 13.5 
MID 15.2 5.5 11.0 10.8 17.2 15.9 12.4 9.0 14.4 12.1 8.7 11.0 
0.75*ULOQ 6.4 7.6 9.0 8.3 8.0 10.7 9.1 4.2 6.9 8.9 6.6 9.7 
RBC 
absolute 
matrix effect 
[%] 
3*LLOQ 154.4 110.0 91.5 102.6 100.9 119.9 143.2 112.3 87.6 101.9 108.3 126.4 
MID 84.5 85.3 101.0 90.6 84.1 90.4 88.9 83.7 96.1 86.2 114.7 102.9 
0.75*ULOQ 77.0 89.1 101.3 96.0 84.3 103.7 74.9 91.2 102.0 96.6 111.3 105.4 
relative 
matrix effect 
[%RSD] 
3*LLOQ 3.8 6.6 7.1 9.9 34.7 19.7 7.4 6.0 2.7 8.8 4.2 5.7 
MID 9.5 8.8 7.2 3.0 9.9 7.6 9.1 7.3 5.5 4.3 5.0 2.9 
0.75*ULOQ 5.8 3.2 7.0 2.3 7.0 1.9 2.8 3.8 8.3 2.4 7.7 1.5 
absolute 
recovery [%] 
3*LLOQ 11.9 95.8 22.5 102.5 *19.0 *102.6 30.7 106.0 29.5 110.7 27.9 105.9 
MID 14.1 94.7 25.6 97.4 33.8 91.1 43.2 105.8 30.2 115.1 29.9 113.6 
0.75*ULOQ 14.0 107.0 23.3 100.4 24.4 84.8 43.2 115.9 27.0 115.6 27.4 117.2 
relative 
recovery 
[%RSD] 
3*LLOQ 34.6 11.0 30.8 3.2 *15.6 *15.4 30.9 13.1 22.2 13.3 27.0 11.6 
MID 17.9 7.5 6.9 5.8 22.3 17.8 11.9 14.6 6.5 5.9 7.7 7.0 
0.75*ULOQ 14.1 14.5 21.4 7.1 38.1 11.3 20.2 11.7 25.3 10.6 23.3 4.0 
Table V.7: Results following the analysis of matrix effects and recovery. The maximal achievable recovery (plasma 64.5%; RBC: 44.4%) was not taken into account in the 
values of the absolute recovery. * Although not a statistical outlier, 1 extremely deviating sample was omitted. LLOQ: lower limit of quantitation; MID: intermediate 
concentration; ULOQ: upper limit of quantitation.  
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5.2.4. Stability 
Folates present in the plasma fraction of whole blood proved stable for 24 h, while the folates 
present in RBCs proved stable up to 10 days (Figure V.2). As observed by Hannisdal et al., 
the stability of plasma folates can be improved through the use of heparin or citrate instead of 
EDTA as anticoagulant.(Hannisdal et al. 2009b) Therefore, if sample stability is an issue, it is 
unlikely that the use of heparin as an alternative anticoagulant would negatively influence 
method performance.  
 
Figure V.2: Stability of folates in whole blood stored at 4°C in both plasma (A) and red blood cell 
fractions (B). Averages are shown, together with standard deviations (n=3). 
Storage of plasma extracts at −80 °C was possible up to 4 weeks (Figure V.3 A-C). RBC 
folate levels in extracted samples showed a steady decrease upon storage at −80 °C, where 
after storage for 4 weeks losses regularly exceeded 20% (Figure V.3 D-F). Processed samples 
were stable for at least 24 h in the refrigerated autosampler at 4 °C (Table V.8). Although 
samples with a low folate concentration were more susceptible to the effects of freeze-thaw 
cycles, up to three freeze–thaw cycles did not have an unacceptable effect on the folate levels 
measured in both plasma and RBC samples at higher concentration levels (Table V.9). In 
general, freeze-thaw cycles should be avoided. 
A: Plasma [% bias] THF FA 5MeTHF 5,10CH
+
THF 10FoFA 5FoTHF 
LLOQ -15.91 -3.90 10.02 8.96 10.26 5.87 
3*LLOQ 9.31 -3.67 3.31 7.40 -5.05 -0.86 
MID -6.29 -1.58 0.49 1.38 -6.25 -8.91 
0.75*ULOQ 13.02 0.37 -0.53 -10.25 3.77 -6.18 
B: RBC [% bias] THF FA 5MeTHF 5,10CH
+
THF 10FoFA 5FoTHF 
LLOQ 4.43 -6.12 -14.29 13.47 0.41 -13.84 
3*LLOQ 16.13 2.36 -7.26 1.91 2.08 4.84 
MID 0.17 0.61 -1.28 2.23 -0.08 3.24 
0.75*ULOQ 4.85 3.05 2.77 -0.78 1.42 2.92 
RBC extract 14.93 -0.55 -6.04 -1.29 <LLOQ <LLOQ 
Table V.8: Autosampler stability expressed as the percentage difference between samples 
analyzed immediately after sample treatment and following 24 hours in the autosampler 
(averages are shown, n=3). Quantitation of the latter was done using a freshly prepared 
calibration curve. The RBC extract was obtained from a healthy volunteer. LLOQ: lower limit 
of quantitation; MID: intermediate concentration; ULOQ: upper limit of quantitation.  
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Figure V.3: Stability of folates in plasma or RBC extracts spiked at 3*LLOQ (A,D), MID (B,E) and 0.75*ULOQ 
(C,F), stored at -80°C until analysis. Averages are shown, together with standard deviations (n=2). LLOQ: lower 
limit of quantitation; MID: intermediate concentration; ULOQ: upper limit of quantitation. 
  
Chapter V: Folate determination in plasma and red blood cells 
107 
 
 
A: plasma [%bias] # cycles THF FA 5MeTHF 5,10CH
+
THF 10FoFA 5FoTHF 
3*LLOQ 0 0 0 0 0  0 0 
3*LLOQ 1 -10.2 -0.02 -9.05 -3.01 6.61 37.4 
3*LLOQ 2 -11.5 2.24 -18.4 -12.5 30.1 63.1 
3*LLOQ 3 -9.32 -0.48 -12.6 1.31 22.1 -6.40 
MID 0 0  0 0 0 0 0 
MID 1 0.62 -9.41 -1.55 10.6 2.50 -5.50 
MID 2 0.22 -11.1 0.29 -0.25 -9.08 -5.94 
MID 3 -6.98 -7.13 -2.44 -3.09 -0.39 5.35 
0.75*ULOQ 0 0 0 0 0 0 0 
0.75*ULOQ 1 4.04 2.33 1.05 -0.07 10.4 7.66 
0.75*ULOQ 2 4.99 1.53 -0.54 -1.12 9.51 10.5 
0.75*ULOQ 3 4.09 -5.78 2.13 -0.53 3.86 2.46 
B: RBC [%bias] # cycles THF FA 5MeTHF 5,10CH
+
THF 10FoFA 5FoTHF 
3*LLOQ 0 0 0 0 0 0 0 
3*LLOQ 1 -6.15 7.45 3.65 -9.60 -3.29 -14.3 
3*LLOQ 2 30.4 -6.21 14.0 3.81 16.20 12.8 
3*LLOQ 3 28.1 6.64 35.1 13.2 7.83 24.3 
MID 0 0  0 0 0 0 0 
MID 1 -16.2 -1.31 -0.11 -4.54 0.26 1.01 
MID 2 -2.91 -1.66 0.17 1.77 11.14 6.82 
MID 3 0.05 -2.84 0.64 -0.82 9.27 -3.81 
0.75*ULOQ 0 0 0 0 0 0 0 
0.75*ULOQ 1 -3.77 3.17 3.73 -3.52 -0.04 0.31 
0.75*ULOQ 2 -3.58 7.30 5.96 -4.87 9.89 11.1 
0.75*ULOQ 3 4.26 -0.60 2.18 -2.02 1.62 0.14 
RBC extract 0 <LLOQ 0 0 0 0 <LLOQ 
RBC extract 1 <LLOQ 2.78 -4.28 -4.30 10.70 <LLOQ 
RBC extract 2 <LLOQ 2.23 2.30 -17.2 1.37 <LLOQ 
RBC extract 3 <LLOQ -1.41 0.05 -16.2 -7.54 <LLOQ 
Table V.9: Stability results obtained for 1 to 3 freeze-thaw cycles. Percent bias is expressed relative to the 
average value (n=2) obtained without any freeze-thaw cycle. The RBC extract was obtained from a healthy 
volunteer. LLOQ: lower limit of quantitation; MID: intermediate concentration; ULOQ: upper limit of 
quantitation.  
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5.3. Application 
In the plasma certified reference material (NIBSC 03/178), analyzed in sevenfold, only 
5MeTHF could be detected and quantified in a concentration of 11.1 nM (SD: 0.233 nM). 
While this concentration is slightly higher than that reported by the NIBSC and by Fazili et al. 
(Fazili et al. 2013) (resp. 13.8 and 7.8%), the total folate concentration measured is slightly 
lower than that reported by the NIBSC (8.3%). Also, Fazili et al. (Fazili et al. 2013) measured 
higher total folate (15.9%), reporting on the presence of FA and MeFox (an oxidation product 
of 5MeTHF) as well (Table V.10). There is no real discrepancy between our results and those 
of Fazili et al. First, although the FA concentration reported by these authors is low, lying 
between the LOD and LLOQ of our method, we did not detect FA. We cannot exclude that 
slight differences in FA formation during sample processing may account for this. Second, 
MeFox was not included in our method given the lack of commercially available reference 
standards. Also, MeFox was not detected in samples using the mass transitions described for 
this compound. 
 For RBCs, peak areas are back-calculated to the folate concentration in the reconstituted 
reference material. THF, 5MeTHF and 5,10CH
+
THF could be quantified in the reference 
material. Also FA and 10FoFA were present, with peak areas between the LOD and LLOQ, 
while no 5FoTHF was detected. The sum of the individual folates only exceeds the total folate 
measurement reference value set by the NIBSC by 6.0%. All values can be found in Table 
V.10. 
  
THF FA 5MeTHF 5,10CH
+
THF 10FoFA *5FoTHF *MeFox sum 
plasma 
Average 
(n=7) [nM] 
<LOD <LOD 11.1 <LOD <LOD <LOD - 11.1 
SD [nM] - - 0.233 - - - - 0.233 
CV [%] - - 2.09 - - - - 2.10 
value NIBSC 
[nM] 
- 0.74 9.75 - - 1.59 - 12.1 
deviation [%] - - 13.8 - - - - 8.26 
Fazili et al. 
[nM] 
- 0.66 10.3 - - 
- 
2.24 13.2 
deviation [%] - - 7.77 - - - - 15.9 
RBC 
Average 
(n=2) [nM] 
0.820 
<LLOQ 
28.8 0.400 
<LLOQ <LOD 
- 30.0 
SD [nM] 0.029 - 0.387 0.017 - - - 0.433 
CV [%] 3.54 - 1.34 4.25 - - - 1.44 
value NIBSC 
[nM] 
- - - - - - - 28.3 
deviation [%] - - - - - - - 6.01 
Table V.10: Results obtained from the analysis of the NIBSC reference materials (Vitamin B12 and Serum 
Folate - 03/178 and Folate in Whole Blood Hemolysate - 95/528) and comparison with reference values. *Since 
not all LC-MS/MS methods for 5FoTHF and MeFox achieve a complete separation of these compounds, it is 
possible that the 5FoTHF measured in the reference material is actually MeFox.(Fazili et al. 2013) CV: 
coefficient of variation; LOD: limit of detection; LLOQ: lower limit of quantitation; SD: standard deviation. 
  
Chapter V: Folate determination in plasma and red blood cells 
109 
 
The method was tested on blood samples obtained from 6 healthy volunteers (4 male and 2 
female) after overnight fasting. Results are depicted in Figures V.4 and V.5. The total plasma 
folate concentration ranged from 6.30 to 16.0 nM. The main folate form was 5MeTHF, minor 
folate forms exceeding the LLOQ were 10FoFA, THF and FA. 
 
Figure V.4: Results following the analysis of folates in plasma and red blood 
cells (RBCs) in samples obtained from 6 healthy volunteers. Values lower than 
the lower limit of quantitation are not depicted. Threshold for folate deficiency 
(plasma: 10 nM and RBC total folate: 340 nM; see I.3.2) is indicated by a red 
line. 
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In only four out of six subjects, RBC folate monoglutamates exceeded the LLOQ, 5MeTHF 
being the major folate species and THF being quantifiable in only 1 sample. Total folate 
concentrations in RBCs ranged from 222 to 504 nM. Similarly to plasma, 5MeTHF is the 
major folate species in RBCs, while THF and 5,10CH
+
THF are present in minor amounts. 
FA, 10FoFA and 5FoTHF could also be quantified in some samples. Based on the total folate 
concentration and the concentration of folate monoglutamates, the degree of 
polyglutamylation of RBC folates was calculated, which appeared to be fairly constant in 
samples obtained from these volunteers, ranging from 96.9 to 98.4% (n = 4). 
 
Figure V.5: UPLC
®
-MS/MS chromatogram (A) of a stripped plasma sample, (B) a stripped plasma 
sample spiked at lower limit of quantitation (LLOQ) level, (C) a sample of a healthy volunteer, (D) a 
stripped red blood cell (RBC) sample, (E) a stripped RBC sample spiked at LLOQ level, (F) a RBC 
sample of a healthy volunteer.  
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V.6. Conclusion 
Due to the similarity between the plasma and RBC analyses, these can be performed 
simultaneously, thus optimizing workload and sample throughput while minimizing the 
consumption of solvents and consumables. 
Starting from a single sample of 300 μl EDTA-anti-coagulated whole blood, the fully 
validated analytical method presented here allows to quantitatively determine 6 folate species 
in plasma and RBC extracts. The validation data showed linearity of the method from 1 to 150 
nM for plasma samples and 5 to 1500 nM for RBC samples, encompassing the clinically 
relevant ranges. Our method includes selective and reproducible ammonia-based RBC lysis, 
the addition of DTT to all solvents and acidic protein precipitation. In RBCs, both free folate 
monoglutamates and total folate (monoglutamates + polyglutamates) can be quantified. From 
this, the degree of polyglutamylation can be calculated. This may provide information on the 
efficacy of the FPGS enzyme responsible for the intracellular accumulation of folate 
polyglutamates. Our method can also be used to identify individuals with a polymorphism in 
the gene encoding the methylenetetrahydrofolate reductase enzyme, based on the 
determination of individual folate species. A significant difference in folate speciation has 
been observed in blood samples obtained from these individuals.(Bagley and Selhub 1998) 
For instance, individuals homozygous for the 677T polymorphism will have lower 5MeTHF 
concentrations and higher THF and 5,10CH
+
THF concentrations compared to heterozygotes 
and 677C homozygotes. 
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VI.1. Abstract 
The biological impact of folates from folate rice, a metabolically engineered (biofortified) rice 
line, rich in folates, was investigated. Its consumption may be helpful to fight folate 
deficiency. Our objective was to investigate the potential of folate rice to supply the organism 
with folates and evaluate its biological effectiveness using a rat model. 
Five groups of 12 Wistar rats were monitored during a 7/12-week depletion/repletion trial. 
Animals receiving folate-free diet (0 µg/rat/day) and those additionally receiving wild type 
rice (on average 0.11 µg/rat/day) suffered from decreased hematocrit and lower folate 
concentrations in both plasma and red blood cells (RBCs). This resulted in serious morbidity 
and even lethality during the trial. In contrast, all animals receiving a daily supplement of 
folate rice or folic acid fortified rice (on average 3.00 µg/rat/day and 3.12 µg/rat/day, 
respectively) and those receiving a positive control diet (11.4 to 25.0 µg/rat/day), survived. In 
these groups, the hematocrit normalized, plasma and RBC folate concentrations increased and 
pronounced hyperhomocysteinemia was countered. 
Using an animal model, we demonstrated that biofortified folate rice is a valuable source of 
dietary folate, as evidenced by folate determination in plasma and RBCs, the alleviation of 
anemia and counteraction of pronounced hyperhomocysteinemia. 
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VI.2. Introduction 
In 2007, our research consortium presented a metabolically engineered rice variety, known as 
folate rice, which contains approximately a hundredfold the folate content of wild type 
rice.(Storozhenko et al. 2007) Locally grown folate rice could be a valuable asset to reduce 
the health burden caused by folate deficiency in poor rural regions where other ways of 
sustained supplementation are difficult to implement. These regions, like the Shanxi province 
of China, are confronted with a prevalence of neural tube defects (60.9/10 000 live births; 
38% folate deficient individuals) far above that found in more developed regions (±2.9/10 000 
live births; <10% folate deficient individuals).(De Steur et al. 2010; De Steur et al. 2012) In 
2010, De Steur et al. theoretically investigated the potential health impact and willingness to 
accept folate rice in China and found that the implementation of this modified crop could have 
a positive effect on the health and economic burden of folate deficiency. However, an 
improved nutrient status of a consumer cannot be simply inferred from the intake of food with 
an increased nutrient content. First, the biological effectiveness of this genetically modified 
crop needs to be demonstrated, which is a pivotal step towards public acceptance.(De Steur et 
al. 2010; Jeong and Guerinot 2008) 
Several studies have investigated the potential health benefits of genetically modified crops 
with modified nutritional characteristics as functional food. Best known and most thoroughly 
studied is Golden Rice, in which genes are expressed that lead to a higher provitamin A 
content.(Beyer et al. 2002) A human trial has been conducted with this rice variety, 
demonstrating bio-accessibility and bio-availability (via retinol in plasma) in human 
volunteers.(Tang et al. 2009) In 2005, Haas et al. investigated the potential of a high-iron rice 
variety to improve the iron intake of Filipino women by measuring serum-ferritin, total body 
iron and hemoglobin during a 9-month trial with modest results.(Haas et al. 2005) 
Furthermore, Morris et al. investigated whether the increase of calcium accumulation in 
carrots leads to an increase in calcium intake upon consumption in both humans and 
mice.(Morris et al. 2008) Recently, Castorena-Torres et al. reported on the folate bio-
availability from lyophilized biofortified tomatoes using a murine model, making a 
comparison with orally dosed synthetic 5-methyltetrahydrofolate (5MeTHF) and folic acid 
(FA). These authors found that folates from tomato had a comparable bioavailability as 
synthetic 5MeTHF but were absorbed more slowly into the bloodstream than synthetic FA. 
FA was also found to be less bioavailable (±50%). (Castorena-Torres et al. 2014) However, 
although demonstrating a proof-of-principle of bio-availability, only one single administration 
was performed, with only a 12-h follow-up. Much more relevant to support a potential benefit 
for human health is a long term evaluation, in which repeated administration of biofortified 
food is performed, meanwhile periodically evaluating the long term RBC folate status, as well 
as the short term folate status in plasma.(Shane 2010; Visentin et al. 2014) This is only 
possible in a long term study spanning at least one full RBC life cycle, which in rats takes 
about 67 days.(Kurata et al. 1993) 
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Since folates play a key role in the methylation cycle and the formation of nucleotides, 
indicators of the disruption of these processes may provide additional information on the 
folate status of a subject. As folate deficiency has an impact on the cell cycle in any given 
cell, it also impacts erythropoiesis, leading to anemia.(Koury 2014) Folate deficiency also 
leads to an increased plasma concentration of homocysteine, as its conversion to methionine 
is folate-dependent.(Ward et al. 1997; Glier et al. 2014)  
VI.3. Objectives 
The aim of this study was to investigate the effectiveness of folates present in genetically 
engineered folate rice to serve as a supply of folates for the organism. To this end, we 
analyzed folates in RBCs and plasma and measured hematocrit, overall blood cell profile and 
homocysteine as indirect markers of folate status during a 7/12-week depletion/repletion 
feeding trial using rats as a model organism. 
VI.4. Materials and methods 
4.1. Reagents and materials 
The metabolically engineered rice or folate rice used in this study was created in the 
Nipponbare variety. It was generated by introducing into the rice genome transgenes encoding 
Arabidopsis GTP cyclohydrolase I (GTPCHI) and aminodeoxychorismate synthase (ADCS) 
from a single T-DNA locus, hence the acronym GA rice.(Storozhenko et al. 2007) This leads 
to an increased production of the folate building blocks deoxyneopterin and p-aminobenzoic 
acid, resulting in a hundredfold increased folate concentration over wild type rice seeds. The 
folate rice used in this study contained on average 1563 µg folates/100g, of which 92% was 
5MeTHF, while only 1% was FA (Table VI.1). 
To prepare FA fortified rice, wild type rice seeds of the Nipponbare variety underwent a 
parboiling process in which these seeds were soaked in a FA (Sigma-Aldrich, Schnelldorf, 
Germany) solution of approximately 120 µg/ml at 70°C for one hour with regular 
mixing.(Kam et al. 2012) After filtration, the rice seeds were spread over a large sheet of 
tinfoil and left to dry in darkness for two days at room temperature. Thereafter, the seeds were 
stored at -80°C prior to analysis and the preparation of aliquots for feeding. This FA fortified 
rice contained on average 1385 µg folates/100g, of which 99% was FA, while only 0.5% was 
5MeTHF (Table VI.1). 
All experiments were approved by the ethical committee of Ghent University (ECD 09/28). 
Sixty female Wistar Han rats were obtained from Harlan Laboratories (Horst, The 
Netherlands). These were 3 to 4 weeks old at the start of the experiment. The animals were 
randomly housed in a room maintained at 23°C and 40% humidity on a 12-h day/night-cycle. 
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aliquot 
daily ration 
of rice [mg] 
folate concentration in rice [µg/100g] 
THF FA 5MeTHF 5,10CH+THF 10FoFA 5FoTHF total 
WTR1 244 1.0 4.2 19.7 1.7 3.5 16.0 46.0 
WTR2 311 1.4 1.6 15.5 1.0 3.7 10.1 33.4 
WTR3 232 1.4 3.2 18.8 1.5 3.6 15.1 43.7 
average 267 1.3 3.0 18.0 1.4 3.6 13.7 45.0 
%/total / 3.1 7.3 43.9 3.4 8.8 33.5  100 
GAR1 230 12.6 15.6 1197 5.7 49.3 32.7 1313 
GAR2 221 13.6 10.5 1290 6.3 26.8 26.5 1373 
GAR3 208 5.8 15.8 1283 7.2 57.6 67.4 1437 
GAR4 164 13.5 13.5 1713 13.8 37.7 39.2 1830 
GAR5 173 5.4 18.2 1595 10.7 44.6 60.6 1734 
GAR6 176 6.6 15.1 1534 6.1 51.4 74.0 1688 
average 197 9.6 14.8 1435 8.3 44.6 50.1 1563 
%/total / 0.6 0.9 91.9 0.5 2.9 3.2  100 
FAR1 260 0.2 1139 1.6 0.4 4.7 4.9 1151 
FAR2 478 0.1 600.8 7.1 0.5 5.3 7.0 621 
FAR3 245 0.1 1196 6.3 0.7 5.6 4.7 1213 
FAR4 290 0.1 964.3 3.8 0.3 5.7 13.5 988 
FAR5 168 0.7 1802 9.4 1.0 4.8 10.8 1829 
FAR6 120 0.1 2488 10.7 0.7 4.2 5.7 2509 
average 220 0.2 1365 6.5 0.6 5.1 7.8 1385 
%/total / <0.1 98.6 0.5 <0.1 0.4 0.6  100 
Table VI.1: Folate concentrations in different batches of rice used in the feeding trial. GAR; folate rice 
group; FAR: folic acid fortified rice group; WTR: wild type rice group 
During the 7-week folate depletion phase, chosen to sufficiently reduce effects of previous 
exposure to a diet rich in folates, animals were housed socially with 6 rats per cage. All 
animals were fed a folate depleted diet containing 1% succinylsulfathiazole (a sulphonamide, 
inhibiting folate biosynthesis) to limit the release of folates from the intestinal microbiota 
(TD.06691, Harlan Laboratories). 
At the start of the repletion phase, a block randomization was performed to create 5 treatment 
groups of 12 animals each. The animals were housed individually to monitor feed intake on a 
daily basis and to ensure full consumption of administered rice. The negative control group 
(NEG) continued to receive the negative control diet including succinylsulfathiazole and 
served as a control for a prolonged lack of folate intake. Prior to euthanasia of the negative 
control group, pair feeding was maintained: the consumption of feed, provided to this group 
ad libitum, gradually decreased, and determined the amount of feed provided to the other 
groups, with a minimum of 6 g/animal/day. After euthanasia of the negative control group 
(from day 24 on), the remaining animals received a restricted amount of diet of approximately 
12 g/animal/day (Figure VI.1).  
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Figure VI.1: Experimental set-up: the different groups and different phases of the feeding 
trial are depicted. The crosses indicate the time of euthanasia, at which blood was 
sampled for analysis of folates in plasma and RBC, homocysteine and vitamin B12 
measurement in plasma, hematocrit estimated via dried blood spots (DBS) and 
hematological analysis of whole blood. The arrows indicate time points at which tail vein 
blood was obtained for analysis of folates in plasma and RBC and hematocrit prediction 
via DBS. NEG, negative control group; WTR, wild type rice group; GAR, folate rice 
group; FAR, folic acid fortified rice group; POS, positive control group. 
The wild type rice group (WTR) received the same depleted diet including 
succinylsulfathiazole. However, these animals additionally received a daily amount of wild 
type rice (on average 267 mg rice/day or 13 grains/day providing 0.11 µg folate/animal/day) 
to account for any compound present in the wild type rice elucidating an unknown effect. The 
actual amount of rice provided to these animals depended on the rice intake of the groups 
receiving folate rice or folic acid fortified rice (see further) and was calculated as the daily 
average rice supplementation of these groups. In addition to the folate depleted diet including 
succinylsulfathiazole, the folate rice group (GAR) additionally received on average 197 mg of 
folate rice per day (±10 grains), resulting in an intake of 3.00 µg folate/animal/day. Similarly, 
the folic acid fortified rice group (FAR) continued to receive the folate depleted diet including 
succinylsulfathiazole and on average 220 mg folic acid fortified rice per day (±11 grains). 
This resulted in an average folate intake of 3.12 µg/animal/day. As such, the FAR group 
serves as a control group closely related to the GAR group, in that these animals receive a 
supplementation of folic acid in an amount nearly identical to that received by the GAR group 
and also receive intact rice grains. The amount of rice provided to the animals was determined 
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by three aspects: i) the amount of rice that can be grown on a lab scale is limited; ii) this 
amount should be sufficient to maintain a viable folate status(Clifford et al. 1989; Bailey and 
Gregory 3rd 1999; House et al. 2003); iii) administration of too high amounts may mask 
subtle differences between groups. From the start of the repletion phase on, the positive 
control group (POS) received a rodent diet containing 2000 µg folic acid/kg feed resulting in 
a folate intake of 11.4 to 25.0 µg folate/animal/day, depending on the amount of feed 
provided and consumed, with an average folate intake of 20.4 µg/animal/day (see Table VI.2). 
While the FAR group served as a control group for the supplementation of a limited amount 
of folic acid through the feeding of fortified rice, the POS group served as a reference for the 
effects of a non-restricted folate intake. Due to the high amount of folate present in this 
positive control feed, these animals present the clinical parameters associated with an 
adequate folate status. Optimal erythropoiesis is expected to lead to a normal hematocrit while 
homocysteine concentrations should be fully reduced to baseline levels due to the high 
availability of 5-methyltetrahydrofolate in the circulation. Both the folate depleted diet and 
the positive control diet are standardized AIN-93G diets, similar in carbohydrate, fat and 
protein content. The letter G indicates that this diet is specially formulated to be used during 
the growth phase of the rodents’ life. 
Irrespective of feed limitations, wild type rice, folate rice and folic acid fortified rice were 
provided to the animals prior to providing the rest of the feed. Non-ground, intact grains were 
provided separately from the feed in a porcelain bowl to allow evaluation of the bio-
accessibility of the rice folates. At all stages we visually confirmed that all animals fully 
consumed the rice grains provided. 
4.2. Blood sampling 
Blood sampling was performed in a random order after overnight fasting. After 50 days of 
folate depletion and at days 11, 24, 41, 55 and 65 of the supplementation period, blood 
samples of approximately 300 µl were obtained from the lateral tail vein under isoflurane 
anaesthesia using a 30G needle (BD Microlance
TM
 3) and a 2-ml disposable syringe 
(Terumo). Blood samples were immediately transferred to an amber-colored microcentrifuge 
tube containing 20 µl of a 6% EDTA solution (Sigma-Aldrich). At the time of euthanasia a 1-
ml sample was obtained via cardiac puncture using an 18G needle (BD Microlance
TM
 3) and a 
10-ml disposable syringe (Terumo). Blood samples were immediately transferred to a 5-ml 
tube containing 100 µl of a 6% EDTA solution. Samples were immediately stored on ice in a 
light-protecting box. At every time point, a dried blood spot (DBS) was collected on 
Whatman 903 filter paper (Novolab) after the needle was withdrawn from the vein, to 
determine the haematocrit (HCT) through potassium measurement.(Capiau et al. 2013) Figure 
VI.1 gives a schematic overview of the sampling schedule. 
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Group NEG WTR GAR FAR POS 
n (total) 12 12 12 12 12 
n (at time of euthanasia) 8 9 12 12 12 
animal weight at the start 
of the repletion period [g] 
204
±14  a
 207
±13  a
 199
±18  a
 210
±16  a
 211
±14  a
 
animal weight at time of 
death [g] 
154
±19  a
 175
±20  a
 254
±17  b
 253
±12  b
 241
±16  b
 
day of euthanasia (after 
the 50-day folate 
depletion period) 
24 29 83 83 83 
feed consumption on the 
second day of the 
repletion period [g/day] 
8.64
±1.38  a
 9.15
±1.14  a
 9.86
±0.18  a
 9.53
±1.12  a
 9.81
±0.29  a
 
feed consumption two 
days prior to euthanasia 
[g/day] 
4.1
±2.7  a
 5.4
±4.8  a
 11.3
±1.1  b
 11.7
±0.3  b
 11.2
±1.1  b
 
rice consumption entire 
supplementation period 
[mg/day] (min – max) 
/ 
267 
(224 - 361) 
197 
(156 - 243) 
221 
(112 - 487) 
/ 
folate intake entire 
supplementation period 
[µg/rat/day] (min – max) 
0 
0.11
±0.01  a 
(0.075-0.120) 
3.00
±0.07  b 
(2.69-3.19) 
3.12
±0.78  c 
(2.34-3.32) 
20.4
±4.2  d 
(11.4-25.0) 
Table VI.2: Key experimental parameters; Values indicate mean ± standard deviation; groups with shared 
letters are not significantly different; Daily feed consumption shown in Figure VI.2. Average folate intake 
during the entire supplementation period, expressed per kilogram feed, was calculated only when feed intake 
surpassed 6 g/day; NEG, negative control group; WTR, wild type rice group; GAR, folate rice group; FAR, 
folic acid fortified rice group; POS, positive control group. 
4.3. Sample analysis 
Plasma and RBC folates were analyzed using a validated in-house developed liquid 
chromatographic tandem mass spectrometric (LC-MS/MS) method.(Kiekens et al. 2015a; 
Chapter V) Briefly, 500 µl phosphate buffered saline (PBS) was added to 300 µl of whole 
blood. After centrifugation, the supernatant was collected and L-ascorbic acid, dithiothreitol 
and 
13
C-labeled internal standards were added prior to storage at -80°C. The remaining cell 
pellet was washed three times with PBS after which the RBCs were selectively lyzed using 
800 µl of an ammonium carbonate buffer. RBC extracts were treated with rat serum folate 
conjugase to convert folate polyglutamates to the corresponding monoglutamates. Sample 
clean-up was performed for both plasma and RBC extracts using reversed phase C18 solid 
phase extraction in a 96-well format. The purified samples were injected onto a Waters 
Acquity UHPLC system equipped with a Waters HSS T3 C18 column and a Vanguard guard-
column. Detection of the 6 folate species (tetrahydrofolate, THF; folic acid, FA; 5-
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methyltetrahydrofolate, 5MeTHF; 5,10-methenyltetrahydrofolate, 5,10CH
+
THF; 10-
formylfolic acid, 10FoFA and 5-formyltetrahydrofolate, 5FoTHF) was performed using an 
ABSciex API 4000
TM
 triple quadrupole mass spectrometer in scheduled MRM-mode. The 
method was validated based on EMA guidelines and the acceptance criteria specified therein. 
This validation encompassed selectivity, accuracy, precision, linearity, matrix effect and 
recovery, as well as long term stability during sample storage at -80°C and autosampler 
stability. 
The folate content in both folate rice and FA fortified rice was verified with the same 
equipment as described above, using an existing validated LC-MS/MS method, with minor 
modifications.(De Brouwer et al. 2010) Four hundred rather than 200 units of α-amylase were 
added to further reduce the viscosity of the sample. In addition, scheduled multiple reaction 
monitoring (sMRM) was applied, allowing the acquisition of more data points per analyte. 
Although a presence, up to 10.9%, of 10-formyldihydrofolate was reported in white rice, its 
accurate quantification is not possible due to the lack of a pure reference standard.(Pfeiffer et 
al. 1997) When following the mass transitions of this compound, we could not detect it in 
wild type rice and folic acid fortified rice, while it was present at trace amounts (<1% of total 
folate) in GA rice. Folate concentrations in rodent diets were determined using the method 
described in Chapter IV.(Kiekens et al. 2015b) 
Haematological analysis was performed using a Sysmex XE-5000 Automated Haematology 
System. Quantification of potassium in DBS extracts (which allows to estimate the HCT) was 
performed using a Cobas
®
 8000 Modular Analyser (Roche Diagnostics). Briefly, a 3-mm 
punch was collected and extracted twice with 50 µl of 2.5 mM of KCl. After centrifugation 
for 1 minute at 5000 g, respectively 40 and 50 µl of supernatant were collected into an 
injection cup. Calibrators were prepared by removal or addition of rat plasma, starting from a 
pool of rat whole blood with a HCT of 0.39, as verified by haematological 
measurement.(Capiau et al. 2013) 
Homocysteine and vitamin B12 measurements were performed with a homocysteine Liquid 
Stable Reagent Kit enzymatic assay (Axis-Shield) and Vitamin B12 immunoassay (Roche 
Diagnostics) using a Modular-P and Modular Analytics E170 system (Roche Diagnostics), 
respectively. Because of the limited sample volume, all samples were diluted 3-fold with PBS 
prior to analysis.(Kellogg et al. 2005) 
4.4. Statistical analysis 
All statistical analyses were performed using IBM SPSS22. Multiple comparisons were 
performed using the Dunnett’s T3 algorithm as nearly all groups show differences in sample 
size and variance. Results below the limit of quantification were not included into the 
statistical analysis. When less than 6 results remained, this was mentioned since this 
compromises the power of the statistics. The treatment groups were compared at the 5% 
significance level. Where possible the 95% confidence interval was indicated in the graphs. 
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All box-and-whisker plots, composed of the first, second (=median) and third quartiles as well 
as the minimal and maximal values, were made in Microsoft Excel
®
. 
VI.5. Results and discussion 
Folates present in the diet are transported from the small intestine to the portal circulation. 
Upon arrival in the liver, they are either polyglutamylated and stored in the hepatocytes or are 
released into the systemic circulation or the bile.(Steinberg et al. 1979) The latter causes an 
enterohepatic recirculation and reabsorption into the portal circulation.(Kurata et al. 1993) 
Every study evaluating biological efficacy of a food item in laboratory animals has the 
intrinsic shortcoming that animals can never fully replace humans. With respect to folates, a 
relevant difference is e.g. that rats release bile into the intestine through a bile duct, causing a 
difference in the enterohepatic recirculation. Also, in rats the activity of intestinal folate 
conjugase is lower than that observed in humans. However, since 90% of folates in folate rice 
are present as monoglutamates, the effect of this limitation in enzymatic deconjugation should 
be negligible.(Wang et al. 1985; McKillop et al. 2006; Storozhenko et al. 2007) In this study, 
using a folate-depleted rat model, we determined whether or not folates, present in folate rice 
are released in the gastrointestinal system and can reach the systemic circulation.  
A first factor determining the biological availability of a compound is its bioaccessibility, or 
its availability for absorption in the GI-tract. This was nicely demonstrated for ferulic acid, 
the most abundant phenolic acid in wheat, which has very low bioaccessibility from wheat 
and derived products but high bioaccessibility when added in free form to e.g. flour.(Mateo 
Anson et al. 2009) In addition, in animal studies investigating the biological availability of a 
compound of interest from a natural crop, these crops are usually ground or lyophilized and 
the resulting powder is mixed into food pellets. This can possibly influence the liberation of 
nutrients through the destruction of the natural barriers. In the case of rice, the nutrients 
contained within the endosperm, such as folates, can easily be released when the rice is 
ground into a fine powder. This was clearly observed by O’Dea et al. in an in vitro 
digestibility study of ground and unground rice. These authors found that after 30 minutes of 
incubation with pancreatic amylase, ground polished rice was 71.8% hydrolyzed while 
unground polished rice was only 30.8% hydrolyzed. In unpolished rice, the difference was 
even greater with a respective hydrolysis rate of 68.2 and 17.6% of ground versus non-ground 
rice. Since folates are contained within the endosperm, or the starchy interior, of the rice 
grain, the use of ground rice would affect the speed by which folates are released from the 
grain.(O’Dea et al. 1981; Gregory 3rd 2001) To avoid this potential artefact in this study, we 
provided the animals with intact rice grains. Full consumption of these rice grains was 
observed before providing the daily amount of rodent diet to the animal. Following this 
procedure, the folates are absorbed from the rice grains in a more realistic way. 
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5.1. Food consumption, animal weight and general health status 
Over the 50-day depletion period the animals consumed on average 12.1 grams of folate 
depleted rodent feed per day, with a minimum of 9.6 and a maximum of 13.8 g/animal/day. 
From 37 days of folate depletion on, a decreased feed intake was observed in all animals. This 
feed intake continued to decrease in the negative control and wild type rice group, with a 
respective average feed consumption of only 4.1 (day 22) and 5.4 (day 27) grams of feed per 
animal per day (Table VI.2, Figure VI.2). A paired feeding approach was applied, in which 
the negative control group, which consumed least feed -provided to this group ad libitum- 
determined how much feed the other groups received, with a minimum of 6 g/day. After 
euthanasia of the negative control group (day 24), the amount of diet given to the remaining 
animals was augmented again to 12 g/day per animal. The wild type rice group showed a 
transient increase in feed consumption, before a sharp drop shortly prior to euthanasia (day 
29). In the other groups, the food was entirely consumed, although a slight decrease in food 
consumption was observed during the later stage of the study, possibly due to the fact that the 
animals neared their mature body weight while a growth diet was provided to them. Animal 
weight showed strong correlation with feed intake (Figures VI.2 and VI.3). At the time of 
euthanasia of the negative control group, the average weight of these animals had dropped 
more than 20%, from 204 to 160 grams (weight of animals that died spontaneously was not 
taken into consideration). Given the paired feeding approach, also all other groups had lost 
weight, although less pronounced. After euthanasia of the negative control group, the 12 
gram/day diet per animal allowed the average bodyweight to increase gradually to 
approximately 250 grams at the end of the trial. Neither at the time of euthanasia of the wild 
type rice group, after 24 days of supplementation (p≥0.06), nor at the end of the trial, after 83 
days of supplementation (p≥0.18), was there a significant difference in bodyweight of the 
animals assigned to different treatment groups.  
On day 11 of supplementation the first visual symptoms of folate deficiency appeared. 
Animals from both the group receiving folate depleted diet and the group additionally 
receiving wild type rice suffered from hemorrhagic lesions at the mouth and front paw region, 
leading to lethality, starting at day 18. Seven animals died spontaneously during the trial: 4 in 
the negative control group and 3 in the wild type rice group. In some animals a lesion at the 
corners of the eyes was observed. For ethical reasons, to limit the distress of the animals, 
euthanasia was performed on day 24 for the negative control group and on day 29 for the 
animals receiving wild type rice. 
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Figure VI.2: Average feed consumption per animal per day; NEG, negative control group; WTR, 
wild type rice group; GAR, folate rice group; FAR, folic acid fortified rice group; POS, positive 
control group. 
 
 
Figure VI.3: Average weight of the animals during the course of the feeding trial; NEG, 
negative control group; WTR, wild type rice group; GAR, folate rice group; FAR, folic acid 
fortified rice group; POS, positive control group. 
Only animals in the negative control and wild type rice group suffered from hemorrhagic skin 
lesions and natural deaths, which can be linked to the pronounced folate deficiency. The feed 
intake of these groups gradually decreased down to 33% of the original feed intake. To avoid 
that differences between the distinct groups would merely reflect differential feed intake, we 
applied pair feeding, taking food consumption of the negative control group as the reference. 
With the exception of some animals from the wild type rice group, all other animals fully 
consumed the limited amount of feed offered to them through pair feeding. After euthanasia 
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of the negative control group, the amount of feed offered was increased to 12 g/animal/day, 
after which a steady increase in body weight was observed. Though folate intake is not 
directly related to animal weight, it can be concluded that severe folate deprivation has an 
impact on overall health status, which results in a reduced feed intake, leading to a decrease in 
body weight. These observations are consistent with previous reports on folate-depleted 
rats.(Aboko-Cole and Lee 1974; Clifford et al. 1989) 
5.2. Folate status 
At the start of the supplementation (i.e. after 50 days of folate depletion) there was no 
significant difference in RBC folate concentrations between the different treatment groups 
(p=1.00). However, readily at the first blood sampling (day 11), three distinct groups could be 
distinguished, based upon RBC folate concentrations (Figure VI.4A). In both the negative 
control group and the wild type rice group a significant decrease in folate status was observed 
(p<0.01), where after 24 days of supplementation, total folate concentrations had dropped to 
122 and 172 nM, respectively. In contrast, RBC folate concentrations in the positive control 
group -receiving approximately 20 µg FA / day- rose to an average of 1093 nM after 24 days 
and continued to rise to 1884 nM at the end of the trial. In the groups receiving the minimal 
folate supplementation of approximately 3 µg folate/day, either via folate rice or via FA 
fortified rice, the total RBC folate concentrations on day 24 were 385 and 271 nM, 
respectively. For these two groups, RBC folate concentrations stabilized at the end of the trial, 
respectively yielding concentrations of 451 and 507 nM, with no significant difference 
between the two groups (p=0.27) (Table VI.3) . 
group (n) NEG (8) WTR (9) GAR (12) FAR (12) POS (12) 
plasma folate [nM] <LLOQ <LLOQ 5.4
±1.2  a
 10.1
±2.4  b
 137
±11  c
 
RBC folate [nM] 122
±49  a
 143
±33  a
 451
±66  b
 507
±94  b
 1884
±189  c
 
homocysteine [µM] 154
±32  a
 155
±45  a
 46.6
±18.0  b
 30.3
±10.6  b 
8.5
±2.7  c
 
vitamin B12 [ng/l] 503
±213  a b 
448
±96  b
 741
±105  a 
691
±121  a
 804
±131  a
 
Table VI.3: Plasma and RBC analysis; Data obtained at the time of euthanasia; Values indicate 
mean ± standard deviation; groups with shared letters are not significantly different; <LLOQ, 
lower than 1 nM; NEG, negative control group; WTR, wild type rice group; GAR, folate rice 
group; FAR, folic acid fortified rice group; POS, positive control group. 
 
When looking at the pattern of folates, 5MeTHF was the main folate species that could be 
quantified in RBC extracts, constituting 88-97% of total folates (Figure VI.5). At the time of 
euthanasia of the negative control group and wild type rice group, the amount of non-
5MeTHF-folates had risen to 27.5 and 17.3%, respectively. In contrast, towards the end of the 
trial the fraction of non-5MeTHF-folates declined to 3.3% in the positive control group. In the 
FA fortified rice and folate rice groups, the non-5MeTHF fraction remained fairly constant 
throughout the trial and ranged from 6.1 to 9.9%, with a maximum value of 12.7% at 24 days 
of repletion. Apart from 5MeTHF also THF and 5,10CH
+
THF could be consistently 
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quantified in RBCs, with respective concentrations of 6.2 to 24.4 and 6.7 to 45.7 nM. FA was 
only found up until 24 days since the start of the repletion, in concentrations ranging from 5.7 
to 20.7 nM (Figure VI.5). 
 
Figure VI.4: Panel A: RBC total folate; panel B: plasma total folate; both 
represented on a log-scale; NEG, negative control group; WTR, wild type 
rice group; GAR, folate rice group; FAR, folic acid fortified rice group; 
POS, positive control group. 
Similar to the folate concentrations measured in RBC’s, three response groups could be 
distinguished based on the plasma folate concentrations (Figure VI.4B). In both negative 
control and wild type rice groups the plasma folate concentration was halved after 11 days of 
rice feeding and was no longer quantifiable after 24 days. In contrast, plasma folate 
concentrations increased slowly in the groups receiving folate rice or FA fortified rice to 
respectively 5.2 and 5.1 nM after 24 days of supplementation, which were not significantly 
different (p=1.00). At the end of the trial, the plasma folate concentrations of these groups, 
resp. 5.4 and 10.1 nM, were significantly different (p<0.01) (Table VI.3). In the positive 
control group the plasma concentration increased rapidly to 71.2 nM after 24 days of 
supplementation and continued to rise to 137 nM at the end of the trial. During the study FA 
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could occasionally be quantified in samples of all groups, in a concentration ranging from 1.3 
to 3.8 nM (Figure VI.6). 
The plasma folate concentrations were clearly related with folate intake. Concentrations in 
both the negative control and wild type rice group continued to decline after the folate 
depletion phase of the trial. This shows that the limited amount of folates present in wild type 
rice is too low to serve as a considerable folate source, since no folates were measurable at the 
time of euthanasia. The positive control group did show a strong increase in plasma folate 
concentrations, as could be expected from the large amount of FA present in the diet. After 24 
days, plasma folate concentrations in groups receiving folate rice and FA fortified rice were 
significantly different from both the positive control group, the negative control group and the 
group receiving wild type rice (p<0.01). At the end of the trial (day 83) there was also a 
significant difference between the groups receiving either folate rice or FA fortified rice, with 
an almost double plasma folate concentration (Figure VI.4B) in the latter group (p<0.01). 
Several reasons may underlie this result. First, a difference between the GAR and FAR groups 
could be explained by a somewhat lower bio-availability of natural folates.(Lewis et al. 1999) 
Second, a difference in kinetics between FA and 5MeTHF may also lead to this observation. 
As described in literature, there is a difference in absorption and absorption rate of FA and 
food-derived THF species: while FA requires reduction and methylation in the bowel 
epithelium or in the liver, 5MeTHF does not and is thus readily transferred to the systemic 
circulation.(Wright et al. 2005; Caudill 2010; Castorena-Torres et al. 2014) As a result, the 
plasma response to FA may be slower and, in our case, may still be increased to a higher 
extent at the time of sampling than the response following ingestion of natural folates 
(primarily 5MeTHF).(Wright et al. 2005) While cut-off values for rodents are lacking, 
Clifford et al. reported on animal weight and serum and liver folate concentrations. These 
authors found that 125 to 500 µg FA/kg diet resulted in serum folate concentrations of 
approximately 16 nM, somewhat higher than the concentrations we observed with GA or FA 
rice supplementation (resp. 5.4 and 10.1 nM), while a higher supplementation led to a drastic 
increase of the serum folate concentration, similar to what we observed in the positive control 
group.(Clifford et al. 1989) Although FA in serum has been reported when high amounts of 
FA are consumed (Kelly et al. 1997), we could only occasionally quantify FA in plasma 
samples. As these FA-positive samples appeared in all groups, FA presence was not related to 
FA intake. These findings are in accordance with literature: while a peak concentration of FA 
in serum occurs rapidly after intake of FA (< 2h) in both rats and humans (Steinberg et al. 
1979; Castorena-Torres et al. 2014), we performed sampling after overnight starving of the 
animals, to rule out short-term differences that could be related to very recent feed intake. 
Similar to plasma, the RBC folate concentrations were not significantly different between the 
negative control group and the group receiving wild type rice, with respective average RBC 
folate concentrations measured prior to euthanasia of 121.7 and 143.4 nM (p=0.33). These 
concentrations correspond with a severe depletion of folate stores in these groups. It is clear 
that this will strongly impair nucleotide synthesis, thus disrupting homeostasis (e.g. normal 
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erythropoiesis), leading to symptoms of severe folate deficiency and eventually death.(Bills et 
al. 1992; Stabler 2010) In contrast, repletion with a folate-rich positive control diet after the 
50-day depletion period resulted in a quick re-establishment of RBC folate concentrations, 
with an average measured total folate concentration of 1884 nM at the end of the trial. Also 
the groups receiving folate rice or FA fortified rice were able to maintain an adequate RBC 
total folate concentration, at the end of the trial stabilizing to a concentration of respectively 
450.7 and 507.3 nM. Although these concentrations were not significantly different (p=0.27), 
the lower concentrations in the folate rice group are likely the result of the reported 
approximate 80% bioavailability of food folates, as compared to FA in humans.(Winkels et 
al. 2007) However, a small part of the difference between these two groups may also originate 
from the slightly lower average folate intake of the animals in the folate rice group (3.00 
compared to 3.12 µg/animal/day; see Table VI.2). The RBC-folate concentrations measured -
though not as high as those observed in the positive control group- are above the 340 nM cut-
off value for folate deficiency in humans, as suggested by the World Health Organization 
using homocysteine as a metabolic indicator.(WHO 2012) Also, it is possible that the FA does 
not penetrate the rice grain completely during the parboiling process. This could also facilitate 
the release of FA from fortified rice in the bowel. 
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Figure VI.5: Average red blood cell folate speciation with day of sampling specified above; only measurements exceeding the lower limit of quantitation are 
shown, reducing sample size. When averages represent less than 6 values, n is indicated; all other measurements are averages of measurements from at least 
half of the animals; NEG, negative control group; WTR, wild type rice group; GAR, folate rice group; FAR, folic acid fortified rice group; POS, positive 
control group. 
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Figure VI.6: Average plasma folate speciation with day of sampling specified above; only measurements exceeding the lower limit of quantitation are 
shown, reducing sample size. When averages represent less than 6 values, n is indicated; all other measurements are averages of measurements from at 
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5.3. Homocysteine and vitamin B12 concentrations 
At the time of euthanasia, the average plasma homocysteine concentration in the negative 
control and wild type rice groups was more than 18 times higher (resp. 154 and 155 vs. 8.5 
µmol/l) than in rats receiving the positive control diet containing approximately 2000 µg 
FA/kg feed (Table VI.3; Figure VI.7). While average plasma homocysteine concentrations in 
rats receiving a limited folate supplementation of 3 µg folate /day via folate rice or FA 
fortified rice were significantly lower (resp. 46.6 and 30.3 µmol/l) than those in the negative 
control and wild type rice group (p<0.01), these concentrations remained significantly higher 
than those in positive control diet animals (p<0.01) (Figure VI.8).  
 
Figure VI.7: Plasma homocysteine concentration at time of euthanasia (Table VI.3); groups with 
shared letters are not significantly different; NEG, negative control group; WTR, wild type rice 
group; GAR, folate rice group; FAR, folic acid fortified rice group; POS, positive control group. 
Analysis of homocysteine in plasma clearly showed the disruption of the methylation cycle in 
the negative control and wild type rice groups, with a more than 18 fold higher concentration 
than in samples obtained from the positive control group. This observation is in line with the 
report by Duncan et al., who observed an inverse correlation between plasma folate and 
homocysteine concentrations.(Duncan et al. 2013) Moreover, the plasma homocysteine 
concentrations we observed for the folate rice and folic acid fortified rice group (respectively 
46.6±18.0 and 30.3±10.6 µmol/l) are in line with those reported by House et al. (25.0±2.8 
µmol/l), who supplemented rats with a diet containing 250 µg folate/kg during a 4 week 
repletion trial following 6 weeks of depletion.(House et al. 2003) However, also samples 
obtained from rats receiving folate rice or FA fortified rice had on average 5- resp. 3-fold 
higher plasma homocysteine concentrations than those observed in the positive control group 
(Figure VI.7). Similar to what was observed from the RBC folate measurements, the 
difference between the plasma homocysteine concentrations in the GAR and FAR groups, 
46.6 ±18.0 and 30.3 ±10.6 µmol/l respectively, might indicate a lower net absorption of 
folates from folate rice compared to folic acid fortified rice. Hence, it can be concluded that, 
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while a 12-week folate supplementation via folate rice (3.00 µg folates/day or 311 µg 
folate/kg feed) or folic acid fortified rice (3.12 µg folate/day or 313 µg folate/kg feed) is 
sufficient to prevent or counter prominent homocysteine accumulation in rats, an even higher 
supplementation is needed to keep (or bring) homocysteine concentrations down to normal 
levels (about 6.4 µmol/l, as observed by Miller et al.), as those observed in our positive 
control group. (Miller et al. 1994) 
Although at the time of euthanasia all groups had plasma vitamin B12-concentrations higher 
than the cut off value of 300 ng/l for deficiency in humans (Klee 2000), lower concentrations 
were present in the negative control and wild type rice group. Only the latter was significantly 
lower than the concentrations measured in the folate rice, FA fortified rice and positive 
control group (p<0.01) (Table VI.3; Figure VI.8). The lower vitamin B12 concentrations in 
the negative control and wild type rice group are likely due to the fact that these animals were 
sacrificed at the time they had a reduced feed intake. 
 
Figure VI.8: Plasma vitamin B12 concentration at time of euthanasia (Table VI.3); groups with 
shared letters are not significantly different NEG, negative control group; WTR, wild type rice 
group; GAR, folate rice group; FAR, folic acid fortified rice group; POS, positive control group. 
5.4. Dried blood spot hematocrit estimation 
After the 50-day depletion period the average HCT estimated via dried blood spot potassium 
analysis had dropped from the normal value of approximately 0.40 (Harlan Laboratories 
2011) to approximately 0.32. While the anemia observed in the folate rice, FA fortified rice 
and positive control groups quickly normalized, the average HCT of the negative control and 
wild type rice group continued to decline. As compared to the other groups, the negative 
control and wild type rice group had a significantly lower estimated HCT of respectively 0.20 
and 0.27 after 11 days of supplementation (p<0.01) and 0.18 and 0.20 prior to euthanasia at 
resp. 24 and 29 days after the start of the trial (Figure VI.9A). In contrast, in all other groups, 
the hematocrit had already normalized after 11 days of supplementation, not yielding 
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significant differences between these groups (p≥0.76) and remaining normal throughout the 
trial, irrespective of the extent of folate supplementation (limited in the GAR and FAR groups 
and high in the POS group). 
 
Figure VI.9: Panel A: hematocrit estimation based on DBS-sampling via potassium 
measurement; panel B: hematocrit measurement in whole blood at time of euthanasia 
(Table VI.4); groups with shared letters are not significantly different; extreme values 
are indicated by dots NEG, negative control group; WTR, wild type rice group; GAR, 
folate rice group; FAR, folic acid fortified rice group; POS, positive control group. 
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5.5. Hematological analysis 
Analysis of whole blood samples obtained at the time of euthanasia confirmed the results 
obtained via K-based HCT estimation: the average HCT of the negative control and wild type 
rice group was significantly lower (p≤0.05) than that of the other groups (Figure VI.9B). The 
same trend was found for the relative reticulocyte (immature RBCs) count (p<0.01). Only the 
negative control group had a significantly lower average RBC size, expressed as mean 
corpuscular volume (MCV), compared to all other groups (p≤0.04) (Table VI.4). 
group (n) NEG (8) WTR (9) GAR (12) FAR (12) POS (12) 
mean hematocrit 
from WB [-] 
0.248
±0.043 a
 0.203
±0.026a
 0.438
±0.024 b
 0.410
±0.058 b
 0.448
±0.039 b
 
mean hematocrit 
from DBS [-] 
0.177
±0.035 a
 0.201
±0.030 a
 0.441
±0.056 b
 0.420
±0.065 b
 0.455
±0.030 b
 
mean corpuscular 
volume [fl] 
51.7
±1.4 a
 54.8
±2.0 b
 57.8
±2.0 b
 58.3
±3.5 b
 55.3
±1.8 b
 
relative reticulocyte 
count [‰] 
6.2
±3.3 a
 7.2
±5.3 a
 26.0
±2.7 b
 27.6
±5.8 b
 22.7
±3.7 b
 
Table VI.4: Results obtained following hematological and dried blood spot (DBS) analysis of whole blood 
at the time of euthanasia; Values indicate mean ± standard deviation, groups with shared letters are not 
significantly different NEG, negative control group; WTR, wild type rice group; GAR, folate rice group; 
FAR, folic acid fortified rice group; POS, positive control group. 
The HCT measurements clearly show that only the animals receiving a diet supplemented 
with FA in case of the positive control group and the animals receiving folate or FA fortified 
rice were able to regain a normal HCT value. Folate deficiency results in the impairment of 
deoxynucleotide synthesis and the loss of terminally differentiating erythroblasts through 
apoptosis during the S-phase of the cell cycle. In mature animals, this typically results in the 
release of immature, large erythroblasts, which can be measured by an increase of MCV, 
known as megaloblastic anemia. However, the MCV values found for the negative control 
and wild type rice groups were lower than those found for the other groups, which is in 
agreement with Koury et al., who found that macrocytosis does not accompany anemia in 
young animals due to their larger folate requirement.(Koury et al. 1997) Also, using the 
Sysmex XE-5000, erythroblasts are not included in the MCV measurement. While no 
significant difference was observed between the folate rice, FA fortified rice and positive 
control groups (p≥0.19), the significantly reduced (p<0.01) relative reticulocyte count of the 
negative control and wild type rice group clearly indicates an impairment of erythropoiesis 
and the failure to remediate the onset of the anemia present in these animals. Overall, these 
findings are in accordance with those of Kim et al. who recorded bodyweight, hematological 
parameters and plasma folate and homocysteine during a 5 week study. (Kim et al. 2002)  
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VI.6. Conclusion 
The use of an accepted fortification technique, the fortification of rice with synthetic FA by 
parboiling, served as a benchmark for synthetic folate-fortified food. From the data gathered 
here, it is clear that both folate rice and FA fortified rice could sustain a folate status that 
allowed the animals to grow and remain apparently healthy. The observed difference in 
plasma folate concentrations is likely the result of a difference in absorption rates between FA 
present in FA fortified rice and 5MeTHF and other folates present in folate rice. Even the 
limited folate supplementation of 3 µg folate/day, supplied either via folate rice or via FA 
fortified rice allowed rapid normalization of HCT values. The resulting folate concentrations 
were sufficient to counter the major rise in plasma homocysteine concentrations, although not 
yet optimal, as a result of the limited folate supplementation as compared to normal rat feed. 
All together, we have provided evidence that folates from folate rice are released in the 
gastrointestinal system following consumption by rats, reach the systemic circulation, are 
incorporated in RBCs and are biologically active, as evidenced by folate determination in 
plasma and RBCs, the alleviation of anemia and counteraction of pronounced 
hyperhomocysteinemia. Pending confirmation of these findings in a human trial, locally 
grown folate rice may serve as a source of folate in regions of the world where traditional 
fortification techniques are not feasible. 
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VII.1. Abstract 
While following decades of research, the importance of folate status for the health of an 
individual is evident, the manner in which folates influence health status is often not so clear. 
Few studies have evaluated the direct impact of folate concentrations in plasma or growth 
medium on cellular responses. 
In 2004, Courtemanche et al. reported a significant difference in proliferation behavior 
between CD4+ and CD8+ T lymphocytes in response to different folate concentrations. As 
the reason for this difference was not clarified, further research was needed to characterize 
how folate deficiency affects different immune responses and the proliferation of lymphocytes 
in particular. 
We performed an in vitro study, investigating the influence of the folate species used, folic 
acid or 5-methyltetrahydrofolate (the main species in vivo), on the proliferation of CD2+, 
CD4+ and CD8+ primary T lymphocytes. Besides monitoring cell proliferation, we also 
determined the folate concentration within these subsets following cultivation. From these 
results, it was apparent that the dependence of cell replication on folate concentration depends 
on the folate species used. 
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VII.2. Introduction 
Cellular metabolism relies on a continuous supply of folate, a group of water soluble B-
vitamins (B9), to maintain DNA-synthesis and proper cell proliferation. Folate deficiency has 
been implicated in several health disorders including cancers, neural damage and cardio-
vascular disease as a result of hyperhomocysteinemia. To date, only the link with neural tube 
defects has been formally proven.(Stover 2004; Blom and Smulders 2011; Jagerstad 2012) 
Since folate status impacts nucleotide synthesis and therefore cell proliferation, folate 
deficiency hypothetically impacts the functioning of the immune system by arresting the cell 
cycle in the S-phase. This was demonstrated by Courtemanche et al. through in vitro culturing 
of peripheral blood mononuclear cells (PBMCs). Interestingly, these authors found an inverse 
relation between the CD4+/CD8+ lymphocyte ratio and folic acid (FA) concentrations in 
vitro.(Courtemanche et al. 2004) This was primarily owing to the fact that the proliferation of 
activated CD8+ cells appeared to be more sensitive to differences in FA concentrations. 
However, Kishimoto et al. investigated the immune function of a patient suffering from 
hereditary folate malabsorption prior to and after treatment. Apart from a low general 
lymphocyte proliferation rate due to the morbidly low folate status of the patient, no 
difference was observed in the relative presence of CD4+ and CD8+ lymphocytes before and 
after intravenous administration of 12 mg 5FoTHF/day.(Kishimoto et al. 2014) In a study 
investigating the influence of folate supplementation on age-related immune suppression 
using a rat model, cell proliferation was improved when dietary folate intake was increased, 
however, no significantly different CD4+/CD8+ ratio was observed between the treatment 
and the control group.(Field et al. 2006) While 5-methyltetrahydrofolate (5MeTHF) has been 
used as an in vitro folate source to investigate the effect of folate status on DNA stability, 
only the use of high FA concentrations in the growth medium increased cell viability after 9 
days of incubation.(Wang and Fenech 2003) In this chapter, we investigated the influence of 
the folate concentration in the growth medium on the in vitro cell proliferation of CD2+, 
CD4+ and CD8+ lymphocytes and quantified the resulting intracellular folate concentration. 
VII.3. Objectives 
Based on an in vitro study performed by Courtemanche et al., we wanted to evaluate whether 
the intracellular folate concentration correlates with the extracellular folate concentration (i.e. 
the concentration in the growth medium) or remains constant, which is important to maintain 
DNA methylation. As such, the relationship between the proliferation rate and the 
intracellular folate concentration could be evaluated. Also, the use of 5MeTHF instead of FA 
as a folate source should be evaluated since the former more closely resembles in vivo 
circulating folate speciation. 
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VII.4. Materials and methods 
4.1. Reagents and materials 
4.1.1. Cell separation 
The basic procedure proposed by Courtemanche et al. was upscaled to obtain a larger amount 
of cells for intracellular folate analysis.(Courtemanche et al. 2004) Concentrated buffy coats 
were obtained from the Belgian Red Cross and treated as described by Meyer et al.(Meyer et 
al. 2005) Briefly, 10 ml of concentrated buffy coat was mixed with 10 ml of sterile PBS. This 
mixture was then layered carefully on top of 15 ml Ficoll-Paque
TM
 Plus (GE Healthcare Bio-
Sciences AB, Uppsala, Sweden). Following centrifugation at 445 g for 35 minutes at room 
temperature, the cells at the interface of the Ficoll and plasma/PBS layer were transferred to a 
sterile tube. To remove remaining traces of Ficoll, these cells were washed twice with 20 ml 
of sterile PBS and centrifuged at 200 g for 15 minutes. 
4.1.2. Cell culture 
Cells were cultured at 37°C and a CO2 concentration of 5 vol% in 20 ml folate free RPMI 
1640 medium (Life Technologies, Carlsbad, CA, USA) at an initial density of 10
6
 cells/ml. 
This medium was supplemented with 10% dialyzed fetal bovine serum to sustain cell viability 
(dFBS, Life Technologies) and Pen-Strept 5000U (Life Technologies) as antibiotic. At the 
start of the incubation, phytohemagglutinin (PHA, Sigma-Aldrich, Darmstadt, Germany) and 
interleukin 2 (IL-2, ED 50 range = 0.08-0.5 ng/ml, Life Technologies) were added in 
concentrations of 22 µg/ml and 0.01 µg/ml, respectively. The medium was refreshed every 3 
days, at which time the cells were spun down at 200 g for 5 minutes at 21 °C and 90% of 
medium was replaced by fresh medium. While fresh IL-2 was added to promote cell 
proliferation, PHA was only necessary for initial cell activation and was only included at the 
start of incubation. At the second time of refreshing, the cells were counted and returned to 
the original density to prevent too high cell densities. 
FA (Sigma-Aldrich) or (6S)-5MeTHF (Schircks Laboratories, Jona, Switzerland) were 
weighed, dissolved and diluted in deoxygenated PBS to a final concentration of 4.4 and 4.6 
µg/ml (9.98 and 10.0 µM), respectively. This solution was sterilized using a 0.22 µm syringe 
filter. Aliquots were stored at -80 °C and discarded after use. 
4.1.3. Cell sorting and lysis 
Positive cell selection was performed using Easysep
TM
 kits for human cells expressing the 
CD2, CD4 and CD8 antigens, which were obtained from Stemcell Technologies (Grenoble, 
France). This selection was performed as prescribed by the manufacturer. Briefly, cells were 
suspended at a concentration of 10
8
 cells/ml in 10/90 v/v% dFBS/PBS. Then, 50 µl/ml (CD4) 
or 100 µl/ml (CD2 and CD8) of positive selection cocktail was added, followed by incubation 
at room temperature for 3 (CD4 and CD8) or 5 minutes (CD2). Then, 50 µl/ml of magnetic 
microparticle suspension was added and incubated for 3 (CD4 and CD8) or 10 minutes (CD2) 
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at room temperature. After adding 10/90 v/v% dFBS/PBS to a total volume of 2.5 ml, the 
sample was placed in an Easysep
TM
-magnet for 3 minutes, after which the supernatant was 
poured off. The cells were washed twice with 2.5 ml of 10/90 v/v% dFBS/PBS. The 
supernatant was either collected after each step pending the selection of another cell type or 
transferred to waste. 
The selected cells were washed twice with and resuspended in PBS to remove any 
extracellular folates due to the presence of dFBS. Cell counting was performed manually 
using a Bürker counting chamber following staining with trypan blue. For intracellular folate 
analysis, the cells were lysed using 200 µl of Focus Whole proteome lysis buffer 
(GBioscience, St. Louis, MO, USA). To this, 250 µl of PBS and 50 µl of 100 mg L-ascorbic 
acid and 50 mg DL-dithiothreitol (Sigma-Aldrich)/ml, pH 7 was added. The internal standards 
(ISs, 
13
C5-THF, 
13
C5-FA, 
13
C5-5MeTHF, 
13
C5-5,10CH+THF) were added to the antioxidant 
solution in a concentration of 0.1 µg/ml. 
4.1.4. Extract purification and LC-MS/MS analysis 
Further analysis of the samples was performed as described earlier for the analysis of folates 
in plasma and red blood cells (RBCs).(Kiekens et al. 2015; Chapter V) Due to the need for 
enzymatic polyglutamate deconjugation, the sample treatment procedure for RBCs was 
applied to the cell extract. The efficacy of the rat serum conjugase (Harlan Laboratories, 
Horst, The Netherlands) treatment was verified by spiking 5MeTHF di-, tri- and 
tetraglutamate (Schircks Laboratories) to a mixture of cell lysis buffer, PBS and antioxidant 
solution and was found not to be hindered by the lysis buffer. However, due to the incomplete 
removal of endogenous folates from rat serum by treatment with activated charcoal (as 
described in Chapter V paragraph 4.1), the treatment was performed twice to further remove 
this folate background and increase sensitivity.  
4.1.5. Calibration 
Similar to the standard preparation procedure described in Chapter V for plasma folate, the 
calibration curves were generated by spiking individual folates (tetrahydrofolate (THF), FA, 
5MeTHF, 5,10-methenylTHF (5,10CH
+
THF), 10-formylFA (10FoFA) and 5-formylTHF 
(5FoTHF)) to a mixture of cell lysis buffer (200 µl), PBS (250 µl) and antioxidant solution 
(50 µl), matching the sample matrix. Apart from a zero sample (blank + ISs), 7 calibrators 
were used with concentrations of each folate individually ranging from 0.26 to 26 nmol/l. 
4.2. CD2+ proliferation in response to folate status 
Following Ficoll separation of PBMCs, 2*10
7
 cells were brought in 20 ml of folate free 
culture medium supplemented with 0, 10 or 100 nM of either FA or 5MeTHF. To verify the 
amount of folates in the growth medium, samples were collected after 3 days of incubation. 
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4.3. Stability of folates in growth media 
The chemical stability of FA and 5MeTHF was monitored by spiking either FA or 5MeTHF 
in a concentration of 100 nM to 20 ml folate free culture medium (in the absence of cells). 
Duplicate culture flasks were kept for 3 days in the incubator. Samples were collected daily, 
including one at the start of the experiment. 
4.4. CD4+ and CD8+ proliferation in response to folate status 
Based on the investigation into the proliferation of CD2+ cells and the evaluation of folate 
stability in growth medium, two changes were made to the study protocol. First, the folate 
free sample (0 nM) was omitted since it has limited clinical relevance. Second, 5 or 50 nM 
5MeTHF was added daily to replenish this folate species, which was lost due to degradation 
during incubation. From day 6 to day 9, the folate concentration in the medium was monitored 
to verify the efficacy of the 5MeTHF replenishment. 
Since culturing was performed in duplicate, the cell isolation order was altered between both 
replicates to reduce the potential influence of incomplete recovery. When CD4+ cells were 
selected first in one replicate, CD8+ cells were selected first in the other replicate. After 
selection of the distinct cell subsets, the cells from both replicates were counted and pooled 
for intracellular folate analysis. 
VII.5. Results and discussion 
5.1. CD2+ proliferation in response to folate status 
As was observed by Courtemanche et al., the FA concentration significantly influences the 
cell count after 9 days of incubation, as depicted in Figure VII.1A. The addition of 10 nM FA 
as a source of folate resulted in a 3-fold higher CD2+ cell count compared to cells exposed to 
folate free medium. However, an additional 15-fold increase in CD2+ cell count was observed 
for cells exposed to 100 nM of FA, indicating a concentration dependent growth response. 
This was accompanied by an increase in intracellular folate concentrations. While 5MeTHF 
was detectable in cells exposed to 10 nM FA folates, the signal was too low to allow for a 
quantification of its concentration. In the cells exposed to 100 nM FA, both 5MeTHF and FA 
could be quantified, as depicted in Figure VII.1B. The presence of FA is surprising since this 
is not a metabolically active compound. Given cell sorting and subsequent washing steps, the 
presence of FA is unlikely to be the result of contamination with growth medium. One 
possibility is that FA enters the cells as a result of passive diffusion. 
Also when 5MeTHF was present in the growth medium, cell counts significantly exceeded 
those obtained in the absence of folate (0 nM). Strikingly, cell counts for 10 and 100 nM 
5MeTHF were quite similar, lying in the same range as when supplementing the medium with 
100 nM FA. The intracellular concentrations did however show a dependence upon 
extracellular concentrations during incubation. In the cells exposed to 10 nM 5MeTHF, THF 
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and 5MeTHF could be quantified with THF being the major species. In cells exposed to  
100 nM 5MeTHF, 5MeTHF was the major folate species, while THF and 5,10CH
+
THF were 
also present. 
 
Figure VII.1: A: Total CD2+ cell count and B: Measured intracellular folate 
species following 9 days of incubation with varying folate content in the growth 
medium. 
5.2. Stability of FA and 5MeTHF during incubation in growth medium 
Analysis of the medium at the end of the CD2+ trial revealed a significantly decreased 
5MeTHF concentration, 10 times lower than that initially added to the medium. To investigate 
this further, a stability experiment was conducted, comparing the stability of 5MeTHF and FA 
during incubation. Daily sampling over a 3 day period revealed that FA remains fairly stable 
over time, while the 5MeTHF concentration decreases by approximately 50% per day (data 
depicted in Figure VII.2A). After 3 days, only approximately 10% of the initial 5MeTHF 
concentration remained. Based on the concentration over the first 48 hours, the area under the 
curve (AUC) was calculated. For 5MeTHF (2591 nM.h), the AUC was only 57% of that 
calculated for FA (4525 nM.h). 
Chapter VII: Effect of folate status on lymphocyte proliferation and intracellular folate levels 
 
154 
 
To remedy this disadvantage of 5MeTHF compared to FA, daily addition of 50% of the 
original 5MeTHF concentration was evaluated during the CD4+/CD8+ experiment. Over 2 
days, the medium was sampled prior to and after addition of fresh 5MeTHF and 6 hours after 
addition. This data, depicted in Figure VII.2B, shows the 5MeTHF and FA concentration over 
a 48-hour period. While the average 5MeTHF concentration is still lower than that of FA, its 
degradation is partly compensated for, avoiding the low 5MeTHF concentrations after 3 days 
measured during the CD2+ experiment. By replacing the 5MeTHF lost due to degradation, 
the AUC increased to 3740 nM.h while the AUC of FA (4739 nM.h) remained virtually the 
same. Relative to the AUC of FA, the AUC of 5MeTHF increased to 79% which is a vast 
improvement over the 57% obtained when the degradation of 5MeTHF is not compensated 
for. 
 
Figure VII.2: Periodic evaluation of FA and 5MeTHF stability in growth medium without (A) and 
with (B) replacement of degraded 5MeTHF (n=2). Note the difference in scale on the x and y-axes. 
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The observed instability of 5MeTHF, when not checked and compensated for, may have 
profound effects on the conclusions drawn from in vitro studies.  E.g. Wang and Fenech 
observed a higher cell viability at high FA concentration versus low FA and low or high 
5MeTHF concentrations which they related to a preferential uptake of FA compared to 
5MeTHF into lymphocytes. However, our findings suggest that their results are likely 
confounded by the limited stability of 5MeTHF during incubation.(Wang and Fenech 2003) 
5.3. CD4+/CD8+ proliferation in response to folate status 
Similar to the evaluation of CD2+ cell proliferation, the addition of 100 nM FA to the growth 
medium resulted in higher cell counts compared to 10 nM FA (Figure VII.3A). Also, as 
previously observed by Courtemanche et al., the CD8+ cells are most affected by the 
difference in FA concentration in the growth medium.(Courtemanche et al. 2004) This is 
reflected by a respective CD4+/CD8+ ratio of 0.69 and 0.48 for 10 and 100 nM FA. However, 
this concentration dependence was not observed when comparing 10 to 100 nM 5MeTHF. 
The calculated CD4+/CD8+ ratios were 0.46 and 0.53 respectively and were both comparable 
to the results obtained when cells were incubated with 100 nM FA (cfr. Table VII.1). 
  CD4+ CD8+ ratio 
CD4+/CD8+ concentration 
[nM] 
average 
cell count 
SD average 
cell count 
SD 
FA 
10 1.49E+07 1.59E+06 2.15E+07 2.44E+06 0.69 
100 2.39E+07 1.06E+06 5.00E+07 1.91E+06 0.48 
5MeTHF 
10 3.50E+07 6.15E+06 7.65E+07 7.64E+06 0.46 
100 3.24E+07 7.21E+06 6.08E+07 4.45E+06 0.53 
Table VII.1: Cell count and ratio of CD4+ and CD8+ cells following 9 days of incubation in response to varying 
folate levels. SD: standard deviation 
One explanation for this phenomenon is that the cells’ ability to use FA as an in vitro folate 
source depends on the activity of specific folate carriers (proton coupled folate transporter) 
and reducing enzymes (dihydrofolate reductase)(Shane 2010), respectively capable of 
transferring FA to the cytosol and reducing it to THF. 
The increased amount of cells per sample provided clearer data concerning the evaluation of 
intracellular folate concentrations, of which the results are depicted in Figure VII.3B. For 
cells incubated with FA, similar results were obtained when compared to the analysis of 
CD2+ cells. Here, some 5MeTHF could be quantified in cells exposed to 10 nM FA, while 
folate concentrations were much higher in cells exposed to 100 nM FA. Strikingly, the folate 
concentration is substantially higher in CD8+ cells compared to CD4+ cells. However, the 
levels in cells exposed to 10 nM FA are too low to make a sound conclusion. Also, in CD8+ 
cells exposed to 100 nM FA, FA was present at quantifiable levels while this folate species 
does not participate in folate metabolism. 
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As can be seen in Figure VII.3B, when 5MeTHF is used as a folate source in the growth 
medium, the intracellular concentration is directly related to the extracellular concentration 
for both the CD4+ and CD8+ cells. There is, however, no appreciative difference between 
CD4+ and CD8+ cells at each respective 5MeTHF concentration level. While THF 
concentrations also increase when the 5MeTHF concentration in the medium is increased, the 
bulk of the concentration increase can be attributed to 5MeTHF.  
 
 
Figure VII.3: A: Total CD4+ and CD8+ cell count (n=2) and B: Measured intracellular folate 
species following 9 days of incubation with varying folate content in the growth medium 
(n=1). 
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VII.6. Conclusion 
We were able to successfully replicate the results obtained by Courtemanche et al., by using 
FA as a folate source during incubation. However, we provide evidence that the obtained 
results depend on the folate species that is used. The use of FA in cell cultures is easy because 
of its stability and its lower cost compared to 5MeTHF. However, if the carrier proteins or 
metabolic enzymes are not or inadequately expressed or if they present a rate limiting step, 
the results of the study will be influenced by the folate species used during incubation. 
While 5MeTHF is the main circulating folate species in vivo, its chemical instability poses a 
problem in in vitro experimentation. While not perfect, periodic addition of 5MeTHF to the 
growth medium can help to stabilize the 5MeTHF concentration. By replacing the degraded 
5MeTHF on a daily basis, we were able to show that the relationship between the 
proliferation rate of CD8+ versus CD4+ cells and the folate status, might not be as dramatic 
as reported by other authors. 
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VIII.1. Abstract 
Increasing the activity of the folylpolyglutamate synthase enzyme in a plant may result in the 
presence of a larger folate storage pool, which may increase folate stability during storage of 
folate-biofortified rice. Determination of polyglutamylation is typically done in an indirect 
manner, via the quantification of free monoglutamates on the one hand and total folate on the 
other, the latter following enzymatic hydrolysis of polyglutamates to monoglutamates. From 
the difference between these measurements, the % polyglutamylated folate can be derived. 
However, due to analytical and biological variation, the degree of polyglutamylation cannot 
always be determined with adequate statistical confidence. In addition, another research 
question is equally relevant: to what extent are these folates polyglutamylated, i.e. what is the 
length of the polyglutamate chain? 
To investigate the feasibility of setting up a method to quantify individual polyglutamates in 
rice, we developed a method for 5-methyltetrahydropteroylpolyglutamates since this is the 
major folate species in genetically engineered rice. The sample treatment procedure used for 
the determination of free and total folate concentrations was evaluated to check for potential 
hydrolysis of polyglutamates by native γ-glutamylhydrolase enzyme released during sample 
homogenization. 
Since not all polyglutamate standard materials are commercially available, some require in-
house synthesis and verification of the final concentration in the obtained standard solution. 
By modifying an existing method, involving chemical reduction and methylation of 
commercially available pteroylpolyglutamates, the conversion yield was increased. 
Overall, the method can be used for to compare the degree of polyglutamylation between 
different rice samples. (e.g. to determine the success of genetic engineering). However, 
method validation was not possible as a result of difficulties verifying the concentration of the 
standard solutions.  
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VIII.2. Introduction 
Folates do not only differ in oxidation state and the presence of covalently bound substituents, 
they also differ in length of the glutamate tail, ranging from monoglutamate to octaglutamate 
species or even longer. Folate polyglutamylation serves a dual purpose. While this process is 
responsible for the retention of folates within the cells and restricting inter-organellar 
movement (Matherly and Goldman 2003), it also increases the affinity for folate-dependent 
enzymes.(Ravanel et al. 2004) Given that folate polyglutamates serve as a storage pool, 
increased polyglutamylation might result in a higher total folate content in the plant material 
and a reduced folate loss during storage.(Blancquaert et al. 2010; Blancquaert et al. 2014) As 
such, one possible strategy to further increase folate concentrations and augment stability 
during storage is to increase polyglutamylation by overexpressing the folylpolylutamate 
synthetase (FPGS) enzyme in rice. In Arabidopsis, folate polyglutamates are formed by the 
action of the FPGS isozymes that are specified by three genes, FPGS1, 2 and 3, which 
reportedly encode plasmidic, mitochondrial and cytosolic isoforms, respectively.(Mehrshahi 
et al. 2010) The folate polyglutamate stores can in turn be released through the action of the γ-
glutamyl hydrolase (GGH) enzyme. This vacuolar enzyme is able to remove glutamate units 
and, together with FPGS, is involved in plant folate homeostasis.(Akhtar et al. 2010) 
For the determination of folate polyglutamylation, several possible strategies exist. Basic 
determination of the degree of polyglutamylation is possible by analyzing the folate content in 
2 (sub)samples. One sample is treated with folate conjugase, to hydrolyze the polyglutamate 
tail to the corresponding monoglutamate form, allowing measurement of total folate. The 
other sample is not treated with conjugase enzyme, allowing measurement of free 
monoglutamates. The difference between the amount of folate monoglutamates in treated and 
untreated samples is a measure for the degree of polyglutamylation.(De Brouwer et al. 2010) 
Alternatively, by performing acid hydrolysis, the folate polyglutamates can be split into a 
pterin and a pABA-(poly)glutamate moiety. These pABA-glutamates can then be determined 
by either LC-MS, LC coupled to electrochemical detection or GC-MS analysis. Using such a 
method, it is possible to quantify different glutamate chain lengths present in the sample, 
though information per folate species is lost. (Shane 1982; Santhoshkumar et al. 1995; Bagley 
and Selhub 2000) In 2001 Ndaw et al. published an alternative method for the analysis of 
folate polyglutamates, applying a precolumn conversion of all folates present to 
5MeTHPGlun, with varying polyglutamylation. While limiting the need for a full spectrum of 
reference standards, this approach also enables the use of fluorescence detection.(Ndaw et al. 
2001) In 2010 Wang et al. omitted the precolumn conversion and measured native 
5MeTHPGlun using LC-MS/MS to investigate the inhibition of GGH during sample 
extraction of vegetables.(Wang et al. 2010) Other methods have been developed to quantify 
individual folate mono- and polyglutamate species simultaneously. In the method by van 
Haandel et al., extrapolated MS settings and response factors are used to obtain a 
semiquantitative folate profile for individual folate species with varying degree of 
polyglutamylation since not all are commercially available.(van Haandel et al. 2012) As such, 
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different approaches are available from literature to assess or quantify the degree of 
polyglutamylation. However, the method of choice depends on the availability of sample 
material, equipment and the desired result. 
VIII.3. Objectives 
While an available method for the quantification of free and total folates in rice allowed to 
derive general polyglutamate data, we investigated here to what extent this method could be 
adapted for quantitation of individual polyglutamates of 5MeTHF. To achieve this, several 
key objectives needed to be achieved. 
First, the required pure reference standards needed to be obtained or synthesized if 
commercially unavailable. Next, the adaptability of the LC-MS method for monoglutamate 
analysis to polyglutamate analysis was investigated. Finally, the sample preparation method 
should be appropriate and able to prevent hydrolysis of glutamate units during all preparation 
steps. Given that 5MeTHF is the major folate species in biofortified rice, polyglutamates of 
this folate species were selected to limit the complexity of method development. 
VIII.4. Materials and methods 
Whenever possible, all experiments were carried out under subdued light and in glassware for 
light sensitive samples. All water used was prepared using a Synergy-UV purification system 
(H2O-MQ, Merck-Millipore, Darmstadt, Germany). 
4.1. Preparation of reference materials 
While 5MeTHF mono- to tetraglutamates (5MeTHPteGlu1-4) were available from Schircks 
Laboratories (Jona, Switzerland), larger polyglutamates were not and required in-house 
synthesis. As a basis, pteroylpenta-, hexa- and octaglutamate (PteGlu5,6 and 8) could be 
obtained from Shircks Laboratories. Sodiumborohydride was obtained from Acros Organics 
(Geel, Belgium). L-Ascorbic acid and formaldehyde 37% were from Sigma-Aldrich 
(Schnelldorf, Germany). Ammonium acetate and 5N sodium hydroxide were obtained from 
Merck KGaA (Darmstadt, Germany). 
To obtain the corresponding 5MeTHPteGlun species from PteGlun, a procedure described by 
Ndaw et al. and adapted by Wang et al. was used, though with some key 
modifications.(Ndaw et al. 2001; Wang et al. 2010) To reduce cost, this procedure was 
optimized using FA monoglutamate. The different steps of this procedure are presented 
graphically in Figure VIII.1. 
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2 mg PteGlu
n 
+ 1 ml of reducing buffer* 
+ 4 ml of NaBH
4
 (3.2 M; 75 mM NaOH; 0 °C) 
20 minutes incubation at room temperature 
+ 2x 750 µl 5M acetic acid → pH 7.4 
+ 60 µl of 37% formaldehyde 
shaking for 1 minute 
+ 4 ml of NaBH
4
 (3.2 M; 75mM NaOH; 0 °C) 
40 minutes incubation at room temperature 
+ 15 ml reducing buffer* → pH 7.4 
adapted procedure procedure by Wang et al. 
2 mg PteGlu
n 
+ 1 ml of reducing buffer* 
+ 4 ml of NaBH
4
 (3.2M in H
2
O) 
10 minutes incubation at room temperature 
→ pH 7.4 with 5M acetic acid  
+ 30 µl of 37% formaldehyde 
shaking for 30 seconds 
+ 4 ml of NaBH
4
 (3.2M in H
2
O) 
20 minutes incubation at room temperature 
to 25 ml with reducing buffer* 
Figure VIII.1: Schematic representation of the procedure to prepare 5MeTHPGlun from PteGlun based on the 
procedure published by Wang et al. 2010. *reducing buffer: 0.1 M ammonium acetate, 1% ascorbic acid,  
pH= 7.9. 
Chapter VIII: Folate polyglutamate analysis 
 
166 
 
The final procedure was successful in converting FA to 5MeTHF and was also successfully 
used to convert PteGlu5,6 and 8 to 5MeTHPteGlu5,6 and 8, respectively. First, 2 mg of standard 
powder was weighed and transferred to a 30 ml brown glass bottle. Next, 1 ml of reducing 
buffer (0.1 M ammonium acetate, 1% ascorbic acid, pH= 7.9) was added and the folate 
powder was dissolved. 1.2 grams of NaBH4 powder was weighed and transferred to a similar 
glass bottle. To this, 10 ml of 75 mM NaOH was added and the crystals were dissolved. This 
solution was kept on ice while capped less than hand tight. 5 M acetic acid was prepared by 
diluting pure acetic acid obtained from Merck. Under a fume hood, 4 ml of NaBH4 solution 
was added to the standard solution, mixed and allowed to stand for 20 minutes at room 
temperature. To halt the reaction, 1.5 ml of 5M acetic acid was added in two aliquots to avoid 
the solution bubbling over. As hydrogen gas was escaping, ignition sources were kept well 
clear. When the reaction had stopped, the pH was adjusted to 7.4. Then, 60 µl of 37% 
formaldehyde was added, the bottle was capped and shaken for 1 minute. Next, another 4 ml 
of the alkaline NaBH4 solution was added and left uncapped for 40 minutes at room 
temperature. To halt the reaction, 15 ml of reducing buffer was added and the pH was adjusted 
to 7.4 using 5 M acetic acid. To remove the solid sodium metaborate (NaBO2) formed during 
the reaction, the solution was filtered using a 0.22 µm syringe filter prior to aliquoting and 
storage at -80 °C. 
4.2. Enzyme preparation 
Enzymes α-amylase (Type Ia, 700-1400 U/mg protein; E.C. 3.2.1.1) and protease type XIV 
(>3.5 U/mg; E.C. 3.4.24.31) were purchased from Sigma Aldrich (Diegem, Belgium). The 
protease powder was dissolved at a concentration of 5 mg/ml in deionized water. As a source 
of γ-glutamylhydrolase enzyme (GGH; E.C. 3.4.19.9), non-sterile, non-hemolyzed rat serum 
was obtained from Harlan Laboratories (Horst, The Netherlands). Both the protease solution 
and the rat serum were stirred on ice for 1 hour with 100 mg/ml of activated charcoal (Sigma-
Aldrich) to remove endogenous folates.(De Brouwer et al. 2008) Following removal of the 
activated charcoal by centrifugation at 4500 g for 15 minutes at 4 °C, the solutions were 
filtered over a 0.45 µm syringe filter (CA-S 30/0.45, Whatman, GE Healthcare, Little 
Chalfont, UK), divided into aliquots and frozen at -20 °C. 
4.3. Chromatographic separation and detection 
4.3.1. HPLC separation of folate polyglutamates to evaluate standard purity 
The final method to evaluate the purity of the reference standard concentrations consisted of 
HPLC-UV analysis using an Agilent Zorbax Eclipse XDB-C8 (150x4.6 mm; 5 µm, Santa 
Clara, CA, USA) column and a LaChrom HPLC system from Merck Hitachi (Tokyo, Japan) 
with a binary pump (type L-7100), autosampler (type L-7200) and interface module (type D-
7000). The detector was a DAD-detector also from Merck Hitachi (type LaChrom L-7455). 
The mobile phase consisted of 0.1% formic acid in H2O-MQ and acetonitrile at a flow rate of 
1.0 ml/minute and a column temperature of 40°C. The injection volume was 50 µl. Gradient 
elution was performed as described in Table VIII.1. UV detection was performed at a 
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wavelength of 290 nm, a slit width of 2 nm and a spectral interval of 200 ms. Peak smoothing 
was switched off while auto zero was performed at injection. All polyglutamates had retention 
times between 6.3 and 6.6 minutes while ascorbic acid formed part of the solvent peak. 
Table VIII.1: Gradient elution settings for HPLC-UV determination of folate polyglutamates 
4.3.2. UHPLC separation of folate polyglutamates 
Quantitation of folate polyglutamates was performed using a Waters Acquity UPLC
®
-system 
equipped with binary pump, refrigerated autosampler and column oven. To assure 
compatibility with the analysis of folate monoglutamates in rice samples, the same column 
(Waters HSS T3
®
, Milford, MA, USA) was used as for monoglutamate analysis. Mobile 
phases composed of 0.1% MS-grade formic acid in H2O-MQ and LC-MS-grade acetonitrile 
(Sigma-Aldrich, Saint Louis, MI, USA and Biosolve, Valkenswaard, The Netherlands) were 
used at a flow rate of 0.6 ml/minute and a column temperature of 60°C. A sample volume of 
10 µl was injected on the column. Following injection, respectively 600 and 800 µl of strong 
(10/90 v/v% H2O-MQ/ACN) and weak wash solvent (90/10 v/v% H2O-MQ/ACN) were used 
to rinse the needle and prevent carry-over. Samples were stored in an autosampler at 4 °C. 
Once optimized, gradient elution was performed as described in Table VIII.2. 
Table VIII.2: Mobile phase composition of the optimized HSS T3
®
method 
4.3.3. Mass spectrometric detection of folate polyglutamates 
The API 4000TM triple quadrupole mass spectrometer was used as detector for UHPLC 
polyglutamate analysis. The obtained and prepared reference standards were infused at a 
concentration of 1 µg/ml in 50/50 v/v% H2O/ACN with 0.1% formic acid. From these 
experiments, quantifier and qualifier ions were selected and the source parameters were 
optimized by injecting a 1 µg/ml mix of all polyglutamates using flow injection analysis at 
600 µl/min of 90/10 v/v% H2O/ACN with 0.1% formic acid. The solvent composition of the 
injected sample was the same as that of the mobile phase. The obtained settings can be found 
in Table VIII.3. As 5MeTHPteGlu7 was not used for early method development, the 
parameters for this compound were extrapolated from the parameters obtained for 
5MeTHPteGlu6 and 5MeTHPteGlu8. 
  
time [min] 0 1.5 4 5 6.5 6.6 9 
% H2O 0.1% HCOOH 95 87 85 5 5 95 95 
% ACN 0.1% HCOOH 5 13 15 95 95 5 5 
time [min] 0 0.5 3 5 5.05 6 6.05 9 
% H2O 0.1% HCOOH 98 98 95 89 5 5 98 98 
% ACN 0.1% HCOOH 2 2 5 11 95 95 2 2 
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component parameters 
component  Q1 [amu] Q3 [amu] DP [V] EP [V] CE [V] CXP [V] 
5MeTHFPteGlu1 460 
313 
180 
42 
10 30 8 
11 52 6 
internal standard 465 313 42 10 31 8 
5MeTHFPteGlu2 589 
313 
180 
66 
10 30 4 
10 64 4 
5MeTHFPteGlu3 718 72 
11 46 8 
10 82 4 
5MeTHFPteGlu4 847 84 
10 50 4 
11 90 4 
5MeTHFPteGlu5 976 96 
10 62 4 
10 106 4 
5MeTHFPteGlu6 1105 96 
10 70 4 
10 114 4 
5MeTHFPteGlu7 1234 97 
10 82 4 
10 123 4 
5MeTHFPteGlu8 1363 98 
11 92 4 
13 122 4 
source parameters 
collision gas setting 12 
curtain gas setting 10 
gas 1 [psig] 80 
gas 2 [psig] 90 
ion spray voltage [V] 2700 
source temperature [°C] 600 
Table VIII.3: Mass spectrometer settings, quantifier ion is indicated in bold, DP: declustering 
potential; EP: entrance potential; CE: collision energy; CXP: collision cell exit potential; V: volt. 
4.4. Sample preparation 
To analyze the 5MeTHPteGlun content in rice samples, 1.5 ml of 50 mM Na3PO4, 10 g/l 
ascorbic acid and 5 g/l DL-dithiothreitol (pH 7.4) including 20 ng/ml of 
13
C5-5MeTHF as 
internal standard was added to 200 mg of rice grains. Heat treatment for 10 minutes at 99 °C 
and 650 rpm softened the rice grains prior to homogenization for 60 minutes at 30 Hz. 
(Retsch MM 301 ball mill, Retsch GmbH, Haan, Germany). After cooling on ice and removal 
of the milling ball, 20 µl of α-amylase was added and the sample was incubated for 10 
minutes at room temperature. Next, 150 µl of protease solution was added and samples were 
incubated for 60 minutes at 37 °C. To denature the protease, the samples were subjected to 
heat denaturation in a heating block/shaker for 10 minutes at 99 °C and 650 rpm. Samples 
were subsequently cooled on ice and divided into two aliquots of 700 µl each, either for free 
or total folate analysis. Two hundred µl of water was added to the first sample and 200 µl of 
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charcoal-stripped rat serum was added to the second sample as a source of conjugase, 
converting poly- to monoglutamates. Both were incubated for 2 hours at 37°C. Finally, heat 
treatment for 10 minutes at 99 °C and 650 rpm, followed by cooling on ice was performed 
and 500 µl was transferred to 3kDa cut-off ultrafiltration tubes (Merck-Millipore, Darmstadt, 
Germany). For LC-MS/MS analysis, 150 µl of filtrate was transferred to inserts while any 
surplus was used to prepare a 20-fold dilution in IS-phosphate buffer to prepare the 
calibration curve. The calibration curves used consisted of serially diluted 5MeTHPteGlun 
mixtures ranging from 0.2 ng/ml to 6.25 µg/ml. Following the analysis of monoglutamates in 
conjugase treated and untreated samples, the samples not treated with conjugase were re-
injected for individual polyglutamate quantitation. 
VIII.5. Results and discussion 
5.1. Preparation of reference materials 
We set off by evaluating the procedure described by Wang et al. for the quantification of 
5MeTHPGlun. This revealed that approximately 10% of THF remained, when quantifying the 
reaction product with the LC-MS/MS method for folate monoglutamate determination 
following deconjugation with rat serum. This result suggested that treatment with 
formaldehyde to add the methyl function to THF was inadequate. This was resolved by 
doubling the amount of formaldehyde and doubling the incubation time. Any remaining 
formaldehyde is later reduced to methanol by the addition of NaBH4. This adaptation 
increased the formation of 5MeTHPteGlun to 99%. 
The use of NaBH4 in this reaction is problematic due to the very limited stability of this 
reagent in aqueous solutions. NaBH4 reacts with water to form NaBO2 and hydrogen gas. As 
such, extreme care should be taken that any and all ignition sources are removed from the 
fume hood when performing this procedure. Containers should also be loosely capped to 
avoid pressure build-up. However, the decomposition of NaBH4 can be slowed down by 
increasing the pH as can be seen in Table VIII.4. 
pH NaBH4 half life 
4.0 0.0037 sec 
5.0 0.037 sec 
6.0 0.37 sec 
7.0 3.7 sec 
8.0 36.8 sec 
9.0 6.1 min 
10.0 61.4 min 
11.0 10.2 hours 
12.0 4.3 days 
13.0 42.6 days 
14.0 426.2 days 
Hydrolysis of NaBH4 in aqueous solution: 
NaBH4 + 2H2O → 4 H2 + NaBO2 
Table VIII.4: Stability of aqueous NaBH4 solutions, data provided by the Applied Nano Bioscience 
Centre at Arizona State University 
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Due to the reactivity of NaBH4, half of this reagent will be lost in about 30 seconds when 
dissolved in water at neutral pH. As such, the working solution of NaBH4 (3.2 M) was 
prepared in a 75 mM solution of NaOH. However, this increases the theoretical pH during the 
reaction from 7.9 to 10.17. Since this was likely to slow down the reduction of PteGlun and 
5,10CH2THPteGlun, the incubation time was doubled. The decrease in reactivity was likely 
countered by the increased stability of the NaBH4 working solution, since evaluation of the 
reduction steps revealed nearly complete (>99%) formation of the reaction product. 
Wang et al. used spectrophotometric and LC-UV analysis to verify the final concentration in 
the solution, relying on the fact that the chromophore group is the same in both mono- and 
polyglutamates and that the length of the polyglutamate tail would not influence the molar 
absorption coefficient.(Wang et al. 2010) However, spectrophotometric detection is hindered 
by the overlapping spectra of 5MeTHPGlun and L-ascorbic acid. Therefore, either L-ascorbic 
acid should be removed from the reaction medium, thereby risking oxidation of the reduced 
folates, or chromatographic separation of L-ascorbic acid and folates should be performed. 
Since ascorbic acid could not be omitted from the reaction medium due to the oxidative 
sensitivity of folates, spectrophotometric determination was deemed not suitable. 
Consequently, LC-UV analysis was used to evaluate standard purity.  
5.2. Chromatographic separation and detection 
5.2.1. HPLC separation of folate polyglutamates to evaluate standard purity 
For purity evaluation of polyglutamates using ultraviolet and/or fluorescence detection on an 
HPLC system, a lower pressure column was needed. The BEH C18 (50 x 2.1 mm; 1.7 µm, 
Waters) and Purospher Star RP18e (150 x 4.6 mm; 5 µm, Merck KGaA) columns gave poor 
retention and peak shape and were not retained for further optimization. While the 
Lichrospher 100 (125 x 4.6 mm; 5 µm, Merck KGaA) provided a good separation, though not 
baseline, peak width was very large. The Zorbax Eclipse XDB-C8 (150 x 4.6 mm; 5 µm, 
Agilent) provided good retention and peak shape and was therefore used for UV control of 
standard concentration. A sample chromatogram can be seen in Figure VIII.2. 
This method was verified using the commercially available 5MeTHPGlu2-4. However, a 
significant discrepancy was observed between the calculated and theoretical concentration. 
Personal communication with Dr. C. M. Pfeiffer and Dr. Z. Fazili of the Centers for Disease 
Control and Prevention (Atlanta, GA, USA), revealed that the reference materials in 
powdered form, obtained from Schircks Laboratories, may contain an unknown amount of 
water, which may account for the difference in results observed during LC-UV evaluation of 
the standard concentration. Then, the actual concentration, determined using 
spectrophotometry in the absence of ascorbic acid, can be used to evaluate the performance of 
the LC-UV verification method. 
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Figure VIII.2: UV chromatogram of 5MeTHPteGlu6 
5.2.2. UHPLC separation of folate polyglutamates 
Given the availability of an optimized method for the analysis of folate monoglutamates, we 
attempted to maintain the column and mobile phase of this method and adapt the parameters 
for polyglutamate analysis. 
 
Figure VIII.3: Chromatogram showing 5MeTHPteGlu1,2,3,4&6 using the method of De Brouwer et al (2008). 
The HSS T3 column is able to retain the different polyglutamate species using the existing 
mobile phase. However, using the elution program developed by De Brouwer et al.(2008), 
significant peak overlap was observed (Figure VIII.3). Since there is approximately 1% cross-
talk of larger polyglutamates towards smaller analytes, chromatographic separation is 
5MeTHPGlu6 
ascorbic acid 
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important to achieve acceptable selectivity. However, some tailing was observed, with peak 
shape deteriorating as polyglutamate length increased. This decreases method sensitivity. 
By altering the gradient elution scheme, the different polyglutamate species could be further 
separated, though baseline separation was not possible, especially for 5MeTHPteGlu1 and 
5MeTHPteGlu2. In this case, the cross-talk effect will result in an additional signal for 
5MeTHPteGlu1 originating from 5MeTHPteGlu2-ions. As such, the evaluation of cross talk 
requires extra attention during method validation. Chromatograms for a standard mix, rice and 
red blood cell (RBC) sample are provided in Figure VIII.4. 
5.2.3. Mass spectrometric detection of folate polyglutamates 
From the mass spectrometric settings specified in Table VIII.3 it is clear that the declustering 
potential (DP) reaches its maximal settings for ions larger than tetraglutamates. This voltage 
is applied to prevent the ions from clustering together. As such, it is possible that cluster 
formation of larger polyglutamates exceeds the capacity of the ion source, leading to low 
sensitivity. This problem should be remediated to achieve the lowest possible quantitation 
limit required for polyglutamate analysis in samples with a low degree of folate 
polyglutamylation. 
5.3. Sample preparation 
Wang et al. found that the release of GGH-enzymes during sample homogenization caused 
the deconjugation of polyglutamates prior to LC-MS analysis. These authors proposed a 
steaming step prior to homogenization to denature the GGH-enzymes and preserve the 
polyglutamates during homogenization.(Wang et al. 2010) In line with this, the boiling step 
performed prior to homogenization can serve as a means to denature the GGH-enzymes and 
preserve the folate polyglutamylation in the sample.(De Brouwer et al. 2008) This was 
verified by adding 5MeTHPteGlu2-6 to wild type rice samples prior to and after sample 
preparation. No indication of deglutamylation was observed. 
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Figure VIII.4: Chromatograms obtained using the optimized T3 method for (A) a standard solution with a 
concentration of 2 µg/ml per species; (B) a folate rice sample with respective concentrations of 459.9, 4.3, 
1.5, 0.9 µg/100g for 5MeTHFPteGlu1 to4, all others <lower limit of quantification; (C) a red blood cell 
extract 
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VIII.6. Conclusion 
Accurate quantitation of individual polyglutamates was not possible due to the lack of 
standards with accurate concentrations. As a result of an observed difference between the 
measured and theoretical concentration for the commercially available 5MeTHPteGlu2-4, the 
LC-UV procedure proved unreliable and should be evaluated further based on purity data for 
the commercially available 5MeTHPteGlu2-4. 5MeTHPteGlu5-8 can be reproducibly prepared 
using the adapted method described in this chapter. However, to use the obtained solutions for 
calibration, the actual concentration should also be reliably determined using the LC-UV 
method. 
Further optimization of the LC-MS/MS procedure could be possible if cluster formation 
during ionization can be prevented. This phenomenon limits the sensitivity of the method for 
folates with larger polyglutamate-tail length. Since the degree of polyglutamylation in rice is 
limited, utmost sensitivity is required to compare different rice varieties. Yet, when sufficient 
material is available, comparative profiling may be achieved. 
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IX.1. Achievements of this PhD project 
The prime achievement of this PhD project lies in the demonstration of the biological 
effectiveness of folate rice following its consumption, using an animal model. To achieve this 
aim, also tools needed to be developed that allow the determination of folates in rodent diets, 
as well as in red blood cells and plasma. These tools, as well as other achievements of this 
thesis, are relevant for future development in the field of folate research. 
1.1. Determination of folates in rodent diets 
While methods for the quantitative determination of folates in several different food matrices 
existed, no method had been developed to measure individual folate species in rodent diets. 
Though these diets are commonly used for folate research purposes, the supplier generally 
only mentions the amount of folic acid (FA) added to the diet. However, when we applied our 
method to folate deficient diets, we observed that these contained an amount of natural folates 
originating from various feed ingredients. As such, the development of a method for folate 
determination provides a tool for future researchers to also account for folate intake from the 
rodent feed.(Chapter IV, Kiekens et al. 2015a) 
1.2. Determination of folates in plasma and RBCs 
While microbiologic or protein binding assays are widely used for the determination of 
clinical folate status, emerging LC-MS/MS assays provide an orthogonal determination 
strategy focusing on exact chemical determination instead of biological activity. While the 
microbiologic assay currently remains the gold standard method for the determination of 
biologically active folates, the protein binding assay is susceptible to differences between the 
folate species present in the sample and the species, mostly FA, used for assay 
calibration.(Pfeiffer et al. 2004)  
The accuracy and precision obtained using LC-MS/MS and the possibility to quantify 
individual folate species has led to an increased interest to implement this technology for 
clinical folate research. The implementation of this technique in a routine clinical laboratory 
will depend on the automation of the sample preparation steps and the availability of LC-
MS/MS equipment. Due to the ease of the assay and possible automation, protein binding 
assays are currently used most to determine the amount of folates in patient samples. 
Comparability of analytical results with other labs is not a major concern for the clinician 
since the use of reference intervals specific for the assay will suffice to distinguish folate 
deficient patients from those with an adequate folate status. For scientific research purposes, 
however, method comparability is necessary to compare findings with those obtained by other 
research groups and as such, LC-MS/MS is the method of choice in folate research.  
Whole blood or red blood cell folate analysis is not yet regularly performed for the 
determination of long term folate status over the lifetime of the RBCs, i.e. approximately 3 
months. This measurement is not influenced by recent folate intake so, contrary to plasma or 
serum folate determination, a fasting period is not strictly necessary. 
Since plasma and red blood cell folate concentrations provide complementary information, 
respectively for acute and chronic folate deficiency, we opted to develop a method to analyze 
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both using a very comparable sample treatment procedure to limit the use of resources, i.e. 
time, equipment and reagents.(Chapter V, Kiekens et al. 2015b) If routine clinical analysis 
using an LC-MS/MS assay is considered, such an approach should make a cost effective 
procedure achievable. To evaluate our method for clinical folate determination, we 
successfully participated in a round-robin test organized by Fazili and Pfeiffer of the Centers 
for Disease Control in Atlanta, GA, USA. These results should be published soon.   
1.3. Folate rice feeding trial 
Since the folates in folate rice originate from genetic manipulations of the rice genome, 
resulting in supraphysiological accumulation of folates within the rice grain, it is clear that 
sound scientific evidence must be provided to prove the usefulness of folate rice as a source 
of dietary folate. Recently, Castorena-Torres et al. investigated the relationship between 
feeding of a folate-biofortified tomato variety on folate status using a murine model. These 
authors chose to apply an area under the curve approach. Following a single intake of folates, 
the area under the plasma response curve was used to calculate the degree to which the folates 
in this biofortified tomato are bioavailable.(Castorena-Torres et al. 2014) Apart from this 
study, no other study had evaluated the impact of folate-biofortified food on folate status. 
We chose a different approach due to the complex nature of folate metabolism in vivo and the 
absence of a zero folate level at the start of the experiment. In contrast to the study on 
biofortified tomato, we performed a long term feeding study to allow for the necessary time to 
reach steady-state levels, indicating the ability of folates in folate rice to maintain a certain 
folate status. More particularly, the blood folate concentrations measured during and at the 
end of our feeding trial provided the information needed to evaluate the efficacy of folate rice 
as a source of dietary folate. As folate metabolism is intertwined with various other metabolic 
cycles, we also monitored other metabolic indicators, i.e. homocysteine and the hematological 
indices of erythropoiesis. (Chapter VI, Kiekens et al. 2015c) 
With this long term study in rodents we have demonstrated that the folates from folate rice 
can be released (i.e. are bio-accessible), are bioavailable (i.e. result in increased folate levels) 
and have biological effects. 
1.4. Lymphocytes and folate status 
This study was ignited by a publication of Courtemanche et al. These authors hypothesized 
that if folate deficiency impairs the proliferation of CD8+ T-cells, it could impair the capacity 
of CD8 cells to eliminate infected or tumor cells. Although these authors found a different 
response between lymphocyte subsets, more research was needed, as readily indicated by 
these authors, to investigate the underlying reason for this difference. (Courtemanche et al. 
2010) 
Besides replicating the experimental set-up performed by Courtemanche et al. (using FA), we 
also used 5-methyltetrahydrofolate (5MeTHF), ubiquitously present in vivo, as a folate source 
in the growth medium of isolated immune cells. The addition of this folate species on a daily 
basis to replace the amount lost due to degradation shows that it is possible to perform in vitro 
experiments using 5MeTHF as a folate source. 
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We were able to demonstrate that there is a concentration dependence between the intra- and 
extracellular folate concentration and that cell replication is likely to be less dependent on 
folate status than was concluded by Courtemanche et al. 
1.5. Folate polyglutamate determination 
The classical approach to determine the degree of polyglutamylation of folates in rice samples 
is not able to discriminate between folates with a different number of glutamate units.(De 
Brouwer et al. 2010) To precisely evaluate the effect an increased expression of folate 
polyglutamate synthase enzyme (FPGS) has on polyglutamate content, a new method was 
developed to quantify individual folate polyglutamate species. 
Folate polyglutamylation is a possible factor influencing both folate stability in the food item 
and bioavailability following consumption. Therefore, a method which allows to quantify 
individual folate polyglutamate species is useful to investigate the effect of this factor on 
stability and bioavailability. 
IX.2. GMO’s in Europe and throughout the world 
In the European Union, the view towards the use of genetically modified organisms, 
commonly known under the acronym GMO’s, is rather negative. However, in the United 
States and China, genetically engineered crops are common. Local GMO legislation tends to 
reflect the acceptance of the general public of crops which contain genes that would not be 
present by natural processes. 
2.1. European policies on GMO’s 
The European Food Safety Authority uses the following definition to describe GMO’s: 
“In recent times, it has become possible to modify the genetic make-up of living cells and 
organisms using techniques of modern biotechnology called gene technology. The genetic 
material is modified artificially to give it a new property (e.g. a plant's resistance to a disease, 
insect or drought, a plant's tolerance to a herbicide, improving a food's quality or nutritional 
value, increased yield).” 
(European Commission. 2016a) 
At this time, only one genetically engineered crop has been cultivated in the European Union, 
the MON 810 maize variety (Figure IX.1). The cultivation license for this maize variety 
expired in November 2013 and the procedure for renewal is ongoing. By introducing a gene 
from Bacillus thuringiensis, the maize plant produces Bt toxin, which is toxic to butterflies 
and moths, including the European Maize Borer. The caterpillars of these moths chew tunnels 
through the stalks of the plants, causing them to fall over. When Bt Maize is cultivated, the 
Maize Borer Caterpillar dies due to the Bt toxin present in the tissues of the plant. Thus, 
productivity per hectare is increased. However, increasing resistance to Bt toxin is reducing 
the effectiveness of this genetic modification.(Tabashnik et al. 2013) 
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Figure IX.1: MON810 cultivation in the European Union in 2013 (European Parliament Press Service, 2015) 
 
While only one GMO was actually cultivated in the EU, in 2014 57 GMO’s were allowed to 
be imported in the EU. (Vlaams infocentrum land- en tuinbouw, 2014) The genetic 
modifications made to these GMO’s can be found in Table IX.1. Most often, the genetic 
modification consists of an introduced resistance to herbicides or to lepidopteran (moths and 
butterflies) or coleopteran (beetles) species. Some genetic modifications result in male 
sterility and render it impossible for this species to reproduce in the wild. The introduction of 
drought stress resistance allows to grow these plants in arid areas. (European Commission, 
2016b) 
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gene effect plant species 
cp4 epsps herbicide (glyphosate) resistance cotton, maize, 
rape and soybean 
pat herbicide (glufosinate) resistance cotton, maize, 
rape and soybean 
cry2Ab2 lepidopteran pest resistance cotton, maize 
cry1Ac lepidopteran pest resistant cotton, soybean 
2mepsps herbicide (glyphosate) resistance cotton 
cry1F lepidopteran pest resistance maize 
cry1Ab lepidopteran pest resistant maize 
cry34Ab1 coleopteran pest resistant maize 
mepsps herbicide (glyphosate) resistance maize 
cry3Bb1 coleopteran pest resistant maize 
cry1A.105 lepidopteran pest resistant maize 
cry35Ab1 coleopteran pest resistant maize 
cry3A coleopteran pest resistant maize 
cspB drought stress resistant maize 
govx247 glyphosate resistant rape 
barnase & barstar male sterility rape 
gat herbicide (glyphosate) resistance soybean 
gm-hra ALS-inhibiting herbicide resistant soybean 
FAD2-1A (fragment) & 
FAT1-A (fragment) 
increased oleic acid production soybean 
DMO herbicides (dicamba) resistance soybean 
Pj.D6D & Nc.Fed3 stearidonic acid production from linoleic 
acid 
soybean 
glycine max-hra herbicide (acetolactate synthase-
inhibiting) tolerance 
soybean 
acetohydroxyacid synthase herbicide (imidazoline) tolerance soybean 
Table IX.1: genetic modifications authorized for import in the European Union. (European Commission, 2016b) 
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2.2. GMO’s throughout the world 
Worldwide, soy (79% of all cultivated), cotton (70%), maize (32%) and rapeseed (24%) are 
the 4 most important GMO crops (Table IX.1). In Asia, North and South America, GMO’s are 
commonly cultivated. Western Europe, Russia and Africa are more reluctant in adopting 
GMO crops (Figure IX.2). (The International Service for the Acquisition of Agri-biotech 
Applications (ISAAA), 2015) 
 
Figure IX.2: GMO's throughout the world (ISAAA, 2015) 
Commonly heard advantages of GMO’s are the increased food production and the reduced 
use of insect- and herbicides. Concerns are generally based on the (perceived) risk that these 
crops may pose for food safety, where views differ, from “demonstrating that GMO’s are 
safe” to “demonstrating that GMO’s are not unsafe”. Moreover, the use of herbicide- or 
pesticide-resistant crops may allow the use of certain pesticides, which by itself may be a 
point of criticism, as exemplified by a study of Bøhn et al., demonstrating glyphosate 
accumulation (0.4 to 8.8 mg/kg) in a glyphosate resistant soy following application of this 
chemical during the growth process. This poses a concern given that glyphosate is under 
scrutiny for possible carcinogenicity. (Bøhn et al. 2014) As the use of GMO’s continues, 
research is being conducted to investigate the impact of GM crops on human health. Well-
conducted, objective studies are important for public acceptance of GM crops, amongst which 
folate rice. 
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IX.3. Folate rice, a recipe for success! 
3.1. Folate rice and folate status 
In this PhD project we were able to demonstrate that folate rice is able to supply folates to rats 
consuming it. Even though, in absolute amounts, the folate supplementation used in our study 
was minimal because of limitations in available folate rice, the rats remained apparently 
healthy during the long term feeding trial. This was in strong contrast to the animals receiving 
wild type rice. While the latter animals showed clear signs of folate deficiency and some even 
perished during the trial, the animals receiving a supplement in the form of folate rice thrived. 
A similar result was observed for the feeding strategy using FA fortified rice. This shows that 
folate rice is able to provide similar results when compared to traditional fortification 
strategies. (Chapter VI, Kiekens et al. 2015c) 
3.2. Economic aspects of folate rice use 
Apart from the investigation into the biological effect of the consumption of folate rice, the 
economic impact of the introduction of folate rice on a population with a high prevalence of 
folate deficiency has been investigated. De Steur et al. calculated the effect of folate rice 
consumption on the health status in China. While rice consumption is lower in the northern 
regions which are confronted with a high impact of folate deficiency compared to southern 
regions, the required folate intake can still be achieved and a significant reduction of the 
health burden related to folate deficiency is possible. Based on a disability-adjusted life years 
approach, implementing folate rice in China would save 37 to 82% of the health burden 
related to folate deficiency.(De Steur et al. 2010) The results obtained in our rodent study, 
demonstrating the adequacy of folate rice, lend further support to the health claims made by 
De Steur et al. (Chapter VI, Kiekens et al. 2015c) 
However, public perception of bioengineered food items can be negative, which may impact 
public acceptance of folate rice. Public acceptance and willingness-to-pay were investigated 
using a technique of experimental auctions of folate rice. While the nutritional effect of folate 
rice is valued positively by the consumers in the Shanxi province in Northern China, educated 
consumers tend to be more negative towards bioengineered rice. The willingness to pay a 
premium for the perceived higher quality rice demonstrates that genetic engineering is 
accepted by a public in need for folate fortification.(De Steur et al. 2012) 
3.3. Recent developments of folate rice 
The usefulness of folate rice also depends on the stability of the folates present in this 
biofortified rice variety during storage after harvest. From a stability experiment it was 
concluded that approximately 50% of folates were lost following 4 months of storage at 
temperatures of 21 and 28 °C. Only 40% of folates present at the time of harvest were still 
present after 8 months of storage. Also, a generation effect was inferred following analysis of 
rice seeds from different generations of this rice species. While in a rice line (GA9.15), up to 
1700 µg of folates were present per 100 g of fresh weight in the fourth generation, this 
concentration decreased to 700 µg / 100 g fresh weight in the seventh generation.(Blancquaert 
et al. 2015) 
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A possible solution for the stability issue and the generation effect was to increase either the 
degree of folate polyglutamylation, through the increase of folylpolyglutamate synthase 
(FPGS) expression, or to introduce the genes necessary for the expression of folate binding 
protein (FBP) in the rice plant. The increased expression of the FPGS enzyme did not succeed 
in augmenting the degree of polyglutamylation due to a concurrent increase of the γ-
glutamylhydrolase enzyme expression opposing the function of FPGS. The introduction of 
FBP in the rice genome resulted in lines with a higher and more stable folate concentration. 
(Blancquaert et al. 2015) 
IX.4. What the future might bring 
Further biofortification of staple crops might extend the use of these food items to more than 
just a source of energy. By adding different vitamins and nutrients, these functional foods can 
support the health status of the individual consuming it. For instance, by further engineering 
of the rice genome, a rice species could be created with an increased concentration of other B-
vitamins such as thiamin (B1). Also a combination with iron biofortification might prove 
beneficial, especially to counteract anemia. Following this approach, true functional foods 
could be created that provide the consumer with a sufficient nutrient intake, irrespective of the 
food diversity available to this consumer. While, apart from extreme cases, a low nutrient 
status may not be all that significant in a clinical context, an optimal intake of essential 
vitamins should increase the overall health status of the population by optimizing in vivo 
metabolism and biosynthesis. By doing so, many illnesses can be prevented before requiring 
medical attention.  
Though it is unlikely that LC-MS/MS will completely replace the microbiologic and binding 
assays used for clinical folate measurement, these higher order assays will be very useful to 
evaluate the systematic differences between different assays to achieve comparability of assay 
results. Since an evaluation of the folate status of different populations depends on the 
comparability of reference values (not biased by systematic differences), the importance of 
certified reference materials, verified using LC-MS/MS, will only increase. LC-MS/MS is 
definitely required when quantitative information on the individual folate monoglutamate and 
polyglutamate species is needed. As such, it is possible to study the enzymes taking part in 
folate metabolism in greater detail, thus allowing to obtain the most information possible from 
complex experiments. 
Although our understanding of folates as an essential nutrient is rapidly growing, much is still 
to be learned on the actual function of different folate monoglutamate and polyglutamate 
species. For instance, the effect that low folate status has on immune response has not been 
thoroughly investigated. While the use of FA is common practice in folate research, this may 
result in biased results, as FA is not an appropriate folate source for in vitro studies. In this 
thesis, we demonstrated that cells exposed to FA behave differently than cells exposed to 
5MeTHF (Chapter VII). While this is an important finding, our understanding of intracellular 
processes involving folate remains limited. With the gradual and ongoing increase in LC-
MS/MS sensitivity, it should be possible to further characterize intracellular folate 
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metabolism. This could be helpful to relate the cause and onset of certain illnesses to folate 
status. A causal relation between folate status and illnesses remains largely elusive to this day.  
IX.5. Conclusion 
The importance of nutrient intake for an optimal overall health status is gaining interest due to 
the distribution of the knowledge gained following decades of scientific research. While the 
quality of the western diet is improving and fruits and vegetables rich in nutrients are 
promoted by the government, an optimal nutrient status may not easily be achieved. 
Especially prior to and during pregnancy an additional folate intake is necessary to minimize 
the risk for neural tube defects. FA supplementation, either as a pill or as food fortification, 
can provide the additional folate intake needed to achieve an adequate folate status. However, 
not in all parts of the world preventive healthcare or food fortification on an industrial scale is 
available to the general public. In this respect, biofortified folate rice can provide a source of 
dietary folate which can be farmed locally. 
One of the steps towards public acceptance of this genetically modified crop is the proof that 
the folates accumulated within the rice grains are effectively biologically available and that 
folate rice helps to maintain an adequate folate status. Using a rat model and by providing the 
rice on a daily basis during a long term feeding trial with periodic monitoring of short and 
long term folate status and other biological indices, we were able to demonstrate that folate 
rice is able to serve as an adequate source of dietary folate. 
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In this thesis, an in vivo study is described that aimed at investigating the nutritional value of 
folate rice, a bioengineered rice species with an increased folate content compared to wild 
type rice. However, to obtain the data necessary for a complete evaluation of folate status, a 
method for folate determination in small blood samples was developed and validated. Also a 
method to assess the presence of folates in rodent diets was developed to exclude constituents 
of these diets as a confounding factor. 
As described in Chapter IV, the development of a method for the analysis of folates in rodent 
diets proved more challenging than initially expected. The synthetic nature of the rodent diets 
resulted in the release of oils and fats during sample extraction, which complicated the 
manipulation of the samples. Though the separation of these oils and fats using an organic 
water-immiscible solvent was evaluated, it provided no improvement. The pH was of key 
importance for the optimal deconjugation of folate polyglutamates. While a pH of 7.4 is 
optimal for the determination of folates in rice, for rodent diet, the optimal pH was 6.0. As 
such, a pH adjustment was introduced as part of the tri-enzyme treatment. Also, a solid-phase 
extraction (SPE) procedure was introduced to remove interfering peaks and assure method 
selectivity. By opting for an orthogonal separation technique using a strong-anion exchange 
sorbent, the remaining triglycerides could be removed prior to the analysis of the samples 
using a reversed phase analytical column. This method, once fully validated based on the 
guideline of the Food and Drug Administration, was published in the Journal of Agricultural 
and Food Chemistry. 
Similarly, a method for the analysis of folates in plasma and red blood cells (RBCs) was 
developed based on the method for folates in rice. However, an all-new sample preparation 
procedure was needed. The limited amount of whole blood (±300 µl) available from the 
periodic sampling of laboratory animals necessitated the use of one aliquot of whole blood to 
measure both the plasma and the RBC folate. To achieve this, a washing procedure was 
devised. First, the plasma fraction is removed after which the RBCs are washed 3 times and 
then lysed using a selective ammonia-based buffer. The sample clean-up procedure, including 
deconjugation for RBC extracts, protein precipitation and SPE was similar for both matrices. 
This allowed simultaneous analysis of both plasma and RBC samples. To increase sample 
throughput, the SPE-procedure was adapted from a 12-port manifold to a 96-well system. 
This method, as described in Chapter V and published in Journal of Chromatography A, was 
fully validated based on the guidelines for method validation of the European Medicine 
Agency. This method was also used during a collaborative study with C.M. Pfeiffer and Z. 
Fazili of the Centers for Disease Control and Prevention (Atlanta, GA, USA) to assess method 
comparability in the first ever LC-MS/MS based round-robin test for folates (unpublished 
data). 
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To evaluate the bioavailability and biological efficacy of folates from folate rice, a rodent 
study was performed. Devised as a long term feeding trial, the animals received either wild 
type, folate or folic acid fortified rice on a daily basis for a period of 12 weeks (cfr. Chapter 
VI). This allowed for the stabilization of the RBC folate levels and allowed to evaluate the 
efficacy of prolonged folate rice consumption. Also, the rice was provided as intact grains to 
avoid artefacts when the rice grains would be ground to a powder and incorporated in the 
rodent diet. As such, daily rice rations were provided to the animals in porcelain bowls, a 
procedure, though uncommon, that allowed visual confirmation that the entire ration of rice 
was consumed. During the trial, the animals in the negative control group (only receiving a 
folate free diet) and the animals in the wild type rice group (receiving both wild type rice and 
a folate free diet) fared less well than animals in the other groups. Following the death of 
some animals in these affected groups, the remaining animals were euthanized and the 
samples were collected as would be the case later on for the groups with folate supplemented 
diets. At the end of the feeding trial, none of the animals receiving folate rice suffered from 
folate deficiency as evidenced by normal plasma and RBC folate levels, moderate plasma 
homocysteine levels and a normal hematology. As such, we concluded that folate rice as a 
food source is able to provide folates to the organism. 
As can be observed from the results obtained during the feeding trial, 5-
methyltetrahydrofolate (5MeTHF) is the main circulating folate species in the bloodstream 
and not folic acid (FA). However, common understanding of the effect of folate status on the 
functioning of the immune system relies on in vitro studies using FA as a folate source (i.e. 
Courtemanche et al. 2004 J Immunol 173 (5): 3186-3192.). In Chapter VII, we investigated 
the difference in both cell proliferation and intracellular folate concentrations in response to 
differences in folate concentrations and the folate species used as a folate source. Due to the 
limited stability of 5MeTHF during incubation, daily replenishment of this folate species was 
necessary to maintain the desired folate levels during the 9-day incubation period. While the 
observations of Courtemanche et al. could be replicated using FA as a folate source, the 
proliferation of CD2+, CD4+ and CD8+ lymphocytes proved less susceptible to concentration 
differences when 5MeTHF was used as a folate source. 
Finally, the quantitative determination of individual folate polyglutamate species was 
investigated. The chromatography and mass detection described in Chapter VIII was 
optimized for the determination of 5-methyltetrahydropteroylpolyglutamates (5MeTHPGlun). 
Given the lack of commercially available reference standards, the chemical synthesis of these 
compounds was optimized. However, although the confirmation of the standard using an 
HPLC-UV procedure did not match the theoretical concentrations of commercially available 
5MeTHPGlun, it has since been clarified that the commercial folates in powdered form 
contain crystalline water due to their hygroscopic nature. Therefore, this procedure should be 
re-evaluated after measurement of the purity of the commercial polyglutamate standards. 
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As described in this thesis, we demonstrated that folate rice serves as a valuable source of 
dietary folate and that it may have the potential of reducing the prevalence of folate deficiency 
in regions where traditional folic acid fortification is not feasible. While the methods 
described in this thesis were purposely developed for the bioavailability trial, these can be 
used in a wider research context. Especially the method for folate determination in plasma 
and red blood cells provides several improvements over existing methods. 
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